Saturday, December 24, 2005

News - Pigs also at risk if deadly bird flu reaches U.S.

WASHINGTON (Reuters) - If deadly bird flu spreads to the United States, the disease could have a sweeping impact on pig production because the animals are susceptible to the H5N1 disease, according to industry and veterinary experts.

The H5N1 strain of avian influenza is known to have killed more than 70 people. To stop the spread of the disease, some 150 million birds have been destroyed worldwide, mostly in Asia, The virus also has been found in Europe.

No cases of H5N1 have been discovered in humans, chickens, turkeys or migratory birds in the United States.

"Not only do poultry people need to look into increasing their biosecurity, so do the swine (farmers)," said John El-Attrache, a veterinary pathologist with Texas A&M University. "Bird flu can readily infect a swine species and for the most part, go from swine on into humans," he added.

Experts do not believe pigs played a role in spreading H5N1 throughout Asia and eastern Europe. But pigs do have receptors for both avian and mammalian viruses. Some fear pigs could act as a "mixing bowl" -- especially on farms where they coexist with humans and poultry -- creating a new virus that spreads from person to person.

Biosecurity efforts at most U.S. farms already include keeping pigs confined and separate from other animals. Human contact is limited and farm employees are encouraged to get annual flu shots.

A spokeswoman for Hormel Foods Corp., which buys hogs from some 1,500 farmers in the Midwest to make Spam and other meat products, said it has safeguards in place for many diseases including bird flu.

Hormel updated its business and crisis plans for all animal diseases after mad cow was found in the United States in December 2003.

Bird flu is "one of many things we're watching," said Julie Craven, a Hormel spokeswoman. "There is a lot of what could best be described as speculation between how the (H5N1) virus might travel, in between what species and what kind of timeline it's on."

The National Pork Board, which represents the industry and is responsible for the "Pork, the other white meat" slogan, said the bird flu situation in Asia and eastern Europe has sparked discussion among members.

"We have to make sure we're doing everything we can to keep it out of our herds and keep it from spreading to protect our species," said Liz Wagstrom, a veterinarian with the National Pork Board.

In addition to surveillance and routine swine vaccinations, Wagstrom said the industry must be prepared to alert farmers swiftly to impose stricter precautions, if needed.

Hogs and pigs have an annual flu season just like humans, poultry and other species.

The United States is the third largest pork producer in the world behind China and the European Union, according to U.S Agriculture Department figures. In its September hogs and pigs report, USDA said hog and pig inventory in the United States was 61.5 million head, up slightly from a year ago.

The USDA said it is not planning to require any new safety measures among pig farmers due to bird flu.

"We're aware that people worry about H5N1 in hogs... but any safeguarding now would be from the bird standpoint," said Jim Rogers, a spokesman with USDA's Animal and Plant Health Inspection Service.

The Bush administration asked Congress in November for $91 million for the USDA as part of a broader request for $7.1 billion in emergency funding to prepare for a possible bird flu pandemic.

Global Coverage Article | Reuters.co.uk

News - Christmas trees combat bird flu

Your used Christmas tree might save you from a bird flu pandemic.

As governments around the world scramble to stockpile the antiviral Tamiflu, generic drug maker Biolyse Pharma Corp. plans to begin next month making shikimic acid, the main ingredient in the manufacture of oseltamivir, commonly known as Tamiflu, from the needles of discarded Christmas trees.

Tamiflu, as almost everybody knows by now, treats seasonal influenza and is also being championed as a first line of defence against a possible pandemic outbreak of bird flu, which has been devastating chicken populations across Southeast Asia and parts of Europe.

So far, the H5N1 virus, which usually strikes people in close contact with diseased fowl or their droppings, has infected an estimated 130 people, killing 70. The worry is that H5N1 will undergo a genetic mutation with a human seasonal influenza virus, morphing into a deadly strain that could jump between people like the common cold.

After being rejected as a Tamiflu supplier by Swiss drug maker F. Hoffmann-La Roche Ltd., which has a monopoly grip on the manufacture of the drug, Biolyse turned its sights to making shikimik acid.

The reason: the price of shikimik acid has soared to more than $500 (U.S.) a kilogram from $45 in the past 12 months on shortages of Tamiflu and skyrocketing demand.

Biolyse specializes in extracting chemicals from plants and biomaterials at its plant in St. Catharines, Ont., and now makes a generic version of the cancer drug paclitaxel from yew trees.

?Our research has shown that 2-to-3 per cent of the biomass from various pine, spruce and fir trees is extractible shikimic acid,? Biolyse principal Claude Mercure said yesterday.

As the process moves to the commercial stage from the laboratory, he said the company is aiming to eventually produce one-to-three tons of shikimic acid a month.

To get started, next month it will receive some 500,000 Christmas trees to be donated by Toronto-based Gro-Bark, a forestry recycling company.

Most shikimic acid is now extracted from star anise, the fruit of a slow-growing evergreen in China, which is harvested for several months each year. That's why Roche's production of Tamiflu takes about 12 months and there isn't nearly enough of the drug to go around for government stockpiling.

?What makes our process more viable is the fact that the particular species of pine, spruce and fir that we are working with are far more abundant than the seedlings of star anise,? said John Fulton, Biolyse's vice-president for new product development.

Mr. Mercure said Biolyse has no plans to make Tamiflu unless Ottawa grants compulsory licences under the Patent Act in a national emergency. In such a case, he said the company could produce the drug in five weeks.

In countries where Roche's patents on Tamiflu aren't recognized, like the Philippines and Thailand, he said Biolyse is in discussions to sell shikimic acid and provide technical assistance so the drug can be manufactured for use in that country.

The Globe and Mail: Christmas trees combat bird flu

Friday, December 23, 2005

News - Tamiflu resistance in avian flu victims sparks concern

A new report says oseltamivir-resistant forms of H5N1 avian influenza virus were found in two Vietnamese girls who died of the infection, raising doubts about the antiviral drug that many countries are counting on to help protect them from a potential flu pandemic.

One of the two girls died even though she started receiving oseltamivir (Tamiflu) within the first 2 days of her illness, the recommended window for effective treatment, according to the report in today's New England Journal of Medicine. The other girl was not treated until the sixth day of her illness.

The authors of the report say their findings suggest that a higher dosage, longer treatment course, or combination with other antiviral drugs may be necessary to ensure the effectiveness of oseltamivir.

Roche, the manufacturer of oseltamivir, agrees with that assessment and says that studies of the safety of a higher dosage are about to get under way.

Second study weighs in on stockpiling
In a separate article published today, a group of experts who have been monitoring resistance to oseltamivir and similar drugs says the evidence so far?including the New England Journal report?does not suggest that stockpiling of the drug is useless.

"The available data do not indicate that potential oseltamivir resistance should be a deterrent to its stockpiling for pandemic response," says the report by Frederick Hayden and other members of the Neuraminidase Inhibitor Susceptibility Network (NISN). It was published online today in Antiviral Therapy.

The report on the Vietnamese patients was prepared by a team from the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam, and Hong Kong University, with Menno D. de Jong of the Vietnamese hospital as first author.

Their study focuses on eight patients who were treated for confirmed H5N1 infection at the Hospital for Tropical Diseases between February 2004 and January 2005. Throat samples were collected from the patients for analysis at admission and later in their illness. H5N1 infection was confirmed by polymerase chain reaction.

All the patients were started on oseltamivir the day of admission to the hospital, which varied from 2 to 8 days after the onset of illness. They received the recommended regimen of 75 mg twice a day for 5 days. Four of the patients died.

The researchers did a sequence analysis of the H5N1 virus's neuraminidase gene to look for resistance, signaled by the substitution of tyrosine for histidine at amino acid position 274. This mutation was found in two patients, a 13-year-old girl and an 18-year-old girl.

The 13-year-old was hospitalized the day after she fell ill with a fever and cough, which was also the day after her mother had died of H5N1 infection. Despite oseltamivir treatment, the girl's condition worsened on her fourth day in the hospital, and she died of severe pneumonia on the seventh day.

The viral load in her throat was higher by the time of her death than it had been earlier, which, along other laboratory evidence, suggests that "the development of drug resistance contributed to the failure of therapy and, ultimately, the death of this patient," the report says.

The 18-year-old was hospitalized and started on oseltamivir 6 days after she had fallen ill, but she died after 2 weeks in the hospital. Nonresistant H5N1 virus was found in a sample taken 2 days after she was hospitalized, but the resistant form was found 6 days later.

Although the connection between viral resistance and the 18-year-old girl's death was less clear than in the case of the 13-year-old, "The presence of replicating virus after 14 days of illness suggests an effect on the outcome," the article says.

It also says the viral load in throat specimens from the four patients who survived dropped quickly to undetectable levels during their treatment.

"Our observations suggest that at least in some patients with influenza A (H5N1) virus infection, treatment with the recommended dose of oseltamivir incompletely suppresses viral replication," the authors write. Consequently, "Strategies aimed at improving antiviral efficacy (e.g., the use of higher doses, longer durations of therapy, or combination therapy) may deserve further evaluation."

Tamiflu manufacturer, study authors comment
Roche, Swiss-based maker of Tamiflu, released a statement today agreeing that such strategies deserve consideration. The company said some data already support the safety of using a higher dosage of the drug, and clinical trials assessing the efficacy of a higher dose are scheduled. Roche is collaborating with the National Institutes of Health and the World Health Organization (WHO) on that research, the statement said.

Tran Tinh Hien of the Hospital for Infectious Diseases, one of the study's authors, says Vietnamese health officials are already recommending increasing the dosage of oseltamivir for avian flu patients, according to a Reuters report published today.

"We still recommend the use of Tamiflu for bird flu cases as soon as possible and at higher doses as there is no replacement yet," he said. He added that the Vietnamese Ministry of Health has increased the treatment period to 7 days from 5 days.

The article published today by NISN, the experts who have been monitoring resistance to the neuraminidase inhibitors, say the new findings do not contraindicate stockpiling of oseltamivir, but much more research is needed. The neuraminidase inhibitors include oseltamivir and zanamivir (Relenza).

The group said no one knows how often resistance emerges in H5N1 patients being treated with oseltamivir, and the clinical consequences of such resistance are also unclear.

Many H5N1 patients treated with oseltamivir have died, but in most cases treatment was started late, after pneumonia had already developed, the report says. Some evidence suggests that the emergence of oseltamivir resistance early in treatment may lead to treatment failure, but more studies are needed.

The group also said there is no indication that H5N1 viruses now circulating in birds are resistant to neuraminidase inhibitors. Further, the likelihood that oseltamivir-resistant strains will spread in the community appears low, in contrast to the situation with two older antiviral drugs, amantadine and rimantadine, to which ordinary flu viruses are often resistant. In animal studies, the article says, the mutation that confers resistance in both H5N1 and H1N1 viruses reduces infectiousness 100-fold and reduces viral replication more than 10-fold.

The NISN statement also says that all avian and human H5N1 isolates tested so far by the Centers for Disease Control and Prevention have been susceptible to zanamivir. However, zanamivir, which is inhaled, has not been tried in human H5N1 patients.

Despite this, "Inhaled zanamivir would be a therapeutic consideration if oseltamivir resistance were likely to be present," the NISN members write. They also say the drug would be "an appropriate choice for pandemic response stockpiles."

Other experts offer opinions
To infectious disease expert Michael T. Osterholm, PhD, MPH, the report from Vietnam "reminds us again that none of us know how much drug [oseltamivir] we have in the stockpile." If a longer, higher-dose regimen is needed, a stockpile now described as 3 million treatment courses is actually smaller, said Osterholm, director of CIDRAP, publisher of this Web site.

Osterholm also said the report suggests oseltamivir resistance can have much graver consequences in H5N1 cases than in ordinary flu. In the latter, drug resistance has not been associated with treatment failure or a severe outcome, but "with H5N1 this may be a very different outcome," he said.

Osterholm called for clinical studies of the use of oseltamivir very early in the illness and at a much higher dosage than is used in ordinary seasonal flu. If that approach improves outcomes, it would have "tremendous implications for how we get Tamiflu to patients in a timely manner," he said.

A WHO official said the resistance findings are "not necessarily alarming" but do point up the need for more information, according to the Reuters report.

"What really is critical is understanding whether the way we are using the drugs contributes" to resistance, said Keiji Fukuda of the WHO's global influenza program.

Some resistance is expected whenever antivirals and antibiotics are used, Fukuda said, adding that using too-small doses or too short a treatment regimen can promote resistance.

CIDRAP >> Tamiflu resistance in avian flu victims sparks concern

News - Abra organizes avian flu task force

Provincial Veterinary Office here is set to create a Provincial Avian Flu Task Force to oversee preventive measures against the bird flu virus.

Dr. Ruston Valera, provincial veterinarian said he is set to present to the Provincial Board a proposal for the creation of said task force. The proposed task force shall be composed of various teams with specific tasks such as quarantine, monitoring, information, education and rapid action, he explained.

"Although there are no reported cases of the virus yet in the country, Abrenios should not take it lightly," Valera added.

The virus which was first discovered from migratory birds in Southern China has affected chicken and other birds. The World Health Organization later found that the virus is deadly to humans. From December last year, 42 human deaths have been reported in Vietnam, five in Indonesia, 20 in Thailand and four in Cambodia.

Valera also said that since there are no traces of migratory birds' visit in the province, importation of poultry products is likely the most possible means of the virus' entry. The virus, he further explained, can only be acquired through direct contact.

Workers in poultry farms are the most vulnerable to contract the virus. However, according to experts, there is no danger in eating contaminated poultry products provided that these are properly cooked. The virus cannot survive under normal cooking temperature, Valera added.

PIA News Releases

News - Bird Flu Expands Worldwide in 2005


Fears of a long-predicted global influenza pandemic grew stronger in 2005 as a deadly form of the virus spread among birds worldwide and killed 36 more people in the disease's Southeast Asian epicenter. Governments and international organizations stepped up cooperative measures to isolate the disease and to deal with a possible pandemic.

The number of human deaths from bird flu more than doubled in 2005 to over 70, according to World Health Organization numbers. So far, bird flu deaths are limited to East Asia, mainly the Southeast, with Vietnam the hardest hit. The death toll accounts for half of all human cases, an alarming death rate in the view of physician Gregory Poland of the Mayo Clinic College of Medicine in Minnesota.

"If that virus gains the ability to easily transmit from human-to-human, it will be a disaster of unprecedented proportion," he said.

Fueling this fear was the global spread of infected birds from Asia, thanks to seasonal migrations. By year's end, birds with the deadly H5N1 form of avian flu had been detected in Europe and Canada. In countries where it was found, tens of thousands of poultry were slaughtered.

The first sign of this spread came in late April at central China's Lake Qinghai, a migratory fowl congregation point where more than 6,300 birds of different species perished within weeks. Until then, the disease had been seen only in domestic poultry, thought to be its source. World Health Organization (WHO) spokesman Dick Thompson said migrating birds must be tracked.

"There's an urgent need to sample and tag and track as many of these species as feasible, especially considering the narrow time frame that we've got available to do it. We need more information on the migratory routes regarding these birds," said Mr. Thompson.

To confront its outbreaks, China embarked on an ambitious effort to vaccinate all of its many billions of chickens, ducks, and geese ? 20 percent of the global total. Vietnam, Indonesia, and Pakistan also inoculated birds against the flu.

The European Union, meanwhile, temporarily banned live bird imports.

The ongoing outbreaks raised concern about the ability of public health systems to respond to an expected influenza pandemic. About three pandemics occur per century and it has been 37 years since the last one. U.S. Health and Human Services Secretary Michael Leavitt said if it comes, it could kill up to 7.5 million people around the world.

"Pandemics happen. It is a fact of biology. When it comes to a pandemic, we are overdue and underprepared," he said.

To overcome the preparation deficit, international conferences were held in Ottawa, Canada and Geneva, Switzerland in October and November to coordinate the responses of governments and global agencies.

Together, the meetings identified five major goals -- reduce human exposure to sick animals, strengthen surveillance and reporting of disease, develop national preparedness plans, intensify rapid containment operations, and accelerate global research to overcome the shortage of vaccines, antiviral medicines, and production capacity.

Canadian Prime Minister Paul Martin emphasized the importance of global teamwork.

"Within our countries and among our countries, each of these efforts will require cooperation and coordination on a scale that is virtually unprecedented," said Mr. Martin. "The consequences of a world that is unprepared are simply unacceptable."

The global standards were in line with President Bush's September announcement at the United Nations of the International Partnership on Avian and Pandemic Influenza. Its aim is to bring key nations together to improve global readiness by elevating the issue on their national agendas and coordinating efforts among donor and affected nations.

Within his own government, Mr. Bush asked Congress for $7 billion for flu pandemic preparations, a large portion of which would go toward new vaccine research. Other money would help other nations train personnel to expand detection and testing.


George Bush
"Together, we're working to control and monitor avian flu in Asia, and to ensure that all nations have structures in place to recognize and report outbreaks before they spread beyond human control," said Mr. Bush.

The lack of medical defenses against bird flu clouds the future. A study from the U.S. government's Centers for Disease Control (CDC) showed that worldwide resistance to influenza drugs increased by 12 percent in the last decade. H5N1 is resistant to one of the two major classes of flu drugs, amantadine, and scientists reported signs in Asia it is learning to defy the other one, which includes Tamiflu, the major drug nations are stockpiling against the disease.

Moreover, no one knows if existing flu vaccines will work against H5N1, and a vaccine specific to it is only in the testing stage.

So University of Maryland flu researcher Daniel Perez said the slaughter of infected birds will a crucial protective measure for the time being.

"Right now, that is the only tool that is effective in controlling avian influenza," said Mr. Perez.

VOA News - Bird Flu Expands Worldwide in 2005

News - Tamiflu could make avian flu pandemic worse - 23 Dec 2005 - World News

The only drug available against a threatened pandemic of avian flu may be useless for many of those infected and could make the pandemic worse, say scientists.

The warning came after a study of 13 Vietnamese patients infected with avian flu and treated with the anti-viral drug Tamiflu found two developed a resistant virus which contributed to their deaths.

Seven of the 13 patients died.

The New England Journal of Medicine, which publishes the findings today, describes them as "frightening". Governments are stockpiling Tamiflu to be used as the first line of defence against a pandemic.

But indiscriminate use of the drug in the event of a pandemic could fuel the growth of a resistant virus, triggering a second wave of infection against which there would be no defence, researchers say.

Sir John Skehel, director of the National Institute for Medical Research, London, and one of the world's leading virologists, said: "That is the great worry. The fear is that all the virus that comes here [to Britain] might be resistant."

Sir John said Tamiflu was better at preventing infection with flu than treating it.

"It's a prophylactic, not a therapeutic. If you give it before the infection develops it is a good drug but if you give it after symptoms appear it has declining value."

He urged the Government to broaden Britain's defence against a pandemic.

Relenza, a drug which works in a similar way to Tamiflu, has not shown signs of triggering resistance but Governments have ignored it because it is harder to take.

"We should be stockpiling other drugs. Some of these mutations are only resistant to Tamiflu. But I am not aware how much Relenza is available," Sir John said.

The H5N1 virus has infected 138 people in the Far East and killed 71, but the fear is it could mutate to become transmissible among humans and spread around the world.

In the Vietnamese study, one of the patients, a 13-year-old girl whose mother had died of avian flu, was treated within 24 hours of developing a cough and fever with a high dose of Tamiflu when "the greatest clinical benefit could have been expected".

But although her condition improved at first, it later worsened and she died eight days after starting treatment. Resistant virus was isolated and at the time of her death the amount of virus in her throat had increased.

"These observations suggest that the development of drug resistance contributed to the failure of therapy and, ultimately, the death of this patient," the authors from the Hospital for Tropical Diseases in Ho Chi Minh City report.

The second patient died after 14 days of illness, also showing signs of an increase in the amount of virus.

Tamiflu could make avian flu pandemic worse - 23 Dec 2005 - World News

News - NIH Vaccine: Live Bird-Flu Virus

In an isolation ward of a Baltimore hospital, up to 30 volunteers will participate in a bold experiment: A vaccine made with a live version of the most notorious bird flu will be sprayed into their noses.

First, scientists are dripping that vaccine into the tiny nostrils of mice. It doesn't appear harmful -- researchers have weakened and genetically altered the virus so that no one should get sick or spread germs -- and it protects the animals enough to try in people.

This is essentially FluMist for bird flu, and the hope is that, in the event of a flu pandemic, immunizing people through their noses could provide faster, more effective protection than the troublesome shots -- made with a killed virus -- the nation now is struggling to produce.

And if it works, this new vaccine frontier may not just protect against the bird-flu strain, called H5N1, considered today's top health threat. It offers the potential for rapid, off-the-shelf protection against whatever novel variation of the constantly evolving influenza virus shows up next -- through a library of live-virus nasal sprays that the National Institutes of Health plans to freeze.

"It's high-risk, high-reward" research, said Dr. Brian Murphy, who heads the NIH laboratory where Dr. Kanta Subbarao is brewing the nasal sprays -- including one for a different bird-flu strain that appeared safe during the first crucial human testing last summer.

"It might fail, but if it's successful, it might prevent hundreds of thousands of cases" of the next killer flu, Murphy said.

FluMist is the nation's nasal-spray vaccine that prevents regular winter flu. Developed largely through Murphy's lab, it's the only flu vaccine made with live but weakened influenza viruses.

The new project, a collaboration with FluMist manufacturer MedImmune, piggybacks cutting-edge genetics technology onto that vaccine to create a line of FluMist-like sprays against different bird flus.

"That is a great, great idea," said Dr. John Treanor of the University of Rochester, among the flu specialists closely watching the project.

Regular winter flu shots are made with killed influenza viruses, and the government is stockpiling experimental bird-flu vaccine made the same way. But those bird-flu shots don't work as well as hoped. They require an incredibly high dose, delivered in two separate injections, to spark a protective immune response in people.

"In theory, a live-virus vaccine might actually work better. We don't know that because we've never tried one before," Treanor said.

Influenza is like a magician, constantly changing its clothes to avoid detection, thus making it difficult to develop effective vaccines. Studding the virus' surface are two proteins called hemagglutinin -- the H in H5N1 -- and neuraminidase, the "N". They act as a wardrobe: There are 16 known hemagglutinin versions, and nine neuraminidases.

They're also what triggers the immune system to mount an attack, particularly hemagglutinin, the protein the body aims for when it makes flu-fighting antibodies.

When people catch the flu, they usually get H1 or H3 flu strains, which their bodies can recognize because variations have circulated among humans for decades. Occasionally, genetically unique strains emerge. Until 1997, H5 strains had never been seen outside of birds. The virus essentially put on a coat that human immune systems didn't recognize. The result: Since 2003, a particularly strong H5N1 strain has infected more than 130 people in Asia, killing at least 70.

H9 and H7 strains also recently have jumped from birds to people, although so far they haven't been nearly as dangerous.

Researchers hope to create at least one live-virus nasal spray for each "H" subtype, a project costing about $16 million of the NIH's annual $67 million budget for flu vaccine research.

"The hemagglutinin is the major protective antigen, so that is what we're focusing on," explained Subbarao, a molecular geneticist who heads the project.

First on her list are the riskiest known bird flus: H5N1, with human tests planned for April. H9N2, which recently underwent the first round of human testing in an isolation ward at Johns Hopkins Bayview Medical Center. Then an H7 strain, followed by an H6 strain believed to share genes with the H5N1.

"By no means are we confident we're picking the right strain" to make first, because flu mutates so easily, Subbarao cautioned.

She chooses vaccine strains from those that U.S. scientists who are monitoring influenza in Asia cull from ducks, chickens and geese, and ship home for research. Subbarao must customize those strains for safe vaccination: First, using a new technique called reverse genetics, she selects genes for bird-flu H and N antigens and removes genetic segments that make them dangerous. Then she adds the remaining gene segments to the regular weakened FluMist virus.

Stocks of the custom virus are grown in fertilized chicken eggs. Each is then carefully cracked by hand to drain out virus-loaded liquid that in turn is purified and put into a nasal spray.

In a high-security section of the lab, Subbarao dons a biohazard suit and exposes vaccinated mice to various bird-flu strains.

Then it's time for human testing -- in a hospital isolation ward just in case the weakened virus could infect someone. It shouldn't, because "those problems don't exist in FluMist," said Murphy, citing studies of regular FluMist in day-care centers where youngsters routinely pass viruses back and forth.

Some studies have found that people can shed the virus shortly after receiving regular FluMist. But, "to spread infection, you'd need much more (virus) than replicates in the nose," he said.

Hopkins researchers gave the first of Subbarao's vaccine candidates -- the H9N2 spray -- to 30 volunteers last summer. To be sure they couldn't spread the virus by coughing or sneezing, the volunteers underwent daily tests of their noses and throats.

The vaccine appeared safe. Scientists now are analyzing whether it also spurred production of flu-fighting antibodies, a sign that people would be protected if they encountered the H9N2 strain. Subbarao expects results by February.

In April, pending final Food and Drug Administration permission, Subbarao will put an H5N1 spray to a similar test.

Here's the catch: Each flu strain has subtypes. An Indonesian version of H5N1, for example, was recently discovered that differs from a Vietnamese strain on which Subbarao's nasal spray -- and the government's stockpiled shots -- are based. She's now testing whether her vaccine protects mice against that new Indonesian strain.

If a novel flu strain begins spreading among people, how will Subbarao tell if her stored nasal vaccines are a good match to fight it?

NIH also will store blood samples from the people who test those sprays. Say a new H9 strain sparks an outbreak. That virus will be tested against those blood samples, and NIH could predict within a day which spray candidates work. If one does, the government could order doses manufactured from that frozen stock; if none do, scientists would have to try to brew a new vaccine.

How quickly doses could be manufactured is a different issue. All influenza vaccines, shots or spray, currently are brewed in chicken eggs, a time-consuming process that other research is seeking to improve.

"These are research projects," Murphy stresses -- the nasal-spray concept could fail. But he's optimistic. Live-virus vaccines, he maintains, are better immune stimulators.

Wired News: NIH Vaccine: Live Bird-Flu Virus

News - CHRONOLOGY-Bird flu developments


Indonesia has confirmed two more human deaths from bird flu, the World Health Organization (WHO) said on Friday, taking the global death toll from the disease to 73, all in Asia.

Here is a chronology of major bird flu developments:

Dec 15, 2003 - South Korea confirms a highly contagious type of bird flu at a chicken farm near Seoul and begins a mass cull of poultry when the virus rapidly spreads across the country.

Jan 8, 2004 - Vietnam says bird flu found on poultry farms.

Sept 27 - Thailand says it has found a case where one human probably infected another with bird flu. It said this was an isolated incident posing little risk to the population.

Oct 10, 2005 - The European Commission announces a ban on imports of live birds and feathers from Turkey to the 25-nation EU. This was in response to Turkey reporting its first case of bird flu two days earlier. It was later confirmed as the type dangerous to humans, the H5N1 strain.

Oct 15 - British tests identify H5N1 in three ducks found dead in Ceamurlia de Jos in Romania, the first case in mainland Europe of H5N1.

Nov 9 - Three days of talks among health experts in Geneva agree a billion dollar strategy to minimise the virus threat at source in animals and humans.

Nov 11 - Kuwait reports the first known case of deadly bird flu in the Gulf Arab region, saying a culled flamingo was carrying the deadly strain of the H5N1 virus.

Nov 15 - Britain says 53 finch-like mesias imported from Taiwan died last month in a British quarantine center where they were believed to have introduced the H5N1 virus. In October, Britain had said a parrot imported from Suriname had been found to have the virus and a mesia may have caught it.

Dec 3 - Ukraine introduces tough steps to combat its first outbreak of bird flu, sending troops to patrol exclusion zones in the Crimea peninsula where the virus was detected.

Dec 23 - Indonesia confirms two further deaths from bird flu. That brings the death toll in Asia to 73, comprising 14 victims in Thailand, four in Cambodia, 11 in Indonesia, 42 in Vietnam and two in China.

Global Coverage Article Reuters.co.uk

News - Spain provides fund to WHO to fight bird flu

The Spanish government has agreed to give the World Health Organization (WHO) some 2.4 million U.S. dollars to help the organization's anti-bird flu programs, local media reported on Friday.

The WHO is developing international structures of support mostly to Asian and African countries to halt the spread of the disease and help them adopt measures to protect their people.

At the same time, Spain is giving some 1.2 million dollars to European Union's research program to develop anti-Human Immunodeficiency Virus (HIV) vaccines, as part of the European and Developing Country Trail Program whose activities include research and development of technologies used to fight malaria, tuberculosis and HIV.

Xinhua - English

News - Stop hoarding bird flu virus samples, China told


The World Health Organization has urged China to share bird flu virus samples with foreign scientists, saying Beijing has failed to release samples of the deadly H5N1 virus from any of 31 reported outbreaks in Chinese poultry this year.

"If we received these samples from animals we would know what kind of changes the virus is undergoing, which is very, very vital in fighting against any potential pandemic," Shigeru Omi, WHO's western Pacific director, told a news conference on Friday.

There was no immediate response from Chinese officials. It was not clear why they would be reluctant to provide virus samples, especially after being criticized for a coverup that delayed other countries' responses to the SARS outbreak of 2003.

Although it still mostly attacks birds, the virus has proved deadly when it jumps to people who handle infected poultry. Scientists fear mutations will enable it to spread easily from person to person, setting the stage for a global tragedy.

China shared samples from people but not birds

Speaking to reporters in Beijing, Omi praised Vietnam for making virus samples from its poultry outbreaks available to WHO scientists.

And he commended China for sharing samples from infected people, if not from birds.

Of more than 70 human deaths attributed to the virus across Asia, China has confirmed just two.


FROM DEC, 22, 2005: Bird flu kills 2 in Vietnam, despite drug treatment

An Oxford University study published this week concluded that in two fatal cases in Vietnam, the virus had developed a resistance to Tamiflu, a drug seen as the best defence against it so far.

Omi said ordinary Chinese remain dangerously ignorant of the risk of infection.

During a five-day visit to China, he talked to a nine-year-old boy who survived the disease in Hunan province, Reuters reported.

"The boy that I met, he did not know anything about this," Omi said. "For him, chickens are friends, so he touched (them)."

CBC News: Stop hoarding bird flu virus samples, China told

News - Europe braces for bigger bird flu outbreak this spring

ISLE OF RIEMS, Germany - No one is worried about the traditional Christmas goose in Europe this year, but health officials are scrambling to prepare for what some believe is the certain arrival this spring of a deadly strain of bird flu in migrating wild birds.


Europe first saw the deadly H5N1 bird flu strain this autumn, with cases discovered among dead wildfowl or small flocks of domestic birds in Croatia, Romania, Russia, Turkey and Ukraine. Experts are convinced that those cases are only a warning of what's to come.


Thomas Mettenleiter, the president of Germany's leading animal disease center, the Friedrich Loeffler Institute, said millions of wild birds left Europe flu-free this autumn to winter in Africa. There they'll mix with migrating birds from Southeast Asia, where the lethal strain of the virus is far more common.


Of the ways the disease could arrive in Europe - through infected meat, live poultry or pets - migration is the most troubling. Government has no control over how many birds will arrive and where they'll land.


"March and April are going to be high alert times here," said Mettenleiter. "We've got a lot of work to do before then."


The European Union issued a directive Tuesday urging nations to deal aggressively with low-threat strains of the virus. Investigations should be launched whenever a suspicion of infection arises, it said.


Philip Tod, a spokesman for the EU Health and Consumer Protection Commission, said bird breeders should enclose their pens to limit contact with wild fowl and that signs of the flu should trigger mass culling in infected areas.


Reinhard Burger, the vice president of Germany's infectious disease center, the Robert Koch Institute, said that in the past Europeans could cull infected birds. "But we've never seen numbers approaching what we're expecting to see - hundreds of millions of infected birds will likely be returning to Europe with the spring weather.


"We're walking on a narrow ledge in high mountains this winter. We're very worried," he said.


The bird flu virus started killing birds in Southeast Asia in 2003. Farms with 10,000 birds were wiped out in 48 hours. Millions of birds died or were culled. Since then, the lethal virus has jumped to humans in 141 cases, resulting in 73 deaths, according to the World Health Organization on Friday.


As Mettenleiter explains: "We don't know if H5 strains can sustain a human pandemic, but if they can, the results are potentially catastrophic."


Humans have no immunity to new strains, and some experts estimate that a pandemic could kill more than 100 million people worldwide.


Currently, the flu passes from infected birds into humans through extended contact. But the virus is constantly mutating. A pandemic could start if it mutates into a form that easily transmits from human to human.




Most troubling is the possibility that humans who already have a human strain of flu will be infected. Flu has the ability to "gene-swap," or essentially trade genetic coding. So the H5N1 strain could turn a nonlethal strain that spreads easily among humans into a lethal one.


A vaccine would greatly decrease the number of deaths from bird flu, but a human vaccine isn't possible until the precise mutation that's passing among humans is known, and that hasn't developed yet.


There is a vaccine for birds. But it only would make them more resistant to flu, not stop them from spreading the disease, Mettenleiter said. "If the strain can jump to humans, that's the last thing we want. For now, at least, chickens are our sentinels."

KR Washington Bureau 12/23/2005 Europe braces for bigger bird flu outbreak this spring

News - Indonesia says 2 more avian flu cases confirmed

Indonesia's human death toll from H5N1 avian influenza rose to 11 today with the report that tests have confirmed that a man and a boy who died last week had the virus.

Samples from a 39-year-old man and an 8-year-old boy tested positive at the US Centers for Disease Control and Prevention, said Hariyadi Wibisono of the Indonesian health ministry, as quoted by Agence France-Presse (AFP) today. The CDC tests confirmed earlier test results in Indonesia.

Their cases are the 15th and 16th reported as confirmed in Indonesia. The World Health Organization (WHO) had not yet included the cases in its online tally at this writing. The WHO's overall count currently stands at 139 cases with 71 deaths in the past 2 years.

The two victims lived in different sections of Jakarta, according to a Bloomberg News report today. The man died Dec 13, and the boy died Dec 15, according to AFP.

The Bloomberg report said the man had had no known contact with sick birds before he died, while the boy lived not far from a market where pet birds are sold.

The story said community groups, soldiers, and student volunteers began a door-to-door campaign in Jakarta today to find and destroy sick birds in houses and backyards.

CIDRAP >> Indonesia says 2 more avian flu cases confirmed

News - Govt informed of bird flu contingency plan - NDTV.com - News on Govt informed of bird flu contingency plan

The Union Cabinet was informed of the contingency plan to be undertaken by the Health Ministry in the event of an outbreak of avian influenza in the country.

The contingency plan will deal with detection of avian flu in birds and detection of avian flu in humans, an official release said.

In both situations, the rapid response teams from the National Institute of Communicable Diseases (NICD) will get mobilised.

Health parameters

In case of avian flu in a bird, the action will be confined to surveillance of the local community and monitoring the health parameters of the cullers and the supporting staff as well as the workers in the farm.

However, if there was a human case of avian flu, then all clinical management protocols will be operationalised and the patient will be isolated in an appropriately equipped hospital. (PTI)

Govt informed of bird flu contingency plan - NDTV.com - News on Govt informed of bird flu contingency plan

News - Global Flu Pandemic Stirs Plenty Of Fear, But Little Perspective

Time for a reality check about avian flu.

The virus already has prompted dozens of governments and thousands of U.S. and European consumers to stockpile Tamiflu, the antiviral drug from Roche that will soon be licensed to other firms.

To companies in the human-resources and workplace environmental field, the fear factor surrounding avian flu has become a business opportunity to promote pandemic action plans for corporations.

And when seasonal flu hits ? as it does every year ? folks might wonder, "Is this the big one?"

"I hear of kids having nightmares and people unsure if they should eat chicken," said Dr. David Butler-Jones, Canada's chief public health officer.

Part of that fear is driven by mathematics. There were three flu pandemics in the last century. The 1918 pandemic was followed by Asian flu in 1957 and Hong Kong flu in 1968.

The concern is that the world is ripe for another pandemic, says Dr. Arnold Monto, professor of epidemiology and a flu expert at the University of Michigan.

"Some of us speculate that because we've had no pandemic since '68, we're due for one," Monto said. "The longer you have not seen the big one, the more you think you're becoming due for the big one."

For his part, Monto says the fear is unwarranted. Butler-Jones echoes that opinion, saying that predicting a new pandemic based on historical patterns is "a mug's game."

"If you toss a coin and get five heads in a row, your chance of another heads on the next toss is still 50-50," Butler-Jones said. "Some kind of pandemic is inevitable, but this strain of flu pandemic is not inevitable."

Should it strike, he says, it won't be like the 1918 flu pandemic, which we now know was also an avian flu.

First, the world population today is healthier. There are no troops in cold, wet World War I trenches. And we know much more about nutrition and hygiene and the science of viral genetic mutation.

Another difference: In 2005, the whole world is on watch.

"In 1918, the avian virus flu could not be recognized," Butler-Jones said. "Now we're looking for it."

Even if the virus mutates from fowl to people ? then mutates again so people can transmit it to other people ? the result need not be calamitous.

"Avian flu could become like SARS in terms of its limited ability to spread," Butler-Jones said.

He should know. SARS, or severe acute respiratory syndrome, hit Canada in 2003. It was brought by travelers from Asia. The Canadian government created Butler-Jones' agency after the SARS epidemic.

For all the drama and disruption over SARS, the virus infected only 8,000 people, killing 800.

SARS was a learning experience. One thing Butler-Jones says he learned is that there's a "fine balance" between preparing for the worst and being immobilized by fear.

Preventive Medicine

While Monto says it's unlikely an avian flu pandemic will happen, it doesn't hurt to be prepared on the off-chance it does.

"You just don't have the lead time once you realize the virus has become pandemic," he said. "That's why we stockpile Tamiflu."

Speed counts when coping with a viral outbreak. One study shows that an avian flu pandemic could be contained if officials act fast with quarantines, vaccine and antiviral drugs.

That positive analysis came from the Models of Infectious Disease Agent Study, a project funded by the National Institute of General Medical Sciences.

Researchers using computer simulations calculated how 500,000 Thais might spread the virus through their daily actions. More such studies are under way.

Authorities in most countries are competent enough to handle a pandemic once one is recognized, Monto says. The wild card is whether they'll be able to recognize it early enough.

Authorities must also be willing to make public what they've learned. Some local Chinese officials have withheld information because they look at it as an "admission of guilt" that they're having problems, Monto says.

Beijing is putting a stop to that practice.

"Everyone now realizes full disclosure is important," Monto said.

Public health agencies worldwide collect and share data. In addition to Tamiflu, governments are stockpiling Relenza, an anti-viral inhalant made by GlaxoSmithKline. (GSK)

Flu vaccine manufacturers Chiron (CHIR), Sanofi-Aventis (SNY) and Glaxo are increasing capacity for seasonal and avian flu.

On Dec. 16, Sanofi-Aventis announced that early tests of its experimental avian flu vaccine showed "good immune response in a significant number of volunteers."

Monto sees another payoff from the work being done to thwart avian flu. "We can use our pandemic preparation to respond to seasonal influenza. It kills 36,000 Americans every year unnecessarily ? and many think the number is conservative."

Investor's Business Daily: Global Flu Pandemic Stirs Plenty Of Fear, But Little Perspective

News - Avian flu scare at NSW farm

A NSW property has become the first in Australia to be locked down because of bird flu fears after a chicken had a weak reaction to an avian influenza test.


Agriculture Minister Peter McGauran yesterday revealed the quarantine measure had been taken as a precautionary step on the property at Wentworth, near the Victorian border.

Fears were sparked after the chicken was submitted to a NSW laboratory for routine testing with suspected Marek's disease, a common endemic disease.

Subsequent tests found the weak reaction to an avian influenza test. However, further laboratory testing excluded highly pathenogenic avian influenza (HPAI).

The CSIRO's Australian Animal Health Laboratory in Canberra is now conducting further testing for bird flu on samples from the chicken.

Chickens and ducks on the property were yesterday placed in cages to avoid contact with migratory birds. But consumers have been advised that it is safe to eat chicken.

Mr McGauran said it was also highly unlikely the chicken had contracted the low pathenogenic influenza strain.

"While it is the remotest of possibilities that any avian influenza variant is present we are taking every precaution," he said.

"Birds are contained on site and with the highly pathenogenic strain ruled out there is no risk to humans."

Concern about an influenza pandemic has intensified in the past year amid fears that avian influenza could mutate into a form that could be transmitted between people.

More than 60 people have already died from avian influenza, mostly in South-East Asia, and experts warned this week that the virus may be mutating to become resistant to the main drug used to fight it.

This came after a 13-year-old Vietnamese girl died despite receiving the right doses of the drug early in her illness.

The Federal Government has spent $555 million on pandemic preparedness and has stockpiled enough anti-viral drugs to give half the population.

However, experts are now warning that new antiviral drugs must be developed to fight the disease.

Mr McGauran yesterday insisted the risk of HPAI was very low but authorities were taking a cautious approach.

"This is consistent with Australia's conservative approach to managing animal health and disease risks," he said.

"I would stress that there is no food safety implications to consumers of poultry products arising from this incident."

Mr McGauran said he would keep the public informed of all results.

A team of experts from NSW yesterday visited the Wentworth property, which is understood not to be a poultry farm, and found no sick or dead birds in the flock.

Tests conducted were negative. However, Mr McGauran said there were "some weak inconclusive results".

The Courier-Mail: Avian flu scare at NSW farm [24dec05]

News - Two more avian-flu deaths in Indonesia

WASHINGTON, Dec. 23 (UPI) -- Two more people have died from avian influenza in Indonesia, the World Health Organization confirmed Thursday.

The latest victims, an 8-year-old boy and a 39-year-old man, both of whom had been previously reported as suspected avian-flu cases, take the total number of bird-flu fatalities in Indonesia to 11.

Meanwhile:

-- Following reports that H5N1 is developing a resistance to Tamiflu, Roche, the makers of the anti-viral, has announced that it is investigating new ways of using Tamiflu effectively in the face of a potential pandemic.

One approach may be to increase the doses, which would have the side-effect of further reducing a global stockpile that has already been deemed insufficient.

The World Health Organization attempted to reassure the public in the face of this latest potential pandemic setback. "Whenever you use any kind of drugs, anti-virals or antibiotics, you expect to see resistance develop," the BBC reported Keiji Fukuda, a scientist in the WHO's global influenza program, as saying.

-- Avian influenza outbreaks in birds are drawing ever closer to the Romanian capital of Bucharest.

On Wednesday outbreaks were reported 100 miles east of the city.

Government officials Thursday confirmed the presence of an H5 avian-influenza outbreak in a village 60 miles east of Bucharest, although they are awaiting confirmation regarding the N1 substrain.

In response to the outbreak, the now usual quarantines and culling of domestic birds have been imposed.

-- Bird flu has been ruled out as the cause of death of thousands of birds found dead in Malawi last week.

Instead, it appears that the birds died as a result of heavy rains.

United Press International - Consumer Health - Two more avian-flu deaths in Indonesia

Thursday, December 22, 2005

News - Russia free of bird flu: minister

Russian Agriculture Minister Alexei Gordeyev said on Thursday the country has been cleared of bird flu cases in fowl.

"No industrial facilities or private households have bird flu at the present moment," Gordeyev told a press conference, quoted by the Itar-Tass news agency.

But Russian experts do not rule out a comeback of the virus in spring, when migratory birds return.

Six Russian regions were affected by the disease since its outbreak in July, according to the Emergency Situations Ministry.

As of early November, 4,500 domestic birds died of bird flu and another 180,000 were culled to prevent the virus from spreading. No bird flu cases have been registered among humans.

Gordeyev said compensation for destroyed fowl was solved at the regional level and did not affect the federal budget.

The bird flu virus, strains of which can spread to humans and can be fatal, has claimed the lives of more than 70 people in Southeast Asia since 2003.

People's Daily Online -- Russia free of bird flu: minister

News - Bird flu may have killed Vietnamese Man

Bird flu may have killed a 36-year-old man in the south of Vietnam, where the deadly virus remains in 10 of the country's 64 provinces, doctors said on Friday.

The man, who was a teacher in Soc Trang province, died on Wednesday of severe lung infection just five hours after being admitted to the Bac Lieu General Hospital in the nearby province of Bac Lieu, doctors at the hospital told Reuters.

They said samples had been sent to the Pasteur Institute in Ho Chi Minh City for laboratory bird flu testing. Results are expected by late next week.

The teacher's family raised fighting cocks but all of the birds were healthy, the doctors said. Soc Trang has had no recent bird flu outbreaks.

The H5N1 virus has killed 73 people in Asia including 42 in Vietnam, the country worst affected, since it swept through late 2003.

Global Coverage Article Reuters.co.uk

News - Bird Flu Drug Resistance Fears


Indonesia's confirmed bird flu death toll has risen to 11 as new disturbing evidence emerges that the virus may be developing resistance to Tamiflu, the only drug known to be effective against the virus.

A 39-year-old man and an eight-year-old boy were Indonesia?s latest victims of the H5N1 strain of the virus, a hospital spokesman said.

"It's been confirmed. We were informed of the results this morning," Ilham Patu, a spokesman for Sulianti Saroso hospital, Indonesia's main centre for the treatment of bird flu said.

Routine samples

Indonesia, the world's fourth most populous nation, routinely sends samples of cases that test positive locally abroad for verification.

The man, a resident of South Jakarta, died on December 13, a day after being admitted to the hospital. The boy died two days later at a private hospital in Jakarta.

Health ministry official Hariyadi Wibisono said the test results were from the Centers for Disease Control in the US and not from a World Health Organisation-linked laboratory in Hong Kong, as Dr Patu said earlier.

Asked about the contradictory information, Dr Patu said: "My information was obtained from the health ministry's research and development center. But in any case, it's confirmed."

Most victims in Indonesia have come from densely-populated Jakarta, where many people still live in close proximity to poultry, providing ideal conditions for the virus to pass to humans.

Hundreds of officials and veterinary students began visiting houses across the capital, looking for sick poultry as part of a nationwide campaign to fight the disease.

"The surveillance is aimed at monitoring poultry that may be infected with bird flu," said agriculture ministry official Makmur.

He said that the students were trained last month by experts from the UN Food and Agriculture Organisation.

Tamiflu resistance

In Vietnam, bird flu had become resistant to the anti-viral drug Tamiflu in two fatal cases, a doctor said in what he called a worrying development.

Tamiflu is considered a frontline defence against bird flu and the most effective treatment available to counter the H5N1 strain.

Menno de Jong, from the Institute of Tropical Diseases in southern
Vietnam's Ho Chi Minh City, said Tamiflu was ineffective in fighting the virus in two girls who died despite being given full doses of the drug.

"Our two patients became resistant despite a full dose of treatment. Both died and in one patient there are some suggestions that the therapeutic failure and ultimately her death may have been caused by the development of resistance," he said.

This patient was a 13-year-old, who died eight days after showing the first symptoms. The other, 18, died three weeks after the onset of symptoms.

"What will be important is to try to learn as much as possible from the next patients. We need to improve treatment of bird flu in this region," he said.

Vietnam has been the country hardest hit by bird flu, which has killed more than 70 people across Asia.

In China state media reported that human trials of a bird flu vaccine had begun this week, with six volunteers being given shots.

The experiments, which will be carried out on 120 volunteers in Beijing, will last nine months but preliminary conclusions are expected in around three months.

Various companies around the world are trying to develop a vaccine against the virus.

But the WHO's top official in China has said that they might be useless in the event of a pandemic because the virus would have mutated.

Scientists fear that H5N1 may mutate into a form that could be easily passed between humans, sparking a pandemic with a potential global death toll of millions.

Increase doses

Swiss pharmaceutical group Roche says increased doses of Tamiflu may be needed to treat human cases of virulent bird flu because of the virus?s growing resistance.

The company says in a statement it may also be necessary to combine the drug with other antiviral agents to treat H5N1.

It says other treatments for the virus need to be explored including higher dose and/or longer duration of treatment with Tamiflu or a combination of antiviral agents.

"Roche agrees that other treatment regimens for the H5N1 virus need to be explored, including higher dose and/or longer duration of treatment with Tamiflu, or a combination of antiviral agents."

Roche said that safety data supported the use of higher doses.

Clinical research was already underway with the World Health Organisation (WHO) and the US National Institutes of Health to assess the effectiveness of a higher dose, before the study on drug resistance was published, Roche spokeswoman Martina Rupp said.

SBS - The World News

News - WHO warns China of possible bird flu attack

The World Health Organization (WTO) warned Thursday that it is too early to tell if the avian influenza in China is under control, adding that prevention and detection measures should be stepped up.

Dr. Shigeru Omi, WHO's Western Pacific regional director, made the remark during a visit to the home of a nine-year-old boy in central China's Hunan Province who survived a bout of the flu. He was China's first human case of H5N1.

"It is too early to say if it is under control," said Dr. Omi. "I will not be surprised if we have more human cases during the winter months."

He said bird flu outbreaks in December, January and February, can be much more serious.

So far, China has reported two deaths among six human cases of bird flu in Hunan, Anhui, Guangxi, Liaoning and Jiangxi provinces.

"Based on the experiences from other countries, the number of cases will drop and then rise again," said Dr. Omi.

"A temporary reduction in the number of cases doesn't mean the circulation of the virus has been halted. We have to assume that the virus is still circulating. That the virus is still there in the environment at least among chickens and ducks," he said.

He warned that the highly pathogenic avian influenza virus is very unpredictable and unstable and could mutate into a form that can pass easily between people, leading to a human pandemic.

"We have to assume that it is impossible for this virus to become so infectious that a global pandemic might happen," he said. "We are very concerned about the possibility this virus can efficiently transmit human to human."

"We don't know when it will happen," he said. "But we have to prepare for the worst situation, and the international community has to do its utmost to try to avert or prevent it."

Vietnam, Thailand and Indonesia have also reported human cases of bird flu in the past few months.

"Fortunately, so far all the reported human patients were infected by sick poultry and where not acquired from human transmission," Dr. Omi said. It is crucial to detect the occurrence of human cases of bird flu.

"Each human case is very important," he said.

The WHO delegation including Henk Bekedam, WHO's representative in China, Lee Chin-Kei, project officer of WHO in China and Roy Wadia, Who's information officer in China congratulated Hunan for successfully treating the nine-year-old boy.

The WHO delegation met with local health officials in Hunan and called for the prompt and quick detection of human cases of bird flu and enhancement of the reporting of animal outbreaks.

WHO warns China of possible bird flu attack

News - Interactive. Bird flu


Check our this Bird Flu interactive provided by the Guardian Unlimited.

Guardian Unlimited Special reports 26.01.04 Interactive. Bird flu

News - Tamiflu still best hope against bird flu, says WHO

A senior World Health Organisation official yesterday sought to calm fears that the drug the world is stockpiling may have limited usefulness in a flu pandemic.
Evidence that some people with bird flu in Vietnam rapidly developed resistance against the drug Tamiflu and died was not necessarily a cause for alarm, said Keiji Fukuda, an expert at the WHO's global influenza programme. More research was needed, however, on the use of the drug.

His comments follow publication of a report in the New England Journal of Medicine on eight people with bird flu in Vietnam who were treated with Tamiflu. Four of them died. In two cases, the patients were very sick and although Tamiflu temporarily improved their condition, they died.
The other two cases have sounded warning bells around the world. Both had the usual strain of bird flu when they were admitted to hospital, but after some days of treatment with Tamiflu, the virus in their bloodstream mutated and became resistant to the drug.

The scientists, from the Oxford University Clinical Research Unit in Ho Chi Minh City, voiced concern that if a resistant strain of flu became easily transferable between humans - as bird flu is not at the moment - it could worsen any pandemic.

Yesterday, however, Dr Fukuda said that resistance was inevitable with any drug and Tamiflu was at the moment the best available treatment.

"Whenever you use any kind of drugs, antivirals or antibiotics, you expect to see resistance develop in organs," he said. "Finding some resistance in and of itself is not surprising and is not necessarily alarming."

The study revealed the need for more information, he said. "What really is critical is understanding whether the way we are using the drugs contributes to that [resistance]," he said.

Work needed to be done on the optimal dose of the drug against H5N1 (bird flu) and the length of the course of treatment.

The study's authors, Jeremy Farrar and colleagues, say that other antiviral drugs are needed alongside Tamiflu. The only other candidate, however, is Relenza, which has limited usefulness because it is administered as a nasal spray. It cannot be used by people who have trouble breathing, which occurs if it is severe flu. Its manufacturer, the British company GlaxoSmithKline, said it would be two years before they could produce an injectable form.

The deputy director of the Hospital for Tropical Diseases in Ho Chi Minh City, who was a member of the study group, said they were still using Tamiflu. "We still recommend the use of Tamiflu for bird flu cases as soon as possible and at higher doses as there is no replacement yet," said Tran Tinh Hien. "More in-depth research is needed to determine the effectiveness of Tamiflu against the H5N1 virus."

Guardian Unlimited Special reports Tamiflu still best hope against bird flu, says WHO

News - China, WHO in cooperation

Chinese scientists have presented the World Health Organization with two samples of the H5N1 strain of bird flu, along with their genetic sequences.

The samples will help scientists worldwide better understand how the highly pathogenic virus mutates. WHO officials say China has made a great contribution by sharing the samples. WHO Western Pacific Regional Director, Doctor Shigeru Omi says China is an important battleground for bird flu and they hope to widen cooperation.

Doctor Shigeru Omi said: "It's not just China. In many countries in Asia, the virus is already entrenched and imbedded in many parts of the countries. It is not an easy task and the challenge is a very difficult one. I think the Chinese government has showed very strong commitment and political leaders are already committed and so is the Ministry of Health."

CCTV-English Channel-????

News - UN urges RI to anticipate bird flu pandemic

The United Nations (UN) urged Indonesia to prepare a contingency plan for the possibility of the avian influenza turning into a global pandemic, a senior UN official said.

UN systems senior coordinator for avian and human influenza David Nabarro said a pandemic of the H5N1 bird flu strain could occur at any time and any place and therefore urged the Indonesian government to start developing a plan for such an eventuality.

"It will happen at some point. Act as though a pandemic will start tomorrow. Don't assume we can wait around and not worry that it won't start in the next six months or one year. If we do, once it starts it will be too late to prepare and we will all will be in crisis," he said at a recent workshop on avian influenza pandemic contingency plans held at the Office of the Coordinating Minister for People's Welfare on Monday.

He warned that should there be a pandemic, it would threaten half the world's population as no medication would be able to stem the tide of illness.

"At that stage, the virus may be resistant to Tamiflu, so we can't rely on Tamiflu," he said, referring to the drug currently given to bird flu patients.

The highly pathogenic H5N1 strain remains a virus essentially in birds. However, scientists fear that it could mutate into a form that could pass easily from human to human.

The government said that as of July, the country was in phase three of the six phases of a flu pandemic, meaning there was the possibility of facing a new subtype of the virus.

There have been bird flu breakouts in Indonesia, Cambodia, China, Laos, Thailand and Vietnam since August 2003. To date, there have been nine confirmed bird flu deaths in Indonesia and more than 10 million poultry killed.

Nabarro stressed the danger of a poor response to the possibility of an outbreak and pointed out that the 1918 Spanish flu was caused by the H1N1 subtype virus and killed 40 million people across the globe.

"To cope with such a threat, we should prevent, prepare and respond," he said.

Coordinating Minister for People's Welfare Aburizal Bakrie said that the government had formulated a plan to control avian influenza and to cope with a possible flu pandemic.

"Among other things, in the near future we will set up an integrated and autonomous organization to do tangible work to prevent and cope with any flu pandemic," he said.

The "National Strategic Plan to Control Avian Influenza and Preparedness to Face a Influenza Pandemic, 2006-2008" proposal says the government will introduce more than a dozen strategies to control the bird flu, including organizing mass culls and poultry vaccinations as well as increasing the stockpile of antiviral drugs and organizing research on bird flu vaccines.

Should a pandemic occur, the government proposal says it will isolate areas in which 80 percent of the population is infected and will mobilize manpower, including soldiers and police officers, to help limit the pandemic spread.

However, Aburizal said he did not know how much money would be needed to finance the implementation of the plan.

"All we have at present is US$150 million, which was agreed upon during the last WHO meeting in Geneva, and the government will add another $10 to $20 million," he said, adding that international aid would be needed to support the government's drive.

Deputy to the State Minister of National Development Planning Dedi M. Masykur Riyadi, whose office drafted the proposal, said should all of the strategies be implemented, the government would need about Rp 15.7 trillion ($1.5 billion) from 2006 to 2008.

The Jakarta Post - UN urges RI to anticipate bird flu pandemic

News - Indonesia confirms bird flu deaths

AN Indonesian man and boy have been confirmed by World Health Organisation tests as having died of bird flu, bringing the country's death toll from the virus to 11, a hospital spokesman said today.

Asked whether test results on the pair had been received from a Hong Kong laboratory, Sulianti Saroso hospital spokesman Ilham Patu said: "It's been confirmed. We were informed of the results this morning.
"So we have now 16 confirmed cases and 11 deaths," he said.

Five people have survived infection of the virus.

The Daily Telegraph | Indonesia confirms bird flu deaths

News -Tamiflu found ineffective in bird flu treatment


The drug most of the world is counting on to prevent an avian flu pandemic may not be a failsafe defence, according to a New England Journal of Medicine report.

The authors say they have found evidence the H5N1 virus can mutate into a form unaffected by Tamiflu -- rendering the world's ever-growing stockpiles of the drug ineffective if the mutated strain were to spread.

According to the study, completed by Dr. Menno de Jong at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam, four out of eight avian flu patients who were given the medication died despite the treatment.

This has many health care experts worried, since many predict bird flu will be the world's next major pandemic.

Toronto infectious disease consultant Dr. Neil Rau says the study has serious implications.

"Here you have the optimal situations, the right dose, the right duration, the right timing and administration and yet you have a bad outcome. That's not a good thing to see," Rau told CTV News.

The drug's maker, Swiss firm Roche AG, said it's trying to figure out why it doesn't work in some patients, and is looking at whether severe cases should be given a higher dose or longer duration of treatment.

Another article in the same journal cautions doctors against prescribing the drug for patients to stockpile. It says if not administered in a large enough dose, the chemical structure of Tamiflu could allow the virus to develop a resistance to the treatment.

Dr. Allison McGeer thinks this should remind doctors and researchers to keep looking for new solutions.

"There's one other drug, GlaxoSmithKline's Relenza, that is licensed that people are starting to talk about stockpiling," said McGeer, a Toronto infectious disease microbiologist. "There are also some other drugs in development. It really tells us that we need to move those drugs in development forward as fast as possible."

While drugs such as Tamiflu don't cure bird flu, experts hope they will help reduce its severity if taken early enough.

Bird flu has not yet appeared in North America and there is no proof that it can spread from person to person. But officials worry that if the virus mutates, it could become as contagious as the annual flu, but much more deadly.

Since 2004, the H5N1 virus has killed at least 71 people in Asia. According to figures updated by the World Health Organization on Dec. 16, there have been at least 139 human cases, including 95 this year alone.

More than 200 companies and governments have asked Roche if they can help manufacture Tamiflu. So far, Roche has allowed Indonesia, Thailand and the Philippines to produce the drug without paying compensation. Tamiflu is not patent protected in those countries.

Counterfeits

Now, consumers are starting to have to deal with questions about Tamiflu's authenticity as well as its efficacy.

The Canadian Press report that British authorities have identified 18 websites -- including two in Canada -- selling what they believe are counterfeit products sold under the Tamiflu brand.

But Health Canada spokeswoman Jirina Vlk said the drug supplied by the Canadian sites in question is, in fact, Tamiflu, and not counterfeit medication.

"(British authorities) may think it's counterfeit because it may not meet their labelling (standards), but they're legitimate Roche products," she said.

The other sites the British authorities flagged are based in the U.S., Britain, Switzerland, Bahrain, the Channel Island of Jersey, Cyprus, Singapore and Malta.

The British Medicines and Healthcare Products Regulatory Agency launched the investigation over concerns that a shortage of the drug in the public market has fueled sales of bogus Tamiflu over the Internet. Test purchases were made from the sites and the drugs are being tested to determine if they are really Tamiflu.

U.S. customs officials recently seized a shipment of counterfeit Tamiflu in San Francisco.

Vlk said even though the Canadian drugs were not counterfeits, would-be Tamiflu buyers should beware.

"Buying drugs from Internet pharmacies that do not provide a street address and telephone number can pose serious concerns. Patients have no way of knowing where the company is located, where it gets its drugs, what is in the drugs, and how to reach the pharmacy if there is a problem,'' she said.

CTV.ca Tamiflu found ineffective in bird flu treatment

News - The psychological impact of bird flu

More than the actual damages to livelihood and health security, it is the psychological impact of a possible bird-flu outbreak that threatens to cut the Philippines gross domestic product by 23 percentage points if the disease hits the country.

The Asian Development Bank estimated that the Philippines would be the least affected by a bird-flu outbreak, but it stressed that the impact would be long term and the economic costs, staggering.

World Bank shared ADB?s observation, as it noted in its report on the avian flu that ?the most immediate economic impacts of a pandemic might arise not from actual death or sickness but from the uncoordinated efforts of private individuals to avoid becoming infected.?

Citing Asia?s experience during the outbreak of the severe acute respiratory syndrome (SARS), the World Bank warned that the economies that would be hit by a pandemic, may grind to a halt, as people try to ?avoid infection by minimizing face-to-face interactions resulting in a severe demand shock for services sectors such as tourism, mass transportation, retail sales, hotels and restaurants.?

The report entitled ?Spread of Avian Flu Could Affect Next Year?s Economic Outlook? also noted that the outbreak could cut to productivity, as employees would refuse to go to work, for fear of contracting the disease, which may force businesses to ?shift to more costly procedure.?

The World Bank warned that ?the costs arising from panic and disruption? may be magnified by ?an initial lack of public information, contributing to a large overestimation by private individuals of the perceived probabilities of infection and death,? as experienced during the SAPS outbreak in some Asian countries.

The multiagency task recently created by President Arroyo has taken into account the need to keep the public well informed of the basic information they need to know about the disease to prevent panic in case of an outbreak.

While the country remains bird-flu free, the multiagency task force, chaired by Agriculture Secretary Domingo Panganiban, has taken steps to prevent the entry of the virus, and to prepare for a worst-case scenario should the disease finds its way intro Philippine territory.

To prevent panic and confusion, Panganiban?s team, which included representatives from the government media group, headed by Secretary Cerge Remonde, set out to embark on a massive information campaign, starting at the grassroots level, top target the first ones to be affected, should the virus hit the country.

The Manila Times Internet Edition | TOP STORIES > The psychological impact of bird flu

News - Today's Trucking: The Online Business Resource for Canada's Trucking Industry

TORONTO -- Recognizing that the threat of a pandemic outbreak of the avian flu is, in the government's words, "a matter of when - not if", the Ontario Trucking Association and the Canadian Trucking Alliance have begun work on a strategy to help carriers deal with such an emergency.

The associations are contacting government agencies and business continuity planning consultants to determine what the industry can do to prepare itself for a pandemic, the OTA states.

"During the SARS crisis in Toronto a number of carriers were impacted by quarantines and other business disruptions and we want to make sure that, to the greatest extent possible, we are better prepared for the much greater threat posed by the avian flu," OTA says.

Today's Trucking: The Online Business Resource for Canada's Trucking Industry

News - OCD 12 leads efforts to avert avian flu in Soccsksargen

Koronadal City (22 December) -- The Regional Disaster Coordinating Council 12, in an effort to avert the entry of fowls carrying the killer virus causing the global disease "Avian Influenza" is now preparing a Contingency Plan which the Office on Civil Defense take the lead.

OCD 12 director Minda Morante, in a briefing with members of the Technical Working Group of the Regional Avian Influenza Task Force stressed that the Arroyo government is seriously addressing this concerns in the light of early signs that the Philippines may not be exempt to becoming host to migratory birds carrying the virus.

The group is now validating suspected areas in the region identified as "highly vulnerable" to be affected with the bird flu disease, especially the areas around the periphery of the Liguasan Marsh in Maguindanao, the forestal area of coastal town Palimbang in Sultan Kudarat province, the province's multi-awarded Bird Sanctuary at barangay Baras in Tacurong City.

The task force is also evaluating reports by the Department of Agriculture that some parts of South Cotabato, Sarangani and Cotabato province may also be visited by the virus-carrier migratory birds.

At the early signs of Bird Flu and as preventive measure, Morante in a meeting with PIA, DOH, DA, PNP and DILG, recommends the 'MANOK POWER" strategy coined by OCD deputy administrator Dr. Anthony Rolando T. Golez' as a battlecry to make Philippines a bird-flu-free country.

MANOK POWER stands for: M-igratory birds should not be disturbed, touched, shot and eaten, A-ct on unexplained deaths of birds or domestic poultry (report to the local veterinary office), N-o to smuggling of wild exotic migratory birds, O-key to eat cooked chicken, K-eep the Philippines Bird Flu-Free!, P-rotect with protective gears like masks, googles, disposable gowns and gloves, O-rder not to touch or go near dead chickens, ducks, game fowls, W-rap dead chickens in impermeable plastic/wash your hands/change your clothings and wash again, E-mphasize not to eat dead Chickens! R-eport the incident Call 117 (or any designated telephone number by BAI).

PIA News Releases

News - Tamiflu-resistant avian flu cases raise concerns

Researchers in Vietnam have reported two additional cases of H5N1 avian flu infection in which the virus developed resistance to the antiviral drug Tamiflu, raising concerns the current dosing regimen is inadequate to combat the virulent strain.
While the findings will likely lead to questions over the future efficacy of the No. 1 weapon in the limited pharmaceutical arsenal against pandemic flu, influenza experts were quick to caution against over-interpreting the results.

Dr. Menno de Jong, lead author of the report, said the drug?s performance against the current purely avian virus can?t be used to predict how effective oseltamivir, or Tamiflu, would be if H5N1 adapts to become a strain that can easily spread among humans.

?For the current sporadic infections with this avian virus, it?s bad news,? de Jong said of his team finding resistance in two of eight cases studied from December 2004 through February 2005.

?But we cannot automatically say: `So, this is the end of the world.? ?

Dr. Keiji Fukuda of the World Health Organization agreed.

?It is . . . unhelpful to paint antiviral drugs as the . . . silver bullet. And it is equally unhelpful on the other stream to start wringing one?s hands and saying, `They?re not going to be helpful,?? Fukuda, a leading flu expert, said from Geneva.

?The truth is ? as it is for every other drug out there ? in between.?

De Jong and his co-authors ? from Oxford University?s clinical research unit at the Hospital for Tropical Medicine in Ho Chi Minh City ? published their report in Thursday?s New England Journal of Medicine.

This week?s issue of the influential journal also ran two commentaries exhorting doctors to refuse requests for Tamiflu prescriptions from people looking to stockpile the drug against a possible flu pandemic.

The de Jong paper is the second in which resistance to oseltamivir has been reported. The earlier case also occurred in Vietnam.

It?s the first, however, to report that someone suffering from H5N1 infection who received standard treatment with the drug during the optimal window ? the first 48 hours ? developed resistance to oseltamivir.

The patient, a 13-year-old girl, started Tamiflu treatment a day after she developed symptoms. Many H5N1 patients have started drug therapy well outside the recommended window for commencing treatment.

But flu experts have been speculating for some time that the current dosing regime, which is based on experience with regular human flu strains, is inadequate to combat the infection caused by this virulent avian strain.

Research studies are currently being set up in Southeast Asia to try to determine whether higher doses, for longer periods, are needed to treat H5N1 infections. Antiviral expert Dr. Frederick Hayden of the University of Virginia has just returned from Asia, where he has been working to try to co-ordinate this research.

For Hayden, the study highlights the many questions that need answering.

?Is an alternative dosing regimen ? higher dose, longer treatment, perhaps combination with another antiviral or a different drug entirely ? going to get around the (resistance) problem?? he wondered.

If it turns out the current dose is too low, that could explain the development of resistance. Doses which are too low allow the virus to evade the drug?s mechanisms.

Should the research prove that H5N1 infections require more drug for a longer period, governments which have been rushing to stockpile Tamiflu would face the unwelcome realization that existing national stockpiles will not protect as many people as they had hoped.

?I . . . worry desperately that the timing and dosage of this drug, if it is to be effective, is going to be very different than the current H3N2 (human flu) model,? said infectious disease expert Dr. Michael Osterholm, who has been warning that current stockpiling calculations may be underestimating the amount of drug needed to treat each person.

In addition to pinpointing the optimal dosing regime, flu experts hope the research will create a clearer picture of whether drug-resistant viruses, when they do arise, are capable of transmitting and spreading in the way antibiotic-resistant bacteria do.

In theory and in laboratory testing, flu viruses that find ways to evade Tamiflu lose what scientists call fitness. In essence, they become wimpier viruses that don?t transmit well ? though there is some evidence in animal models that under the right conditions resistant viruses will spread.

Flu specialists would like to see human data ? and much more of it ? before they can feel assured that the prospect of Tamiflu-resistance viruses emerging and spreading is of low probability.

Concerns about the potential spread of drug-resistant strains of flu were behind the calls in two commentaries that strongly urged doctors to refuse requests from people looking to stockpile Tamiflu.

The authors of one of the pieces, Drs. Allan Brett and Abigail Zuger, argued that personal stockpiling exhausts limited supplies of the drug meant for the treatment of people with human flu and could lead to a rise in resistance if people take the drug inappropriately.

As well, without the guidance of a physician, people could end up taking the drug when they don?t actually have flu, they argued.

?It seems to me . . . that the potential for it to be used wrongly is just so great . . . that it would just be a colossal waste, I think,? Brett, an internal medicine specialist and professor of medicine at the University of South Carolina, said in an interview.

Experts agreed with the concerns raised. But at least one noted that urging people to wait to get and take the drug under the guidance of their doctor could be misrepresenting how likely it is they?d be able to do that during the chaos a pandemic could cause.

?I think before we just summarily dismiss personal stockpiles of this drug or any other drug, we need to be honest about that and say: `OK, what?s the likelihood that people can get this drug? And how soon can they get it?,? ? said Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota.

?I think that the authors make a legitimate point. But I think it?s hardly a complete point,? said Osterholm, who favours rationing Tamiflu for health-care and essential workers, to keep hospitals and crucial services operating during a pandemic.

TheStar.com - Tamiflu-resistant avian flu cases raise concerns

News - Lack of Human Immunity Makes Bird Flu More Worrisome


Amidst all the frenzy over the bird flu virus that's raging among poultry and has killed 71 people since its onset, the issue of human immunity tops the list of grave concerns.

Because the avian flu that?s spreading rapidly among birds in Asia and now parts of Europe is a never-before-seen strain of H5N1, human beings have no natural immunity to it ? and thus no way for their bodies to fight it off should it mutate into a disease that can be passed from person to person.

?People do not have any defenses against this virus because it is entirely new,? said Jennifer Morcone, a spokeswoman for the Centers for Disease Control (CDC). ?It?s not like the other flu viruses that have circulated in the past.?

Scientists and physicians know for sure that human beings don't have any natural immunity to H5N1 because they've measured and analyzed the antibodies in patients' blood serum.

To date, everyone who has fallen ill with this form of avian flu has caught it by handling or coming into close contact with infected birds. So far, there have been 139 confirmed human cases reported since 2003, when the illness was first discovered, and 71 deaths ? a 51 percent mortality rate, according to the World Health Organization?s Dec. 16 figures.

In order for bird flu to mutate so that people can catch it from each other, an infected person has to be carrying another type of human-to-human flu bug at the same time that he or she catches the bird flu, so that the two influenza strains can swap genes.

"The avian flu picks up some genes from the other flu," said Dr. Herbert L. DuPont, director of the Center for Infectious Diseases at the University of Texas School of Public Health. "This has happened three times in the past 100 years."

All three pandemic flus of the 20th century originated from birds. The legendary 1918 Spanish flu took between 20 and 50 million lives, up to 675,000 of them in the United States; the Asian flu of 1957 killed 2 million worldwide, 70,000 in the U.S.; and the Hong Kong flu of 1968 killed 1 million worldwide, 34,000 in the U.S.

With that history in mind, what worries immunologists and other health experts is the fact that the existing form of avian flu is voraciously infecting birds across a wide swath of the globe.

The H5N1 virus initially emerged in poultry in 1996 and the first human cases and deaths were reported in 1997 in Hong Kong. Alarming, widespread poultry outbreaks began happening in 2003, which was also the onset of more human cases in Hong Kong and Vietnam.

Since then, the disease has spread to Thailand, China, Indonesia and Cambodia ? where the other human deaths have occurred ? and also to Japan, Laos, Korea, Malaysia, Croatia, Kazakhstan, Mongolia, the Philippines, Romania, Russia, Turkey and the Ukraine.

"It is a real threat because we know this is a virus that just this year has spread to three different countries in Asia," Morcone said, referring to China, Indonesia and Cambodia, the countries where human deaths have been reported in 2005.

That means it's just a matter of time before this H5N1 will travel closer to home.

?Eventually, when you have migrations of birds, you?re going to get some cases in North America,? said Dr. Gilbert Ross, medical director at the American Council on Science and Health.

In addition, unlike other flu viruses that are generally only fatal among the elderly and infirm, this influenza strain has been killing younger people ? much like the 1918 outbreak. That is in part because most of those afflicted were bird handlers in their 20s to 40s, but it also could be an indication that this strain is similar to the devastating disease of the early 20th century, which was an H1 flu.

"Fifty percent of the people who died in 1918 were between the ages of 20 and 40," said Dr. Ed Septimus, medical director of infectious disease at the Memorial Hermann Healthcare System, a cluster of hospitals in the Houston region. "We're seeing a similar mortality rate and younger people being infected and dying."

Influenza is notorious among diseases for its frequent changes, or drifts, in strain, meaning it is difficult to immunize against via one of the two main ways immunity occurs ? by vaccine or by infection with the illness.

The run-of-the-mill flu that makes an appearance every year is constantly mutating, so a new vaccine needs to be developed annually to combat whatever strain is the most prevalent in the community during that season. It's a challenge to doctors and scientists, who sometimes come up with a less effective vaccine because of the unstable nature of influenza.

?Your best protection is when the vaccine matches the strain that is circulating in the community,? Septimus said. ?In the past few years, the predominant flu bug in the community was not in the vaccine; it was a mismatch. We guessed wrong. But that still gave about 50 percent protection. If it had been a match, it would have been about 80 percent.?

The drifts in the regular cold-weather flu differ from the larger "shifts" in the virus, which happen when the hemoglobin ? the H in the scientific name for the strain ? changes entirely. This current H5N1 avian flu is new because an H5 had never been seen before.

"When the hemoglobin changes, it's a big deal," DuPont said. "When it shifts and goes to a completely different hemoglobin, there's no existing immunity and we have pandemic flu."

The so-called "shift-and-drift" nature of the flu also means that human beings who get their shots or catch that particular bug are only protected from that one specific strain during that one specific time. Unlike immunity to most other diseases, immunity to influenza is fleeting.

?The protective immunity against flu is four months from the influenza vaccine ? you have protective levels of the antibody for approximately four months,? DuPont said. ?That?s why people who get the vaccine in the early part of the season can still get the flu in the later part of the season.?

Immunity is built up when parts of the virus in question are introduced into the body, either because the person has become infected or has been vaccinated. The human system then builds up antibodies to ward the illness off.

There are two types of human vaccines: live vaccines and killed ones. Most flu vaccines are killed, meaning the agent in them is dead and can no longer be grown in a lab, but still produces antibodies and protects against the virus. Vaccines for illnesses like measles, mumps and rubella are live, made with a less virulent strain of the virus that's processed in such a way so as not to cause sickness, while still providing immunity and having the ability to keep growing in a lab.

Many people are exposed to sicknesses of various stripes without ever having any symptoms, as is the case with ?the kissing disease? known as mononucleosis. Of every 1,000 people infected with mono, only five unlucky ones actually fall ill from it ? but all are immune, according to DuPont.

?The most common way to build up immunity is to have an infection with the agent, and most agents do not produce clinical disease when they infect,? he said.

Immunity to illnesses like mono, chicken pox (which is the varicella virus), measles, mumps, polio and smallpox is generally long-lasting among people, with those infected or vaccinated having protection that can last at least a generation, if not a lifetime.

In fact, even when a human immune system hasn't seen a virus for decades and then is reintroduced to it decades later, "memory cells" in the body will often recall it and begin to quickly develop antibodies to fight it off, meaning the person will either not get sick at all or will have a much milder form of the disease.

"Sometimes, seeing a virus that's similar will wake up a dormant immune system and produce antibodies very quickly in response to a challenge from a virus," Septimus said. "It may have an effect on how severely you become ill and the expression of the illness."

Human immunity does diminish slowly over time, but with most diseases other than influenza, exposure to an illness provides at least partial immunity for years even when it has decreased from what it was originally. Flu, of course, is the black sheep.

But experts are trying to soothe those frightened by the current avian influenza that has an increasingly large part of the world in its grips, saying there is hope for a flu shot to be developed that will successfully ward it off.

"We will see an effective vaccine, just like we've seen effective vaccines for nearly every other communicable disease except HIV and malaria," said the American Council's Ross.

He and others in the field urge that in the meantime, the immediate focus should be on taking precautions, both against bird flu and the regular garden variety that's crept up on us again this wintry season.

"If they're traveling to Asia, we recommend that people don't visit live bird markets and don't go to bird farms, be mindful of the food they eat and mindful that food is cooked," said the CDC's Morcone.

Avian influenza aside, the best advice could also be the best medicine: Wash your hands frequently, especially when you're sick with the flu or a flu-type bug, stay home until you get well and cover your mouth when you cough and splutter.

"Let's not get hung up on bird flu, which may not happen ? and if it happens we don't know when," Septimus said. "Do what you're supposed to do this year, and let the scientists and government work out a plan for the potential of a pandemic."

FOXNews.com - Health - Lack of Human Immunity Makes Bird Flu More Worrisome

News - Two die of bird flu in Indonesia

The human death toll from bird flu in Indonesia rose to 11 after the World Health Organization's labs confirmed two more persons died from the H5N1 strain of avian influenza, a health official confirmed Thursday.

Ilham Patu, spokesman at Jakarta's Sulianto Saroso hospital designated to treat bird flu patients, said the confirmation from the WHO's affiliated labs in Hong Kong had been received.

"It's confirmed. We have received the confirmation this morning," Patu told Deutsche Presse-Agentur dpa.

"We have now 16 confirmed (bird flu) cases and 11 deaths, while five others have survived," he added.

Local tests had already shown that a 39-year-old man and an eight-year-boy had died from the avian influenza virus.

The man, living in a South Jakarta suburb, died on December 13, one day after being admitted to Sulianto Saroso hospital, while the boy died two days later at a private Jakarta hospital.

The H5N1 strain of the avian influenza virus is known to have killed more than 70 people in five Asian countries - Indonesia, Thailand, Vietnam, China and Cambodia.

At present, almost all of the human fatalities contracted the H5N1 bird flu virus from poultry. But experts worry it could mutate into a more deadly virus that could spread from human to human, and potentially kill millions of people around the world.

The highly pathogenic avian influenza virus has spread to more than two-thirds of the provinces in the vast archipelago of Indonesia, with more than 17,000 islands, killing millions of poultry since late 2003.

Bangkok Post - Breaking News

News - Frightening Tamiflu report


A new report has cast doubt over the drug used to combat bird flu, after two people died despite receiving the treatment.

A study of 13 Vietnamese patients infected with the H5N1 strain of bird flu found that two developed a rapid resistance to the anti-viral drug Tamiflu.

The report published in the New England Journal of Medicine came as the World Health Organisation (WHO) confirmed that a 39-year-old man and an eight-year-old boy died earlier this month of bird flu in Indonesia.

The Department of Health (DoH) is stockpiling 14.6 million courses of the drug, which it hopes will shorten the length of illness and reduce the symptoms.

A spokesman for the DoH said it would be "carefully considering" the research. She said: "While there is some anecdotal evidence of the build-up of resistance to anti-viral drugs such as Tamiflu, at present the experience is that these drugs do work and that they should work against a pandemic strain."

Tamiflu was the internationally-agreed product of choice, she added.

In the Vietnamese study, a 13-year-old girl died eight days after starting treatment. Her condition initially improved when she received the Tamiflu dose, but gradually worsened.

The girl and another patient, who died 14 days after starting treatment, were found to have an increased amount of the virus in their throats compared with the initial diagnosis.

Commenting on the report in the journal, Professor Anne Moscona of Cornell University in New York, said Tamiflu-resistant H5N1 "is now a reality".

"This frightening report should inspire us to devise pandemic strategies that do not favour the development of Tamiflu-resistant strains," she said.

But a senior WHO official today said some resistance was inevitable with any kind of drug.

Keiji Fukuda, a scientist at the WHO's global influenza programme, said: "Whenever you use any kind of drugs, antivirals or antibiotics, you expect to see resistance develop in organs.

"Finding some resistance in and of itself is not surprising and is not necessarily alarming".

Telegraph News 'Frightening' Tamiflu report

News - Sinovac Biotech Ltd. Begins Pandemic Flu (H5N1) Vaccine Clinical Trials

(Sinovac) (AMEX: SVA - News) announced today it has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers at the Beijing Sino-Japan Friendship Hospital in Beijing, China.

Due to this vaccine's mature technology, China's State Food and Drug Administration (SFDA) earlier approved modification to "fast-track" the clinical trial process from 3 phases to only 2 stages. Stage I includes 120
healthy volunteers, ages 18 - 60 years and is expected to take nine-months. However, preliminary results should be available by the end of March, 2006.

Sinovac CEO and Director, Mr. Weidong Yin commented, "This is a great day for us as we simultaneously advance China's National Pandemic Preparedness Plan and our corporate growth strategy. In addition to our successful R&D program, Sinovac has introduced two new vaccines into the market this year.
Our national and international name recognition is expanding, and I expect tremendous revenue growth in 2006."

Sinovac partnered with Beijing Sino-Japan Friendship Hospital for the successful Phase I SARS clinical trials in 2004. Protocols for clinical trials are strictly regulated and include compliance with SFDA's National Institute
for the Control of Pharmaceutical and Biological Products (NICPBP), World Health Organization (WHO) "Guidelines on Clinical Evaluation of Vaccines," and other relevant regulations. The trials will be compliant with Good Clinical Practices (GCP) procedures, including ethical guidelines.

Sinovac's Deputy General Manager, Mr. Zhang Jiansan stated, "we have established an excellent reputation at Sinovac and maintain disciplined, safe procedures during all of our R&D and production functions." These trials will use Sinovac's proprietary pandemic vaccine, Panflu(TM), which is an al adjuvant, whole virion type. Sinovac has produced sufficient vaccines to complete human clinical trials. If clinical trials are successful, the
Company estimates production capacity may be as high as 20 million doses per year using its current manufacturing facilities.

About Sinovac: Sinovac Biotech Ltd. is a world leader in the research, development, manufacture and commercialization of vaccines for endemic and pandemic viruses such as hepatitis and influenza, and for fast emerging viruses such as SARS and avian influenza (bird flu). The Company's objective is to provide Chinese
children with the best vaccines in the world, and let children in the world use vaccines made in China.

Additional information about Sinovac is available on the Company website, http://www.sinovac.com

For additional information, investor newsletters and corporate updates, please email your request to: info@sinovac.com

THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, SINOVAC'S ANALYSIS OF OPPORTUNITIES IN THE
ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE "SAFE HARBOR" PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN.

Sinovac Biotech Ltd. Begins Pandemic Flu (H5N1) Vaccine Clinical Trials

News - Control tightened on migrators from H5N1 virus-infected countries

All border gates nationwide need to tighten control on migrators entering Viet Nam from countries infected by H5N1 virus as part of the country?s efforts in preventing an outbreak of the flu in humans.

So said delegates at a session held by the National Steering Committee for Bird Flu Prevention and Control in Ha Noi on Dec. 21 to work out drastic measures to prevent bird flu outbreak in humans.

The Ministry of Health has instructed quarantine stations in border gate areas in cities and provinces across the country to conduct strict supervision on foreigners entering Viet Nam by air, land and sea, as well as all poultry products.

Cooperation between local authorities in border gate areas of Viet Nam and other countries is also identified as crucial to accelerating joint health inspection among countries. To this end, the Nam Phao border gate in the central Ha Tinh province is asked to further its coordination with the Health Ministry of Laos.

Over 85,200 people from Type A (H5N1) flu-infected countries entering Viet Nam last week underwent strict supervision. All of them tested negative for the virus.

Participants at the conference also pointed to the need to step up other measures, with focus on scaling up surveillance, launching treatment method training and providing clinics and hospitals with new medical equipment.

Viet Nam has reported no more cases of humans infected with the H5N1 virus since the last one was detected on Nov. 14.-

Wednesday, December 21, 2005

News - Turkey sales survive bird flu

The bird flu scare has failed to dent demand for Christmas turkeys, according to the latest sales figures.

Despite concerns that millions of people would reject turkeys, sales are at least as good as last year, supermarkets said yesterday.

Sainsbury's reported a 25 per cent rise in orders for fresh birds, while Asda and Tesco said bird flu fears have had no impact on demand.

At the height of the scare in October and November, there were fears that demand for turkeys would plummet, even though there have been no cases of bird flu in British poultry and no evidence that the disease can be passed to people through food.

The evidence from supermarkets is backed by a survey of 2,181 people by the market analyst company CACI, which found that 68 per cent of people are planning to eat turkey for Christmas dinner, while five per cent have yet to decide. Last year 72 per cent of people had turkey.

John Rae, director of business development at CACI, said the findings should encourage producers who may have been concerned about the impact of bird flu. "Our research suggests that the average UK consumer is quite traditionalist when it comes to planning the Christmas meal, as turkey has remained popular with many people."

Peter Bradnock, chief executive of the British Poultry Council, said: "There doesn't appear to have been any impact. There's been no reports of any drop-off in sales, while growers for the Christmas trade are reported strong sales."

Around 10 million turkeys are eaten every Christmas. The first fresh Christmas turkeys began appearing in the shops this week.

Meanwhile, the popularity of Brussels sprouts has risen this Christmas, with Waitrose saying yesterday that its sales in December have increased by 15 per cent compared with the same time last year.

Peter Cooke, the supermarket's vegetable buyer, said new growing techniques had made sprouts less bitter and had given them a more nutty flavour.

"Even the children around the dinner table will agree that sprouts are delicious," Mr Cooke said.

Telegraph News Turkey sales survive bird flu

News - Bird flu, AIDS, provide contrast in reaction speeds


New York - If ever there was a vivid contrast between world reaction to diseases, it became apparent this year.

Less than a year after the spectre of a global avian flu epidemic first arose, the world's medical and political infrastructure was in high gear to head off a disease that has not yet even learned the art of human-to-human contagion.

But nearly 25 years and 25 million deaths after the discovery of the AIDS virus, the world is still trying to scrimp together enough money to prevent and treat Acquired Immunity Deficiency Syndrome (AIDS) - a disease that is worst in poverty-stricken African countries.

The disparity throws a spotlight on how economic considerations drive the world's reaction to disease. Among health advocates, government officials and United Nations experts, it's an open secret why wealthier countries have paid greater and more immediate attention to bird flu - which has killed barely about 70 humans - than they did to HIV/AIDS.

Bird Flu could slice away 5 per cent of U.S. economic production as a direct and indirect consequence of a bird flu epidemic, and U.S. Senate majority leader Bill Frist has put a U.S. price tag of 675- billion-dollar on it.

President George W. Bush has pledged 7 billion dollars for vaccine research in the U.S., and a small token of 250 million dollars to help other countries contain the flu.

AIDS has less of a constituency not only because of its slow moving diagnosis and spread, but also because its economic impact is felt hardest in poorer countries, where it is wiping out the young, skilled labour adults vital to raising the next generation. In the U.S. and Europe, on the other hand, AIDS was mainly transmitted among homosexuals.

Finding an effective anti-AIDS cure has eluded the best health laboratories in the world, and research only began gearing up in the mid 1990s. The Global Fund to fight HIV/AIDS, tuberculosis and malaria was created only in 2000.

An estimated 40.3 million people now live with the AIDS virus, including 5 million new infections in 2005, and AIDS deaths could only peak in mid-century.

The avian flu first struck Asia in 2003, and has been carried to wild and domestic bird flocks by migratory birds as far as their wings can fly. It has claimed more than 70 human lives and resulted in the culling of tens of thousands of poultry.

To prevent an avian flu explosion, governments rushed to get licenses to produce anti-virals like oseltamivir, or tamiflu, and Asian are collaborating to produce generic tamiflu.

Richard Feachem, the executive director of The Global AIDS Fund, warns that the inexorable growth of the slower moving HIV/AIDS will still be seen as the 'greatest failure in public health policy and action of all time.'

Feachem says that either the world has done its best against a disease so 'intractable' that it defies human efforts, or we have done far too little, far too late.'

'The truth lies somewhere in between, but is much closer to the second proposition than the first,' Feachem said.

The Global Fund, established in 2000 by Secretary-General Kofi Annan, is the only effort with support from the world's seven richest industrialized nations. With assets of 8.6 billion dollars, it is committed to spending 4.4 billion dollars on 350 programmes in 130 countries to fight HIV/AIDS.

Feachem, who noted the disparity in attention given the two diseases, wondered whether it is because bird flu threatens more white people than black? Or is it because it could bring down the economies of North America, Europe and Asia?

Whatever the case, Feachem urges strenuous application of the lessons learned in fighting HIV/AIDS. Political leadership, technology and the full force of biological science must be mobilized to fight epidemics.

Failure, he says, would be hugely expensive compared to the amount spent to anticipate and head off a bird flu epidemic, for example.

Failure, in fact, is what the world's public health system is already confronting in the HIV/AIDS fight.

The South Africa-originated International Treatment Preparedness Coalition (ITPC), comprised of 600 activist groups in 100 countries, blames the failures on lack of national leadership in many countries - especially in the hard-hit Dominican Republic, India, Kenya, Nigeria, Russia and South Africa - and on severe shortage of healthcare workers.

The facts are dismal. In January, the World Health Organization (WHO) is expected to give details of its failed '3 by 5' AIDS initiative, which has missed its target by at least 50 per cent. WHO's goal had been to provide anti-retroviral treatment to 3 million HIV-infected people in five years ending in December 2005.

The ITPC blames red tape, pervasive stigma against AIDS patients, poor management and inadequate funding for the shortfall.

Taiwan on the other hand is an example of a wealthy country that has tackled both AIDS and bird flu with little outside help - mainly because China blocks its membership in WHO.

Dr. Steve Kuo, director of Taiwan's Center for Disease Control, says his government has been assisted by specialists from the United States, Australia and other Western nations.

'We provide anti-viral (HIV) treatment free to our patients, who number around 10,000' for the whole country, Kuo said. His government is gearing up for avian flu, using the experience of the SARS (Severe Acute Respiratory Syndrome) epidemic in 2003, when dozens of people died in Asia from eating infected animals.

Bird flu, AIDS, provide contrast in reaction speeds

News - Jakarta Residents Are Targets in Indonesia's Bird Flu Campaign

Indonesia's planned door-to-door bird-flu surveillance will begin in Jakarta tomorrow, Agriculture Minister Anton Apriantono said, bolstering the country's efforts to curb the disease that has killed at least nine Indonesians.

Starting Dec. 22, representatives from local communities, the military and student volunteers will traverse the nation's capital of about 9 million people to root out diseased fowl and pet birds in homes and backyards, Apriantono said in a telephone interview late yesterday.

``Hundreds of people will be involved and we will do it for as long as it takes,'' Apriantono said. He declined to say how much the operation will cost or how the government plans to fund the program. At least eight of 14 confirmed cases in Indonesia involved people living in Jakarta.

Indonesian President Susilo Bambang Yudhoyono is under pressure to control outbreaks of the H5N1 avian flu strain in birds that increase the risk of the disease infecting humans and possibly mutating into a form that's easily spread among people.

Human infections from H5N1 have more than doubled this year, fueling concern about a flu pandemic, which World Bank officials last month said may cost the world $800 billion to control.

The H5N1 virus has killed at least 71 people in Asia since 2004. There have been at least 139 human cases, including 95 this year, according to figures updated by the World Health Organization on Dec. 16.

Program Extended

Apriantono said the government's bird-flu surveillance program may be extended to other cities as needed. The Agriculture Ministry will hand out guidelines on how to cull infected chickens, he said. The ministry will cooperate with the Jakarta administration in carrying out the operation.

The government is working on a new measure that may ban people from raising chickens unless they are kept it in a coop to prevent them getting infected by migratory birds, Apriantono said.

``Many of the new cases occurred in chickens raised by families in their backyards and that's why it's getting more difficult for us to detect,'' the minister said.

The Southeast Asian nation has 30 million villages with more than 200 million chickens in backyards, according to the Food and Agriculture Organization.

``We have to do this gradually so that the new measure will be effective in halting the spread of the disease,'' Apriantono said. About 10.5 million chickens in 70 percent of the nation's provinces have died from the disease since the outbreak in 2003, he said.
Bloomberg.com: Asia

News - Defra lifts bird fair restriction


A ban on bird fairs which was brought in to combat the potential spread of bird flu has been lifted in the UK.
Falconry events, pigeon races and other events involving birds can go ahead as they did before the temporary EU-wide restrictions came in during the autumn.

Environment department Defra said the ban was reviewed and risk analyses were carried out before it was lifted.

But the Liberal Democrats accused ministers of making an "unwise and precipitous" decision.

"Defra seems to have caved in to a small group of bird fanciers at the risk of animal welfare and public health," said Lib Dem environment spokesman Norman Baker.

The ban was enforced at the height of fears that the deadly H5N1 bird flu strain could mutate and create a human flu pandemic.

During November, the government described the risk of H5N1 bird flu hitting the UK as "increased but low".

The latest move means bird events within the British Isles may now go ahead under general licence.

Event organisers must advise their local State Veterinary Service Animal Health Office in advance and comply with bio-security measures.

Other relevant legislation will still apply, Defra said.

The British Falconers' Club welcomed the move.

Director John Callaghan said: "We will be vigilant and work within the constraints of what Defra advises."

BBC NEWS UK UK Politics Defra lifts bird fair restriction

News - Bird flu pandemic may cost NZ dearly: report

A bird flu pandemic would cost New Zealand 15 billion to 30 billion NZ dollars (10.5 billion to 21 billion US dollars) in the first year, New Zealand Treasury's report said Tuesday.

The loss to the economy would be around 10 to 20 percent of GDP in the year that a pandemic occurred, it said in a report.

The cost over four years would be up to 40 billion NZ dollars ( 28 billion US dollars).

"The economy would take several years to recover from a shock of this scale and losses could amount to 15-30 percent of annual GDP over the medium term," said the report.

The World Health organization (WHO) has warned that the risk of an influenza pandemic on the scale of the "Spanish flu" outbreak in 1918 has been raised by the emergence of a highly pathogenic strain of avian influenza, H5N1.

If bird flu mutates so it can be transmitted from human to human, the risk of a pandemic is seen as high by the WHO. Under the most severe scenario, the Ministry of Health estimates up to 40 percent of the population could contract influenza, with 2 percent of those infected dying. This could result in up to 33,000 deaths in New Zealand.

Treasury and the Reserve Bank are now helping develop plans in case of the pandemic. Issues of financial support or compensation are also being considered, including who should pay if businesses have to furlough their workers, and the possibility of support for industries heavily affected by a pandemic.

People's Daily Online -- Bird flu pandemic may cost NZ dearly: report

News - China starts human trials of bird flu vaccine

BEIJING, Dec 21 (Reuters) - China has begun human trials of its homegrown bird flu vaccine with six volunteers receiving shots, the official Xinhua news agency said on Wednesday. A total of 120 people, aged from 18 to 60 and all from Beijing and in good health, had volunteered to take part in the trials, Xinhua said.

"After half an hour of clinical observation, the volunteers experienced no bad reaction of either the whole or part of the body," the agency said.

Though the trials will need nine months of tests, initial results are expected within the first three, it added.

Xinhua provided no further details.

China has had more than 30 outbreaks of the deadly H5N1 strain of bird flu that scientists fear could mutate from a disease which largely affects birds to one that can pass easily between people, leading to a human pandemic.

There have been 139 confirmed human cases of H5N1, all of them in Asia, including six in China. Two people have died from bird flu in China, out of 71 known fatalities in Asia.

The head of the company researching the vaccine, Sinovac Biotech, told Reuters last month that it was at least a year away from hitting the shelves.

Development of the vaccine -- called Panflu -- started last year after bird flu outbreaks in Thailand and Vietnam and animal trials have already been completed.

Experts say experimental vaccines for bird flu are unlikely to be a good match for an H5N1 strain that may eventually emerge in transmissible form among humans.

Using current technology it takes six months or more to make a new flu vaccine and there is no way to predict what a pandemic strain might look like.

Currently, Roche Pharmaceuticals' Tamiflu is one of four drugs known to work against influenza. It does not cure the virus but can reduce the severity of infection and in some cases prevent infection.

Doctors believe it may help control a pandemic of H5N1, although evidence suggests it may be less effective than it is against seasonal influenza.

Reuters AlertNet - China starts human trials of bird flu vaccine

Tuesday, December 20, 2005

News - Bird flu could devastate NZ economy - Breaking News - World - Breaking News

A New Zealand treasury briefing paper on possible consequences of bird flu warns it could be the worst economic catastrophe since the Great Depression of the 1930s.

A briefing paper to the New Zealand government said lost output could be of the order of 10 to 20 per cent of GDP, costing $NZ15 billion-$NZ30 billion ($A28 billion-$A14 billion), in the year a pandemic occurred.

Under this severe impact scenario, it could cost the country up to $NZ40 billion ($A37.36 billion) over four years.

Treasury assesses the risk of a severe flu pandemic as low but with a potentially very high impact.

"The economy would take several years to recover from a shock of this scale," the report said.

"If this worst case scenario came to fruition it would probably be the most adverse shock since the Depression, but as not as serious as the Depression," Treasury director Bob Buckle told NZPA.

He and the report stressed considerable uncertainty on the likelihood of a pandemic and its severity.

Fellow Treasury director Jeremy Corban noted there were several less severe scenarios. Flu pandemics in 1957 and 1968 caused minimal economic impact.

"This scenario is very much worst case - 'maximum credible event' are words I've heard to describe it."

Normally, the risk of a flu pandemic is 1-2 per cent over any one year, and 20-30 per cent over 20 years. But Treasury quotes Australia's chief medical officer as putting the odds at 10 per cent over the next few years.

Economists said trade, which comprises over a third of the economy, was likely to come to a standstill as borders here and overseas close. The $NZ4-6 billion tourism industry would halt overnight.

Ordinary businesses would find it difficult to operate, even assuming any workers showed up, as supplies from overseas would be severely disrupted.

Institute of Economic Research director Brent Layton said that under the dire scenario the Reserve Bank would slash the official cash rate, now at 7.25 per cent.

"If we really are looking at a 20 per cent dive in GDP, they would have it (the official cash rate) well down - it wouldn't be too much above zero."

Infometrics managing director Andrew Gawith, like other economists, remains sceptical of the dire scenario.

"All the economic catastrophes I've experienced - the Asian financial crisis of '97/98 was going to do all sorts of dastardly things - in the end, were over remarkably quickly."

He said the consequences of the fear factor were high, "and that, I've no doubt will have quite a severe economic impact, but my impression is you get over that relatively quickly".

Mr Gawith said New Zealand's high foreign debt would see the kiwi dollar savaged. Inflation would be the least of the Reserve Bank's worries, he added.

The World Health Organisation (WHO) has warned of increased risk of a pandemic on the scale of the 1918 "Spanish flu" because of the emergence of a highly pathogenic strain of avian flu, H5N1.

H5N1 has killed just over 60 people in Asia since January 2004, but only if it mutates so it can be transmitted from human to human is it likely to become a pandemic. WHO assesses such risk as high.

Under the most severe scenario, the Ministry of Health estimates up to 40 per cent of the population could contract flu, with 2 per cent of those dying, resulting in up to 33,000 deaths.

Treasury warns of possible shortages of raw materials such as oil, and major disruption to global supply chains as borders close.

"Schools, universities, creches, libraries, bars, cinemas, and other places of gathering may close, either as a public health measure to prevent the spread of disease, or through a downturn in customer numbers," the report notes.

"Many people would be absent from work because of sickness, caring responsibilities, fear of infection, or because they had been requested to stay home by their employer.

"A large number of households may come under financial stress."

Treasury and the Reserve Bank have developed plans to keep the financial system and government payments running.

Treasury has requested that the government consider what support might be needed to help financially distressed households and firms.

It asks who should pay if businesses have to furlough workers and what support might be available for heavily affected industries.

Mr Corban said the government was in good shape to help. One reason why it had been trying to get debt down to prudent levels was to give it the ability to cope with such adverse shocks.

Government tax revenue would fall with GDP while demands would rise. Treasury has not quantified the likely effect on the books.

Mr Gawith agreed the government's relatively low debt meant it was in a good position to provide compensation. However, it would quickly chomp through its budget surplus and could be forced into a debt-financed fiscal rescue.

If the situation became dire, there was even "the outlandish possibility of the government printing money", which was done in the 1930s to re-inflate the economy.

Bird flu could devastate NZ economy - Breaking News - World - Breaking News

News - Sanofi's human bird flu vaccine tests looking good

French drug company Sanofi Pasteur says early stage trials of an experimental vaccine against H5N1 bird flu have shown it provides a good immune response in humans and is safe.
Sanofi Pasteur, the vaccine unit of drug maker Sanofi-Aventis has called the preliminary results of the Phase I trial on 300 healthy volunteers encouraging.

All around the world governments are struggling to control the spread of the H5N1 bird flu virus and prevent an influenza pandemic from developing.

To date the virus has killed 71 people out of 138 known human cases, all of them in Asia.

It is very significant that Sanofi now says its vaccine has proved effective when given at a lower dose than in an earlier trial, which would allow it available to more people in the event of a pandemic triggered.

Sanofi Pasteur says they found that a 30 microgram dose with an additive that boosts the immune response, in a two-dose regimen, showed an immune response consistent with the requirements of regulators to approve seasonal influenza vaccine.

Earlier tests conducted this year along with U.S. government researchers had used two doses of 90 micrograms each.

The company says it plans to conduct further Phase II trials in 2006 as a good immune response was seen in a significant number of volunteers who tolerated the vaccine well, establishing the basis for further trials and research.

The researchers also say immune responses were seen in a number of volunteers receiving lower doses.

Future trials will examine different dosages that could help low-dose strategies widely discussed by public health experts.

Many experts fear the H5N1 virus could mutate into a form easily transmitted from person to person and sweep the world, killing millions within weeks or months.

So far, almost all human cases can be traced to direct or indirect contact with infected birds.

Sanofi Pasteur will use the latest clinical trial results as part of its "mock up" vaccine dossier to the European Medicines Agency.

The process is expected to reduce the time necessary for approval of a pandemic vaccine once a strain is identified and a pandemic is declared.

The French group is one of several vaccine producers, including GlaxoSmithKline Plc and Chiron Corp, racing to develop a vaccine to protect humans from bird flu.

Although the World Health Organisation (WHO) has welcomed Sanofi Pasteur's announcement, it cautions that an effective vaccine that would be commercially available was still a long way off.

WHO spokeswoman Maria Cheng in Geneva says it is a good first step, but it is preliminary and there is not enough evidence that the vaccine will be effective.

She says as yet it is unknown how well any H5N1 vaccine will match a future pandemic strain, but experts hope it will "prime" a person's immune system so they will get stronger effects from a later, better-matched vaccine.

WestLB analyst Oliver Kaemmerer praises the progress but he too notes that current "pre-pandemic" shots are only a halfway house in developing a truly effective pandemic vaccine, which can only be produced once a new strain of flu that spreads easily from humans to humans emerges.

Sanofi's human bird flu vaccine tests looking good

News - Birdflu cost to NZ 'up to $30bn in first year' - 20 Dec 2005 - National News


A birdflu pandemic would cost New Zealand between $15 billion and $30 billion in the first year, Treasury said today.

The loss to the economy would be around 10 to 20 per cent of GDP in the year that a pandemic occurred, it said in a report.

The cost over four years would be up to $40 billion.

"The economy would take several years to recover from a shock of this scale and losses could amount to 15-30 per cent of annual GDP over the medium term," Treasury said.

The report, written on November 2, was published on its website today (link at foot of page).

Normally, the risk of flu pandemic is considered to be 1 to 2 per cent over any one year, or 20 to 30 per cent over 20 years, but Treasury quotes Australia's Chief Medical Officer as putting the odds of a pandemic over the next few years at 10 per cent.

The World Health Organisation (WHO) has warned that the risk of an influenza pandemic on the scale of the "Spanish flu" outbreak in 1918 has been raised by the emergence of a highly pathogenic strain of avian influenza in Asia, H5N1.

H5N1 has killed more than 60 people since January 2004 in Vietnam, Thailand and most recently, Indonesia, all of whom were infected by contact with diseased birds.

If birdflu mutates so it can be transmitted from human to human, the risk of a pandemic is seen as high by the WHO. Under the most severe scenario, the Ministry of Health estimates up to 40 per cent of the population could contract influenza, with 2 per cent of those infected dying. This could result in up to 33,000 deaths in New Zealand.

Border controls imposed either in New Zealand or in other countries would disrupt trade and tourism.

There would be possible shortages of raw materials such as oil, and a major disruption to global supply chains.

"Schools, universities, creches, libraries, bars, cinemas, and other places of gathering may close, either as a public health measure to prevent the spread of disease, or through a downturn in customer numbers," the Treasury report notes.

"Many people would be absent from work because of sickness, caring responsibilities, fear of infection, or because they had been requested to stay home by their employer.

"A large number of households may come under financial stress."

It said demand for non-essential goods and services would be likely to fall, and some firms would close up for the duration, or go out of business. The retail and hospitality sectors would be hard hit.

Treasury and the Reserve Bank are helping develop plans so the financial system and Government payments keep running.

The report said: "Issues of financial support or compensation are also being considered, including who should pay if businesses have to furlough their workers (either as a health and safety measure for their staff, or as a result of a public health intervention), and the possibility of support for industries heavily affected by a pandemic."

Banks' decisions on maintaining credit to distressed firms, for example, and IRD's treatment of tax liabilities, may have an important bearing on firms' resilience, it noted.

Birdflu cost to NZ 'up to $30bn in first year' - 20 Dec 2005 - National News

News - AVIAN FLU PANDEMIC POSSIBILITY INCREASES

This H5N1 virus is slowly changing through genetic re-assortment or mutation. The change is slow, but if this virus undergoes the change that leads to sustained human-to-human transmission, then we have a major problem. Then we probably will have the next human pandemic influenza. This is (a) serious risk.?"

David Nabarro, avian-flu coordinator for the United Nations, was speaking. The bottom line: the world community is "?losing the battle.?" Avian flu in fowl is not lessening but increasing.

Certain areas of the globe are na�ve about the subject. The populations don?t have the basic, critical information. They don?t understand the seriousness of the threat. They go about their daily routines as if all is well, or at least not so bad.

In these geographies where birds are mingling and flying and eaten by humans, the bird flu virus could ignite into a pandemic worldwide.

According to UPI?s Kate Walker, the birds are presently the threat. "?Virologists who study these things say do not get complacent. It is quite feasible that H5N1 could mutate.?"

The world community does not have a full-proof vaccine to combat such a new virus. The time frame for discovering same is not soon.

"?The change is slow, but if this virus undergoes the change that leads to sustained human-to-human transmission, then we have a major problem. Then we probably will have the next human pandemic influenza.?"

Dead birds were everywhere in central Malawi region of Ntchisi. Fork-Tailed Drongos dropped dead in the Mwera Hills district. Humans living there were eating the birds. They did not have any idea that they could be eating their deaths.

"?Someone alerted police that people are feasting on mysterious manna from heaven and when police contacted us we sent officials to caution the people not to eat them since they may have the avian flu which has proved deadly to humans in other countries,? said Wilfred Lipita, director of livestock and animal health in Malawi's Ministry of Agriculture and Food Security."

Some areas are relying on Tamiflu. But there is no guarantee that Tamiflu will stand up to the mutated virus. In the meantime, some shipments from Asia were found to be counterfeit. The Food and Drug Administration stated to media that the shipments were not reliable products unto the standards of Roche?s Tamiflu.

In Indonesia, an 8-year-old boy died of avian influenza.

In Russia, 186 swans were found dead in Kalmykia, having died of bird flu. The municipalities have been quarantined. Neighboring areas are called "high risk" geographies.

Romania informed media that still another "potential outbreak of avian flu" has been registered. It appeared among chickens in a village near Bucharest. Villagers are quarantined.

In China, officials have closed down a university avian-flu laboratory. It was reported not to have "met state regulations."

"?This is a psychologically telling moment for a country that has never had bird flu cases in the past in humans,? said Mr. Wadia. ?This will drive home to citizens across the country that this can happen in our own backyards. It's a very real threat,?" according to Joe McDonald of The Independent.

There is fear that humans dying en masse throughout China could occur because the population is so very close daily to birds. That is why there has been an expanded vaccination of birds throughout the nation.

Other nations are taking precautions worldwide with health experts meeting daily to figure out what vaccine will work to oust the virus if it strikes human beings. However, there is no guarantee that a vaccine can be come upon since no one knows what a mutant virus will be like when it does appear. Therefore, stockpiling present vaccines may in the end prove futile, though stockpiling has become an alarm reaction in many areas.

US President George W. Bush has warned Americans already concerning the possible pandemic. Other freedom-based national leaders have followed with like pronouncements.

China officialdom has concluded that it is inevitable that human infection will occur in that country. In response to that fear, millions of birds have been destroyed.

Australia has responded to bird flu fears by stating that it may be that persons flying into the country will be housed in airplane hangers where medical experts will examine them. If there is any question as to the health of passengers, they will not be permitted to enter the country.

AVIAN FLU PANDEMIC POSSIBILITY INCREASES - J. Grant Swank Jr.

News - Aid for avian flu diagnostic lab upgrade

The Agricultural and Processed Food Products' Export Development Authority (APEDA) has offered financial support to the Namakkal-based poultry exporters to upgrade the animal disease laboratory to handle avian disease diagnosis.

APEDA could extend financial support up to Rs 50 lakh to upgrade an existing lab so as to facilitate setting up a disease certification facility within the Namakkal poultry region itself. It also suggested that such funding would be possible if the existing animal disease lab of the Government veterinary college in Namakkal is upgraded.

The APEDA Chairman, K.S. Money, conveyed this to the members of the poultry exporters at a meeting held in Namakkal under the aegis of the All India Poultry Products Exporters Association (APPEA). The APPEA members in their first national meet on poultry products' exports had pleaded for speedy release of the APEDA-routed freight subsidy for the poultry shipments as the table egg shippers are constrained over the `inordinate' delay in its realisation.

The egg exporters also wanted the five per cent export incentive for poultry products under the Vishesh Krishi Upaj Yogana from 2005-06 to be given with retrospective effect from 2004-05 fiscal, the year when the Yogana was introduced, as was given to the cashew exporters. Read more Finance news.

The APEDA Chairman has offered to expedite the release of the freight subsidy for the table egg exporters by way of simplifying the documentation and also upgrading the APEDA's in-house facility currently handling the processing of the subsidy claims. The President of the APPEA, K. Singaraj, and the advisor to APPEA, Dr P. Selvaraj, made a presentation on the current status of the poultry industry and its growth and export potential to the APEDA Chairman.

Being a key table egg exporting centre in the country, egg exports from Namakkal zone account for 80 per cent of the 3.5 million eggs being exported daily from the country. APPEA had urged APEDA to initiate measures to declare the region as "the special export processing zone for poultry".

Responding to this, Money said APEDA would also facilitate taking up the matter.

Money also assured APEDA would take up the egg exporters request to increase the DEPB scheme benefit from one per cent to five per cent of the f.o.b value.

Aid for avian flu diagnostic lab upgrade - Sify.com

News - Sanofi Pasteur Announces Preliminary Trial Results for a First H5N1 Pre-Pandemic Influenza Vaccine Candidate With an Adjuvant

LYON, France -- Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced that preliminary results of clinical trials fielded in France of an adjuvanted candidate H5N1 pre-pandemic influenza vaccine demonstrated a good immune response in a significant number of volunteers. This is the first trial of an H5N1pre-pandemic influenza vaccine candidate that compared vaccines with and without adjuvants. Preliminary results showed that the vaccine is safe and well-tolerated in 300 healthy volunteers. A 30 microgram-dose with an adjuvant in a two-dose regimen demonstrated an immune response at levels consistent with requirements of regulatory agencies for licensure of seasonal influenza vaccine.

Sanofi pasteur characterized the preliminary results as a sign of progress and providing direction for further development of a pandemic influenza vaccine. The company also noted that immune responses were detected in a number of volunteers receiving lower doses. Subsequent trials will explore different dosages, which may be helpful in answering questions about dose-sparing strategies and which is being widely discussed among the public health community.

The trial was sponsored by sanofi pasteur and fielded in three sites in France: Necker and Cochin Hospitals in Paris, and Garches Hospital, with professor Jean-Louis Bresson as the principal investigator.

The vaccine used the reference strain provided by the UK's National Institute for Biological Standards and Control (NIBSC). Assays were performed at NIBSC and the UK Health Protection Agency.

As definitive results become available, they will be presented and published, as well as submitted to appropriate regulatory authorities for review.

The data will be submitted as part of the company's core "mock up" vaccine dossier to the European Agency for the Evaluation of Medicinal Products (EMEA). The core dossier has been developed in strict accordance to the EMEA guidelines. This process is expected to reduce the time necessary for approval of a pandemic vaccine in Europe once a strain is identified and a pandemic is declared. Follow-up studies, currently being planned, will be performed using vaccine produced at large scale, which will mimic the manufacturing scale that will be used during a declared pandemic.

This is one of a number of initiatives by the company to help prepare the world for the possibility of an influenza pandemic.

- Sanofi pasteur is investing in a major expansion of its influenza vaccine production capacity in the US, and also of its vaccine production capacity in France (Val de Reuil facility).

- Sanofi pasteur has entered into an agreement with the French Ministry

of Health to produce pre-pandemic vaccine in 2005 to create a1.4 million dose

stockpile with the H5N1 candidate studied in this trial. By this agreement,

the company could also provide enough vaccine to protect up to 28 million

people in the event of a pandemic being declared, once the actual virus

strain responsible is identified.

- Sanofi pasteur has entered into a series of contracts with the U.S. government to increase that country's pandemic preparedness efforts. The contracts include investigational doses for clinical trials; bulk vaccine for stockpiles; establishment and maintenance of laying flocks to enable year-round egg production (not just seasonal), as well as a contract to speed the production process for new cell culture influenza vaccines, including the design of a US-based cell-culture vaccine manufacturing facility.

- A contract has also been signed with the Australian government for the supply of vaccine in the event of a pandemic influenza outbreak. There are also contacts concerning pandemic preparedness between sanofi pasteur and other governments in Europe and worldwide

- In addition, sanofi pasteur is the only vaccine manufacturer to participate in FLUPAN, an EU-funded collaboration. FLUPAN partners include the National Institute for Biological Standards & Control (NIBSC -UK), the University of Reading (UK), Istituto Superiore di Sanita, (Italy), the Health Protection Agency (UK), and the University of Bergen (Norway). FLUPAN is intended to improve the level of pandemic preparedness in the EU. Sanofi pasteur is to produce a vaccine to combat another strain with pandemic potential (H7N1) that will be used in a FLUPAN clinical study.

Infection Control Today - Sanofi Pasteur Announces Preliminary Trial Results for a First H5N1 Pre-Pandemic Influenza Vaccine Candidate With an Adjuvant

News - Avian influenza H5N1 detection kits set to launch: News from Applied Biosystems

Kits detect the viral H5 subtype including H5N1 in human and animal samples in less than two hours; set for release for research and epidemiological use now and will be broadly available early in 2006

Applied Biosystems's TaqMan Influenza A/H5 Detection Kits, which detect the viral H5 subtype, including H5N1, in human and animal samples in less than two hours, are set for release to select laboratories around the world for research and epidemiological use before the end of 2005 and will be broadly available early in 2006. The detection kit, which is currently being tested and optimised against viral samples from the Hong Kong outbreaks of avian flu, is designed to run using standardised protocols on the Applied Biosystems real-time PCR system, and is part of a comprehensive package of technologies from Applied Biosystems for public health officials and researchers involved in the evaluation and surveillance of H5N1 avian influenza outbreaks. The package also includes standardised genome sequencing protocols and technology, ongoing genetic sequence information from the virus and access to a global influenza genome database.

The analysis software will also be made available through non-exclusive licenses and laboratories using Applied Biosystems's sequencing platform will be encouraged to submit influenza genome sequence information to the Los Alamos National Library (LANL) Influenza Sequence Database, GenBank, the National Institutes of Health (NIH) sequence database, or other publicly accessible databases, to ensure maximal sharing of scientific information.

Avian influenza H5N1 detection kits set to launch: News from Applied Biosystems

Monday, December 19, 2005

News - Bird flu mutations bringing world closer to pandemic: UN


No human-to-human transmission of bird flu has been found so far, but subtle mutations in the virus are bringing the world closer to a pandemic, the UN's coordinator on avian influenza has warned recently.

"There are some subtle changes in the genetic makeup of H5N1 which suggest that it is making some of the mutations that would enable it to have a higher likelihood of being able to become a human-to-human transmitted virus," said David Nabarro in Phnom Penh during a one-day visit to Cambodia, which has seen at least four human bird flu deaths.

"Virologists who study these things say do not get complacent. It is quite feasible that H5N1 could mutate. The fact that it has taken some years should not lead you to believe that we are through the worst."

He warned that there are difficulties stockpiling enough anti-viral medicines to combat the illness.

"We all would like there to be much more stock of anti-viral medicines. We are in a bit of difficulty because the production capacity, particularly of (Tamiflu), is quite restricted," he said, adding that the UN was in regular talks with drug manufacturers to build up stocks.

The bird flu virus has killed more than 70 people through Asia since 2003 and resulted in the culling of millions of birds, dealing a huge blow to regional poultry industries.

Xinhua - English

News - Flu Virus Discovered in Bird Dropping in South Korea, Govt Says

South Korea discovered a virus that could mutate into a deadly strain of bird flu in a dropping collected as part of nationwide testing, a government official said today.

The H5 subtype was in one of 50 samples of bird droppings to test positive for `low-pathogenic' avian influenza, said Yang Heung Gu, a veterinary officer at the Ministry of Agriculture and Forestry, in a telephone interview in Seoul. Low-pathogenic strains do not cause severe disease in birds.

Health authorities working to avert a global pandemic of bird flu -- predicted to kill as many as 7.4 million people -- are concerned by outbreaks of viruses such as H5 because they can mutate into deadly strains. Since mid-2003, the severe H5N1 virus has infected at least 139 people across Asia, killing 71, according to the World Health Organization.

The H5 virus was in a migratory bird's dropping, found at a lake in Ansan, a city west of Seoul, and the government will take no particular action, Yang said. ``We will act if chickens and geese are infected with H5 or H7 subtypes,'' he said. The investigation of bird droppings began in October, a statement from the government ministry said.

Bloomberg.com: Japan

News - Kirin develops antibody that may work for bird flu

Kirin Brewery Co. Ltd., Japan's second-largest brewer, said on Monday that its U.S. subsidiary has developed an antibody that may be effective against bird flu, sending its share price higher.

A company spokesman said the subsidiary, Gemini Science Inc., is planning to develop a drug through a partnership, but added that it would take time to commercialize any such product.

"It's hard to say how long, but I can say that it's not going to be in two or three years," he said.

Kirin Brewery shares rose 7.1 percent to 1,412 yen after earlier climbing as high as to 1,471 yen, a level last seen in 1999.

The H5N1 strain of avian influenza has killed 71 people since late 2003, spreading through flocks of poultry across Asia and into Europe. Anti-bird flu measures are a closely watched topic in the stock market.

Last Thursday, textile maker Nisshinbo Industries Inc. surged after the company said it and a Japanese university had jointly developed a new fabric that destroys the bird flu virus. It can be used for masks and clothing as well as for materials for chicken coops, the company said.

Global Coverage Article Reuters.co.uk

News - Local tests show Indonesian boy died of bird flu


An eight-year-old Indonesian boy has died from the H5N1 strain of bird flu according to local tests, a Health Ministry official said on Monday.

Hariadi Wibisono, head of a department charged with eradicating animal-borne diseases, said the local test results had yet to be confirmed by a Hong Kong laboratory affiliated with the World Health Organization.

"Based on the results, local tests show he is positive for bird flu," Wibisono told Reuters.

Indonesia has had nine deaths from bird flu confirmed by the Hong Kong laboratory and five cases where patients have survived.

Besides the boy, Indonesia is also awaiting confirmation from Hong Kong of local tests which showed a 39-year-old man died of bird flu last week.

It was unclear if the boy, who died in Jakarta last week, had contact with infected chickens, Wibisono said.

Since late 2003, the H5N1 virus is known to have killed 71 people in five Asian countries -- Indonesia, Thailand, Vietnam, China and Cambodia -- and almost all are believed to have caught it from infected fowl.

The highly pathogenic H5N1 strain is hard for humans to catch and remains essentially a virus in birds. However, scientists fear it could mutate into a form that could pass easily from human to human.

The United Nations urged Jakarta to take steps to halt the spread of the disease.

"We are losing the battle against this particular avian influenza outbreak. It is a very nasty bird flu virus," David Nabarro, the U.N. coordinator for avian influenza, told Indonesian officials at a meeting in Jakarta.

"Act as though a pandemic influenza will start tomorrow. Don't think we can wait around and not worry it won't start for six months or one year," Nabarro said. "Once, it starts it is too late to prepare."

Children would be the most vulnerable group, he said.

Jakarta has designated dozens of hospitals across the country for treating patients with bird flu symptoms, set out plans to produce the anti-viral drug Tamiflu and vaccinate poultry in a bid to stop the spread of the disease.

A bird flu committee with powers to bypass the bureaucracy would be up and running soon, Welfare Minister Aburizal Bakrie said in the same Jakarta meeting.

"Political, financial, logistical, security and bureaucratic constraints are among the biggest threats to an effective response to a pandemic threat. I invite the best brains and expertise to join this committee," he said.

The virus is endemic in poultry in parts of Asia and has affected birds in two-thirds of the provinces in Indonesia, a sprawling archipelago of 17,000 islands and 220 million people.

Indonesia has millions of chickens and ducks, many in the backyards of rural or urban homes. Since August 2003, 10 million poultry have died from the H5N1 strain or been culled.

Global Coverage Article Reuters.co.uk

News - Kirin Develops anitbody that may work for bird flu

Kirin Brewery Co. Ltd., Japan's second-largest brewer, said on Monday that its U.S. subsidiary has developed an antibody that may be effective against bird flu, sending its share price higher.

A company spokesman said the subsidiary, Gemini Science Inc., is planning to develop a drug through a partnership, but added that it would take time to commercialize any such product.

"It's hard to say how long, but I can say that it's not going to be in two or three years," he said.

Kirin Brewery shares rose 7.1 percent to 1,412 yen after earlier climbing as high as to 1,471 yen, a level last seen in 1999.

The H5N1 strain of avian influenza has killed 71 people since late 2003, spreading through flocks of poultry across Asia and into Europe. Anti-bird flu measures are a closely watched topic in the stock market.

Last Thursday, textile maker Nisshinbo Industries Inc. surged after the company said it and a Japanese university had jointly developed a new fabric that destroys the bird flu virus. It can be used for masks and clothing as well as for materials for chicken coops, the company said.

Global Coverage Article Reuters.co.uk

News - Expert says avian flu scare is a money bonanza for researchers

Do you remember the flu epidemic/pandemic that never was? It was the 1976 scare after a soldier at Fort Dix, NJ, contracted and died from swine flu, which led to the Ford administration, with the help of Congress, to launch a crash program to make a vaccine and inoculate 220 million Americans.

Never ones to pass up a buck or shell one out if they could avoid it, the pharmaceutical and insurance industries demanded the federal government assume all risk for any harm to people the vaccine might cause. Congress yielded.

By October of that year, the vaccine was ready and people lined up for shots.

About 40 million people received the vaccine before the program was halted in December 1976, after some 1,000 came down with Guillain-Barre syndrome (a rate seven times normal), a disease that can cause permanent paralysis, others contracted transverse myelitis, a neurological disorder, a reports of death associated with the vaccine range from 30-60. The government paid some $90 million in damages and the cost of the program was about $400 (both in 1976 dollars).

The difference between making a vaccine in 1976 and the current rush to create an avian flu vaccine is that in 1976 they knew what strain of flu the vaccine was supposed to prevent.

Now, nearly 30 years later, the fear card is being played over the possibility of an avian flu pandemic, the likelihood of which Dr. Gary Butcher of the University of Florida say is practically nil. Below is an article from Sunday's Star-Banner, Ocala, FL, in which Dr. Butcher claims the fear-mongering has more to do with money than likely danger to the public.

Ruffled feathers
UF professor says bird flu is not a threat in the U.S.

CATHERINE DOLINSKI
STAR-BANNER
Published Dec. 18, 2005

GAINESVILLE -- Researchers and health agencies continue to sound the alarm about avian flu, and Dr. Gary Butcher, an expert on poultry medicine and disease at the University of Florida's College of Veterinary Medicine thinks he knows why.

"The agenda here is pretty obvious," he said. "People want grant money. This is a bonanza."

Butcher, who advises agricultural ministries and poultry companies around the world, is Florida's lone poultry veterinarian. He has also emerged as a leading naysayer on the prospects for a avian flu pandemic.

Butcher insists the likelihood that the H5N1 avian flu virus in Asia will trigger a pandemic is practically nil. But the fear-mongering will continue, he said, as long as people see a potential for financial and career gain in it.

He believes that the U.S. Department of Agriculture is overstating the threat posed by avian flu to justify its budget, and to a large extent, its existence. The World Health Organization, he said, has issued its warnings for similar reasons.

"They're under intense pressure," he said of the WHO. "They've had so many problems in the past, problems with internal corruption. . . . They're in dire need of new funding and this is their golden goose, as long as they can keep it going."

Butcher knows his words sound harsh, he said, but there is a war on.

"This is a full-on war against agriculture," Butcher said -- and he is firing back.

BUTCHER'S BEEF

Historically, pandemics have tended to recur every 20 to 40 years. The last occurred in 1968. The Hong Kong Flu caused between 750,000 and 2 million deaths worldwide, about 34,000 of those deaths were in the United States.

In November, President Bush asked Congress for $7.1 billion to prepare for the next pandemic flu, pointing to the H5N1 virus that numerous health experts have identified as a potential pandemic threat.

Butcher does not doubt the world is in for another pandemic, he said. But the constant hum of warnings in this country about the avian flu irks him -- especially since influenza has long infected about 30 percent of the native wild duck population when it migrates annually to Canada. As the weather turns cold, the birds migrate south through the United States.

"This occurs every year," Butcher said. "We very, very rarely have infections spread to commercial poultry."

The H5N1 virus is a much more serious strain, he said, but it poses no greater threat of human infection.

"The threat is basically zero," he said. "We're spending all of our attention on this [virus], and another one may sneak up on us."

Realistically, no one knows what is going to happen, said Dr. Sherrill Davison, director of the avian medicine and pathology laboratory at the University of Pennsylvania. "We're having, in the poultry industry, differences of opinion about the risks we're seeing."

H5N1 is highly pathogenic, she said, which is unusual. Davison believes that is cause for concern and preparation, but not panic.

"We get a fair amount of calls from people very concerned, even panicked," she said. "I tell them it's not in the United States, and that we have a policy in the United States that, if we did have something similar to it, the birds would be euthanized and not enter the food chain."

Even if the virus did penetrate the food supply, she said, cooking it would kill it anyway.

CONFLICTS?

Cooking guidelines appear on the World Health Organization's list of safeguards against avian flu infection. Released Dec. 5, the recommendations include not eating raw poultry and washing one's hands after handling raw bird parts.

The guidelines are accurate, Butcher said, but have little to do with avian flu.

"There's nothing new here," he said, explaining that every recommendation is a long-standing general safety guideline for handling poultry. Linking them to the flu, he said, is inappropriately suggestive.

The WHO's Web site also warns that the H5N1 avian flu has killed half of the people it has infected. That's true, Butcher said, but given the fact that the virus has only infected roughly 130 people, that 50 percent statistic paints a misleading picture.

"The guy who wrote this really wants to make this sound like a big thing," Butcher said, reading through the WHO's "frequently asked questions" about avian flu.

"Dr. Butcher is certainly entitled to his opinion," WHO spokeswoman Maria Cheng said in an e-mailed response. "We clearly do not share it."

H5N1 has fulfilled two of three scientific criteria for a pandemic virus, Cheng said. All that is left, she said, is for it to transmit easily between people.

She acknowledged that speaking openly about a possible bird flu pandemic can incite fear, but said it is the WHO's responsibility to warn about the risks.

As for the safety guidelines, she said, the WHO has been deluged by requests for practical advice on minimizing the risk of infection.

"There are many uncertainties about the situation, which the WHO has tried to explain," she said. "We do not know if H5N1 will spark the next pandemic. We know only that, scientifically, it looks to be the most likely candidate."

Butcher disagrees. The H5N1 virus kills the birds it infects, he said, which denies it the opportunity to mutate into something easily transmissible among humans. And because the U.S. poultry industry keeps its birds indoors, he said, they are highly unlikely to contract the virus from infected migratory birds.

The veterinarian reserved some of his harshest criticism for the USDA, which he believes is overstating the threat to justify its intensifying bird surveillance programs and gain funding and influence.

"They're trying to keep [avian flu] in the spotlight," he said.

"Everyone's keeping it in the spotlight," said Madelaine Fletcher, spokeswoman for the Animal and Plant Health Inspection Service division of the USDA.

Fletcher declined to respond to Butcher's accusations about the agency's agenda. "We've tried to keep biosecurity and sick birds in the spotlight so people know what to look for, but that's because our mission is to keep these [viruses] out of the country."

Butcher's perspective is not only that of an academic expert, but that of an industry consultant. When he is not teaching and researching in Gainesville, Butcher often travels to Panama, Russia, Ecuador, Vietnam, Thailand and other countries, advising governments and poultry companies whose survival and profits are threatened by public fears of bird flu.

In his travels, he said, he sees the evidence of serious economic harm caused by misplaced fear. "Poultry consumption is down 50 percent in Europe," he said. "It's a disaster."

From a health standpoint, however, fear of the bird flu has its benefits, said Dr. Nathan Grossman, director of the Marion County Health Department. The result has been increasing preparations at all government levels for some form of pandemic.

"I realize people have the impression we're preparing because the bird flu is coming," Grossman said. "That's a misconception. . . . It happens to be the novel virus that has sparked people to it."

But Butcher remains troubled. "I don't think people understand the effect it's had on economies, industries and even the mental health of people around the world," he said. "It's prudent to be prepared, but it's not prudent to inspire this overreaction."

University of Florida poultry expert says avian flu scare is a money bonanza for researchers

News - H5N1 yet to affect Vietnam tourism


According to the announcement, since December 2003, 93 cases of type A/H5N1 have been reported in Vietnam and 42 have died in 32 provinces and cities.

Most of the patients had contact with diseased fowl but there is no evidence of human to human infection. Since November 14, 2005, no new cases of the virus have been detected in humans but the World Health Organisation (WHO) maintains warnings of a pandemic.

The Vietnam Ministry of Health has taken urgent measures to control the spread of the virus in the country and is working to ensure that tourists are safe.

The Ministry of Foreign Affairs and the Vietnam National Administration of Tourism will join efforts with the Ministry of Health and Ministry of Agriculture and Rural Development to report updated information on the effort.

VietNamNet Bridge

News - Hyderabad pharma firm gets licence for bird flu drug, Ranbaxy too will get one

While major pharma players are looking at the international market to manufacture the Avian flu drug Tamiflu, Hetero Drugs Ltd, a Hyderabad-based company which is relatively young in the pharmaceutical industry, has got the licence to manufacture the drug in bulk for Indian markets.
According to the Drug Controller General of India, licence for Ranbaxy Laboratories is also in the offing.

??Hetero Drugs has been given the licence last week. Ranbaxy is likely to get the licence soon,?? said Dr Ashwani Kumar, Drug Controller General of India. Roche has also been given permission to market the drug in India. ??We just had three applications, no other drug company applied,?? said Dr Kumar.

Ranbaxy is also at an advanced stage of talks with Roche for a licence to make the birdflu drug. ??Talks with Roche are on and are progressing in the right direction. We are also in touch with countries which have no patent issues. We are trying to make arrangements with Roche to do business together,?? said Ramesh L Adige of Ranbaxy Laboratories Ltd. He refused to comment on the licence for the country.

Hyderabad pharma firm gets licence for bird flu drug, Ranbaxy too will get one

News - Taiwan Buddhist group builds houses in tsunami-hit nations

A Taiwan Buddhist group has built more than 4,000 houses for tsunami survivors in Indonesia and Sri Lanka, the group said on Saturday.

The Buddhist Tzu Chi Foundation has built a Big Love Village for 3,700 families and five schools in Banda Aceh, Aceh and another Big Love Village for 649 families and a middle school in Hambantoba, Sri Lanka.

Banda Aceh and Hambantoba are Indonesia and Sri Lanka's worst-hit areas in the Dec. 26, 2004 tsunami which has killed more than 230,000 people in 12 countries.

"Tsunami survivors in Banda Aceh will move into the Big Love Village, which is a housing complex, next Monday. The houses have furniture in them. Indonesian President Susilo Bambang Yudhoyono will visit the Big Love Village next Tuesday," the news release said.

The Big Love Village in Hambantoba will be ready for use in the next few months.

After the tsunami, the Tzu Chi Foundation rushed relief material and medical teams to the disaster areas. It also drew up mid-term and long-term plans to help these areas rebuild.

The foundation's aid also included 7,000 tons of rice and 3,700 tents for Indonesia, 1,196 tons of rice, 296 tents for Sri Lanka and 2,500 body bags and 21 fishing boats for Thailand.

The Tzu Chi Foundation was founded by Master Cheng Yen, 68, nicknamed Taiwan's Mother Teresa, in 1966 and has tens of thousands of members in 28 countries.

It has provided cash and relief materials to flood, earthquake and hurricane-stricken countries all over the world and built Big Love Villages for poor people in China, Iran, Turkey, India, Thailand, South Africa, El Salvador and Paraguay.

The Jakarta Post - Taiwan Buddhist group builds houses in tsunami-hit nations

News - Bird-Flu Bill Slammed as Loophole for Drugmakers - Los Angeles Times

WASHINGTON ? Bird flu preparedness legislation headed for a final vote in the Senate this week would create loopholes allowing vaccine makers to avoid legal liability even if a patient is harmed by negligence, critics said today.

Democrats and the Assn. of Trial Lawyers of America derided the legislation as a gift to the drug industry, but its supporters said the lawyers were acting in their own self-interest. Nonetheless, a leading public health group also criticized the liability language.

"We recognize the need for liability protections to get the industry into the game, but we're uncomfortable with the breadth of the liability protections and the fact that they are not balanced by an appropriately strong compensation program," said Jeffrey Levi, a policy advisor with the Trust for America's Health, which advocates stronger government action to deal with the threat of a flu pandemic.

The liability provisions are contained in a mammoth defense spending bill that would also provide $3.8 billion of President Bush's $7 billion request for pandemic preparedness.

"Washington Republicans tucked a huge Christmas present for the drug companies into the appropriations bill in the dead of night," said Rep. Henry A. Waxman, D-Los Angeles. "The liability shield can be granted to any product used to prevent or treat an epidemic or a pandemic, and the (administration) gets to decide what that means."

Backed by Senate Majority Leader Bill Frist, R-Tenn., the provision would allow the government to extend legal immunity to vaccine and drug makers by declaring a public health emergency.

Manufacturers of drugs designated to deal with the emergency would be shielded from lawsuits unless they had engaged in "willful misconduct." Such a threshold is so high it would protect companies that were negligent or reckless, critics said.

Although the legislation would create a compensation program for patients injured by pandemic vaccines, it allocates no money for the fund. That would be determined according to need in a given emergency, supporters of the bill said.

Some critics said the language is broad enough it could allow the secretary of Health and Human Services to declare an emergency for any serious health problem facing the country, such as obesity or diabetes. The bill specifies that the secretary's decision could not be challenged in any federal or state court.

Backers of the legislation said emergency legal immunity would only be granted in extremely rare cases, such as an outbreak of highly virulent flu or a bio-terrorism attack, and would eventually expire. Amy Call, Frist's spokeswoman, disagreed with critics who say the language is overly broad.

"It is very targeted," she said.

"The trial lawyers apparently would prefer to keep filing frivolous lawsuits and collecting excessive attorney fees rather than making sure public health is protected," she said.

Call said the drug industry had some input into the legislation, but was not totally pleased.

That any pandemic funding would also include liability protections for vaccine makers was widely expected. Indeed, Bush requested it. The specific language was added at the last minute at the request of Frist and House Speaker J. Dennis Hastert, R-Ill., said a Republican staffer involved with the bill.

Such provisions are sometimes called "midnight riders," because they are not vetted through the full process of hearings and committee deliberations.

"This is another midnight rider that should never be given the chance to ride," said Sen. Edward M. Kennedy, D-Mass. "This outrageous provision has nothing to do with protecting our troops, and should be struck from the bill."

Odds of that happening are considered slim. But the Senate should revisit the issue, said professor Carl Tobias of the University of Richmond School of Law. "The question is how high the liability shield needs to be," Tobias said. "I think 'willful misconduct' is too high. We usually use some kind of negligence standard in these situations. It would be very unusual that you could prove that intentional misconduct had happened."

Bird-Flu Bill Slammed as Loophole for Drugmakers - Los Angeles Times

News - Congress cuts $3.46B from Bush's avian flu request

Congress added $3.8 billion, $3.46 billion less than the Bush administration?s request, for avian flu preparedness to the $403.5 billion Defense Department Appropriations bill approved by a House-Senate conference committee yesterday in a rare Sunday session, as lawmakers raced to pass crucial spending legislation for fiscal 2006 before the holiday recess.


The conferees included $29 billion for disaster assistance to hurricane-damaged areas in the South, $10.4 billion more than the administration?s request, in the DOD bill, which passed the full House yesterday and is expected to receive Senate approval before Congress adjourns for the holidays.


The report emphasizes that funds provided for avian flu preparedness and hurricane disaster assistance do not represent any new net spending in the 2006 budget. These expenditures are offset by a 1 percent across-the-board reduction in 2006 discretionary spending by all agencies with the exception of the Department of Veterans Affairs.


Hurricane relief funds in the DOD bill also reflect the reallocation of $23.9 billion in Federal Emergency Management Agency?s previously approved budget.


The final version of the DOD bill was $2.4 billion less than President Bush?s budget request, but the conferees also added $50 billion in emergency funds for operations in Iraq and Afghanistan.


Congress approved an $8 billion increase in procurement accounts for all four services to replace equipment damaged or destroyed in Iraq and Afghanistan, including radio systems, cruise missiles and trucks.


The bill provides $1.36 billion to test and equip units with new improvised explosive device (IED) jammers to the DOD IED Defeat Task Force and an additional $362.7 million to the Marine Corps for procurement of high-powered jammers used in Iraq.


The conference report cut funding by $400 million for a crucial DOD next-generation communications program, the transformational satellite project, designed to provide IP-based communications to warfighters through satellites equipped with space-hardened routers.


The avian flu-funding package added to the DOD bill provides $3.3 billion to the Public Health and Social Services Emergency Fund to strengthen pandemic preparedness.


This budget category includes $350 million to upgrade state and local response capacity, particularly the planning and exercising of pandemic response plans by state and local officials; $241 million for international activities, disease surveillance, vaccine registries, research and clinical trials; and $50 million to increase laboratory capacity through the Centers for Disease Control and Prevention.


The conference report states that the Department of Health and Human Services can use the balance of the funds to support other core preparedness activities, such as expanding the domestic production capacity of influenza vaccine, developing and stockpiling of pandemic vaccine, stockpiling of antiviral medication and other supplies for the Strategic National Stockpile.


The hurricane disaster assistance package in the 2006 DOD bill provides $1.4 billion to rebuild damaged military facilities and $367 million to repair hurricane-battered VA facilities.

Congress cuts $3.46B from Bush's avian flu request

News - Bird flu could cost Canada $12 billion

If an avian flu pandemic spreads to Canada, it could carve as much as 14 billion Canadian dollars (12 billion US dollars) off the country's economy and as many as 6.2 million people could get infected with 133,000 likely to die, financial officials said.

An outbreak could cut as much as 1.2 percent off the country's annual gross domestic product. That may slice almost in half the pace of healthy economic growth, which is expected to grow at an average of 2.8 percent in 2005, Canadian Press reported Monday citing relevant documents.

Certain sectors would be hit harder than others, should a deadly avian flu strain begin to spread from person to person in Canada, the analysis by Finance economists suggests.

Travel and tourism would be obvious early targets but the hospitality and entertainment sectors would also be hit hard as people would likely avoid going out socially and risking infection.

Health experts around the globe are deeply concerned that a pandemic could happen and have been planning for the worst-case scenario.

So far, the virulent H5N1 strain of bird flu has killed at least 71 people in Asia since 2003. Most cases have been linked to contact with infected birds.

Experts have said repeated outbreaks in poultry are increasing the risk the virus could mutate into a form that can spread easily among people, possibly sparking a global pandemic.

Canadian Finance Department officials reviewed several other studies of likely pandemic outcomes, with their calculations largely based on the experience of the 1918 global flu pandemic.

The 1918 outbreak eventually infected half the world's population and killed 40 million people, the vast majority of them between the ages of 20 and 40.

They also considered the economic impacts of flu pandemics in 1957 and 1968, as well as the SARS outbreak in 2003, which killed 44 Canadians and walloped parts of the economy.

Xinhua - English

News - UPDATE 1-U.S. House approves $3.8 billion for avian flu

The U.S. House of Representatives early on Monday approved $3.78 billion to begin preparations for a possible avian flu epidemic. The bill would also shield manufacturers of vaccines and drugs from lawsuits during an epidemic.

The legislation, wrapped into an unrelated defense bill, still faces an uncertain fate in the Senate later this week.

The money would be used for stockpiling potential vaccine and drugs, training emergency officials and increasing international surveillance of the flu which has been sweeping through poultry flocks in Asia and more recently into eastern Europe.

The deadly animal disease has infected at least 139 humans, killing about half and scientists fear that if the disease becomes more easily transmitted to humans, a pandemic could unfold, killing millions across the globe.

Conservatives balked at spending so much money so quickly, and without making other cuts in the budget, at a time of deep deficits and huge expenses for Hurricane Katrina recovery.

Following late-night negotiations between top Republicans, Senate Majority Leader Bill Frist of Tennessee succeeded in including a provision to protect vaccine, drug and medical device makers against civil lawsuits if the products were used in a pandemic or epidemic.

Consumer and health groups opposed the vaccine liability provisions, which were sought by pharmaceutical companies, saying it would protect companies from "gross negligence."

Some lawmakers said the measure could make medical personnel and other emergency workers reluctant to get vaccinated if there was a chance they could suffer negative reactions and not get compensated.

"The Republican leadership ... get everything on their wish list, but nurses, firefighters, and ordinary Americans who will have to take untested vaccines and drugs get no money for compensation if they get injured," said Massachusetts Democrat Edward Kennedy.

The legislation calls for a compensation fund but does not authorize any money for it. The bill "gives carte blanche to the vaccine companies, but doesn't provide a mechanism" for people if they are injured by a vaccination, said Rep. Dan Burton, an Indiana Republican.

The money was about half the $7 billion the Bush administration had requested. Earlier this year, the Senate passed legislation calling for $8 billion in funds to prepare for an avian flu pandemic. But conservative Republicans in Congress opposed the higher spending, citing concerns about the huge U.S. budget deficit.

Stock Market News and Investment Information Reuters.com

Sunday, December 18, 2005

News - A bird flu pandemic is possible

A bird flu pandemic may arrive in a neighborhood near you, and you probably aren?t paying much attention.

You should be.

Government and health leaders are walking a narrow line: trying to inform citizens of the possibility that a pandemic may be in our future, while not panicking people.

?This is a time to inspire planning and not panic,? U.S. Health and Human Services Secretary Michael Leavitt said during a recent St. Paul meeting.

Government officials may be downplaying the threat so much that Americans are not taking it seriously, if the public even knows there is a threat.

The situation is that a strain of flu birds pass to each other has started infecting humans, mostly in Asia where birds and humans often live together in close quarters. Of about 140 people who have caught that flu, half have died.

The real threat will come if the flu begins to pass from human to human.

With no human immunity to the new flu strain, the bug could spread rapidly. Health experts predict millions would die ? 30,000 in Minnesota alone. In fact, there could be 1.5 million sick Minnesotans and just 16,000 hospital beds for them.

The difference between the current situation, mainly a concern in Asia, and a pandemic is whether the virus mutates so it can be transmitted from human to human.

?We know the virus is continuing to evolve,? Dr. Julie Gerberding of the Centers for Disease Control and Prevention told the St. Paul pandemic summit.

It sounds like a science fiction plot, but Gerberding and other medical experts say the current bird flu looks a lot like the 1918 flu strain that swept the world.

Leavitt said the good news is that this may be the first pandemic in which the world has enough warning to prepare. The bad news is that the flu could mutate and spread so fast that nothing can be done to stop a pandemic.

?It will spread at Internet speed,? Gerberding said,

If that happens, life as we know it will change dramatically. You and your family may be ordered to stay home for a week (so you had better stock up on food, games for the kids and MP3 songs for the teens). Schools may close and be turned into temporary hospitals. Business may be hampered by absenteeism that could hit 40 percent.

?Most people won?t be sick, but everybody will be affected,? Leavitt said.

The key to a good bird flu outcome is for the public to understand how to deal with it.

Leavitt and Minnesota Health Commissioner Dianne Mandernach said their agencies are working on fliers, videos and other forms of education that can be put out immediately upon emergence of a mutated bird flu strain. That is not soon enough. Regardless of what government leaders do, people will be in a panic by then. The public needs to be informed now.

Information is available. For instance, www.pandemicflu.gov is a federal site with tons of information on the subject. Before long, it will include a checklist about what families should do to prepare. Also, www.cdc.gov/flu/pandemic is the Centers for Disease Control take on the problem.

It is not time to panic, but it is time to learn about what could happen.

IN-FORUM

News - Ukraine considers tougher measures against bird flu


Ukrainian officials on Saturday considered intensifying measures to contain an outbreak of the deadly H5N1 strain of bird flu affecting more than a dozen villages in the Crimea peninsula.

Agriculture Ministry spokesman Olesksander Horobets said a specialised laboratory in Britain had confirmed results provided by Russian academics -- that the virus detected in Crimea was H5N1, potentially dangerous to humans.

He said Farm Minister Oleksander Baranivsky was in Crimea helping draft measures to preventing the virus from spreading.

"The minister believes that the measures taken earlier on preventing flu are insufficient," Horobets said by telephone.

"The question of imposing a quarantine throughout Crimea is now under discussion. A decision will be descussed today and it could be formally adopted next Tuesday."

President Viktor Yushchenko invoked a state of emergency in several villages after bird flu was detected, with teams of specialists going from house to house to seize and slaughter birds. Exclusion zones were set up and patrolled by police.

But villagers complained that birds had been falling ill since September with officials taking no action. Ukraine's chief veterinary officer was then dismissed.

Horobets said officials were examining new moves throughout Crimea, including confiscation and fines to ensure residents kept fowl inside to avoid contact with migratory birds.

The Emergencies Ministry says 15 villages have been affected by the virus. Mass deaths among domestic birds have been noted in 15 further villages in Crimea, a peninsula jutting into the Black Sea and a a major stopping point on migratory routes.

A Ministry statement said more than 62,000 birds had been seized and destroyed.

The equivalent of more than a quarter of a million dollars in compensation had been handed out, with payments ranging from $3 for a chicken to $18 for a turkey. Doctors had vaccinated nearly 30,000 residents against seasonal flu.

Cases of H5N1 have also been detected in adjacent Romania and Russia. Romanian officials said new cases of one type of virus had been found about 90 km (55 miles) east of Bucharest.

Several of Ukraine's neighbours have imposed a ban on food imports from Crimea and adjoining regions.

Bird flu is endemic in poultry in parts of Asia where it has killed more than 70 people. It remains hard for people to catch, but experts fear it could mutate into a form which passes easily from person to person.

Global Coverage Article Reuters.co.uk

News - New cases of bird blu reported in Romania

Romania has detected new cases of bird flu in domestic fowl in a village about 80 km east of Bucharest, bringing the total number of bird flu outbreaks in the country to 18, the Ministry of Agriculture announced on Saturday.

The latest outbreak was reported in the the village of Marsilieni in Ialomita county, where dead chickens from five farms were confirmed to have carried the H5 strain of bird flu.

In precautionary measures, local authorities have ordered culls of all domestic fowl and imposed a quarantine in the village, said the ministry.

Romania has seen a quite fast spread of the bird flu virus recently, but most of the cases were in the Danube river delta, located some 300 km from Bucharest on a major migration path of wild birds. So far, no human cases have been reported.

A total of 100,000 poultry have been slaughtered in the countrysince the first case was discovered on Oct. 7.

A deadly H5N1 strain of the H5 virus that has killed nearly 70 people in Asia in the past two years remains hard for people to catch, but there are fears that it could mutate into a form easily transmissible among humans and eventually cause a human flu pandemic.

Xinhua - English

News - Expert: Bird Flu's Threat Is `Basically Zero' | theledger.com


Researchers and health agencies continue to sound the alarm about avian flu, and Dr. Gary Butcher, an expert on poultry medicine and disease at the University of Florida College of Veterinary Medicine, thinks he knows why.

"The agenda here is pretty obvious," he said. "People want grant money. This is a bonanza."

Butcher, who advises agricultural ministries and poultry companies around the world, is Florida's lone poultry veterinarian. He has also emerged as a leading naysayer on the prospects for a avian flu pandemic.

Butcher insists the likelihood that the H5N1 avian flu virus in Asia will trigger a pandemic is practically nil. But the fear-mongering will continue, he said, as long as people see a potential for financial and career gain in it.

He thinks that the U.S. Department of Agriculture is overstating the threat posed by avian flu to justify its budget, and to a large extent, its existence. The World Health Organization, he said, has issued its warnings for similar reasons.

"They're under intense pressure," he said of the WHO. "They've had so many problems in the past, problems with internal corruption. . . . They're in dire need of new funding and this is their golden goose, as long as they can keep it going."

Butcher knows his words sound harsh, he said, but there is a war on. "This is a full-on war against agriculture," Butcher said -- and he is firing back.

BUTCHER'S BEEF

Historically, pandemics have tended to recur every 20 to 40 years. The last occurred in 1986, causing about 34,000 deaths in the United States. In November, President George W. Bush asked Congress for $7.1 billion to prepare for the next pandemic flu, pointing to the H5N1 virus that numerous health experts have identified as a potential pandemic threat.

Butcher does not doubt the world is in for another pandemic, he said. But the constant hum of warnings in this country about the avian flu irks him -- especially since influenza has long infected about 30 percent of the native wild duck population when it migrates annually to Canada. As the weather turns cold, the birds migrate south through the United States. "This occurs every year," Butcher said. "We very, very rarely have infections spread to commercial poultry."

The H5N1 virus is a much more serious strain, he said, but it poses no greater threat of human infection.

"The threat is basically zero," he said. "We're spending all of our attention on this (virus), and another one may sneak up on us."

Realistically, no one knows what is going to happen, said Dr. Sherrill Davison, director of the avian medicine and pathology laboratory at the University of Pennsylvania. "We're having, in the poultry industry, differences of opinion about the risks we're seeing."

If the virus did penetrate the food supply, she said, cooking it would kill it anyway.

CONFLICTING INTERESTS?

Cooking guidelines appear on the World Health Organization's list of safeguards against avian flu infection. Released Dec. 5, the recommendations include not eating raw poultry and washing one's hands after handling raw bird parts.

The guidelines are accurate, Butcher said, but have little to do with avian flu.

"There's nothing new here," he said, explaining that every recommendation is a long-standing general safety guideline for handling poultry. Linking them to the flu, he said, is inappropriately suggestive.

The WHO's Web site also warns that the H5N1 avian flu has killed half of the people it has infected. That's true, Butcher said, but given the fact that the virus has only infected roughly 130 people, that 50 percent statistic paints a misleading picture.

"The guy who wrote this really wants to make this sound like a big thing," Butcher said, reading through the WHO's "frequently asked questions' about avian flu.

"Dr. Butcher is certainly entitled to his opinion," WHO spokeswoman Maria Cheng said in an e-mailed response. "We clearly do not share it."

H5N1 has fulfilled two of three scientific criteria for a pandemic virus, Cheng said. All that is left, she said, is for it to transmit easily between people.

She acknowledged that speaking openly about a possible bird flu pandemic can incite fear, but said it is the WHO's responsibility to warn about the risks.

As for the safety guidelines, she said, the WHO has been deluged by requests for practical advice on minimizing the risk of infection.

"There are many uncertainties about the situation, which the WHO has tried to explain," she said. "We do not know if H5N1 will spark the next pandemic. We know only that, scientifically, it looks to be the most likely candidate."

Butcher disagrees. The H5N1 virus kills the birds it infects, he said, which denies it the opportunity to mutate into something easily transmissible among humans. And because the U.S. poultry industry keeps its birds indoors, he said, they are highly unlikely to contract the virus from infected migratory birds.

The veterinarian reserved some of his harshest criticism for the USDA, which he thinks is overstating the threat to justify its intensifying bird surveillance programs and gain funding and influence. "They're trying to keep (avian flu) in the spotlight," he said.

"Everyone's keeping it in the spotlight," said Madelaine Fletcher, spokeswoman for the Animal and Plant Health Inspection Service division of the USDA.

Fletcher declined to respond to Butcher's accusations about the agency's agenda. "We've tried to keep biosecurity and sick birds in the spotlight so people know what to look for, but that's because our mission is to keep these (viruses) out of the country."

Critics could argue that Butcher has his own agenda, since he is protecting the interests of an industry that hires him for consulting services.

When he is not teaching and researching in Gainesville, Butcher often travels as a private consultant to Panama, Russia and other countries, advising governments and poultry companies whose survival and profits are threatened by public fears of bird flu.

Butcher is unapologetic about defending the industry. In his travels, he said, he sees the evidence of serious economic harm caused by misplaced fear. "Poultry consumption is down 50 percent in Europe," he said. "It's a disaster."

Expert: Bird Flu's Threat Is `Basically Zero' theledger.com

Avian Flu concerns spread worldwide

What a difference a year makes ... or not.

We head into 2006 the same way we began 2005: Worried about flu and not enough vaccine.

Last year, the concern was ordinary flu because the United States had only half its usual supply of flu shots. Bird flu creeping across Asia was a vague and distant threat.

This year, bird flu extended its reach, spawning fears that it might mutate into a worldwide super-flu that kills people, not just avians.

Countries scrambled to order an experimental bird flu vaccine and Tamiflu, the lone drug known to work against the germ, but both take achingly long to make and are in short supply. In October, the federal government released a plan to deal with a flu pandemic, relying heavily on low-tech measures like quarantine and travel restrictions.

"Right now the U.S. public should not be worried," because the germ doesn't spread person to person, Drs. William Schaffner and Tom Talbot recently wrote to fellow staffers at Vanderbilt University.

"Until the virus develops this ability, if it ever does, your chances of being infected are virtually zero. Leave worrying about this virus to the infectious disease specialists for now," they advised.

Amid the flu fears there was actually a lot of good news this year. Cancer overtook heart disease as the leading cause of death among Americans 85 and under. Why is that good, you ask? Because deaths from both are falling; it's just that those from heart disease have fallen more dramatically.

Two vaccines proved effective against human papilloma virus, or HPV, the leading cause of cervical cancer, a big killer around the world.

New-generation cancer drugs like Avastin and Herceptin, which more precisely target the disease and leave healthy cells alone, also scored big victories in studies on lung and breast cancer patients respectively, notes the American Society of Clinical Oncology in its first annual report on cancer progress.

Five years ago, these drugs were in the "hope" stage but now are in wide use, said Dr. Roy Herbst, a lung cancer expert at the University of Texas M.D. Anderson Cancer Center.

In the future, "the goal is going to be to combine the targeted therapies and leave the chemotherapy and radiation aside," sparing patients the harsh effects of these older treatments, he said.

Meanwhile, the federal Food and Drug Administration continued to battle allegations that it has been too slow to act against dangerous products, and that political concerns were trumping science.

Despite advisers saying the drug is safe, the FDA has refused to allow over-the-counter sales of Plan B, a "morning after" pill to prevent pregnancy.

A top FDA scientist quit over the dispute, and it held up Lester Crawford's confirmation as FDA commissioner. Two months after winning the job, he abruptly resigned amid questions about ethics and financial reporting. Federal officials are investigating.

The Bryan-College Station Eagle > Health

News - Bird flu outbreak could cost economy up to $14 billion, say Finance officials

If an avian flu pandemic spreads to Canada, it could carve as much as $14 billion off the country's economy, say senior federal Finance Department officials.

In documents obtained by The Canadian Press under an Access to Information request, federal officials say such an outbreak could cut as much as 1.2 per cent off the country's annual gross domestic product, the broadest measure of the economy.

That may not sound like a great loss to Canada's economy in percentage terms.

But with GDP expected to grow at an average of 2.8 per cent in 2005, which the Bank of Canada says is pretty much its optimum speed, a 1.2 per cent loss of about $14 billion would slice the pace of healthy economic growth almost in half.

Certain sectors would be hit harder than others, should a deadly avian flu strain begin to spread from person to person in Canada, the analysis by Finance economists suggests.

Travel and tourism would be obvious early targets but the hospitality and entertainment sectors would also be hit hard as people would likely avoid going out socially and risking infection.

The analysis avoids calculating the human cost of a pandemic to focus on measuring the potential economic hit, said a federal Finance department spokesman.

"Human suffering and loss of life would obviously outweigh economic concerns," said David Gamble of Finance Canada.

"This may appear like more of a balance sheet approach, but that's what we were doing. . .the economics part."

The documents show officials did calculate that if an avian flu pandemic were to hit, as may as 6.2 million Canadians could fall ill and 133,000 would likely die.

South of the border, the administration of U.S. President George W. Bush has taken a darker view.

It has warned that a severe pandemic could infect up to a third of the U.S. population and kill anywhere from 209,000 to 1.9 million Americans, says the Bush administration's recent Pandemic Influenza Plan.

It put the health costs alone, not counting disruption to the economy, at $181 billion US for even a moderate pandemic.

Generally, however, economists are finding it tough to calculate the costs of a pandemic, since a bird flu outbreak is still hypothetical.

However, health experts around the globe are deeply concerned that a pandemic could happen and have been planning for the worst-case scenario.

So far, the virulent H5N1 strain of bird flu has killed at least 71 people in Asia since 2003. Most cases have been linked to contact with infected birds.

Experts have said repeated outbreaks in poultry are increasing the risk the virus could mutate into a form that can spread easily among people, possibly sparking a global pandemic.

Canadian Finance Department officials reviewed several other studies of likely pandemic outcomes, but their calculations are largely based on the experience of the 1918 global flu pandemic, said officials speaking on background.

The 1918 outbreak eventually infected half the world's population and killed 40 million people, the vast majority of them between the ages of 20 and 40.

They also considered the economic impacts of flu pandemics in 1957 and 1968, as well as the SARS outbreak in 2003, which killed 44 Canadians and walloped parts of the economy.

Some of their economic conclusions are consistent with findings from a study last fall by brokerage house BMO Nesbitt Burns.

Chief economist Sherry Cooper figured that for Canada, the costs of an avian flu pandemic could run from $8 billion to $18 billion.

However, her forecast caused a sensation with its worst-case scenarios of an economic crisis to rival the Great Depression, a conclusion Finance doesn't seem to share.

"With the U.S. - the engine of global growth - slowing trade and U.S. activity would slow economic activity worldwide," wrote Cooper.

And the Conference Board of Canada warned of a "sudden an dramatic (global) recession" while the World Bank estimated global GDP could be cut by two per cent in a pandemic.

Finance Department officials reached less dire conclusions, partly because they assume a fairly healthy rebound from a pandemic.

Economies "are quite resilient, people are fairly flexible and adaptable," said one official.

And markets can at least feel confident that Ottawa's books are in very healthy shape, which can help the economy weather almost any storm, Finance Minister Ralph Goodale said in an interview last month.

Ottawa may not be able to vaccinate the economy against a major upset, but Goodale says his government has built up immunity by paying down debt, keeping the books balanced and keeping investor and consumer confidence at healthy levels.

"We should never falter in our confidence. Canada is operating from a position of strength, we have had more than a decade of consistent economic strength," Goodale said.

Bird flu outbreak could cost economy up to $14 billion, say Finance officials

News - U.S. Congress seeks $3.8 billion for avian flu

U.S. lawmakers on Sunday tentatively agreed to earmark $3.78 billion to prepare for a possible avian flu epidemic, about half what the Senate and White House had wanted for stockpiling anti-viral drugs and vaccines and helping communities plan for a health crisis.

The Senate had wanted $8 billion, and President Bush last month requested $7 billion but faced resistance from fiscal conservatives.

The bill does not include a provision sought by Senate Majority Leader Bill Frist, a Tennessee Republican, that would protect vaccine, drug and medical device makers against lawsuits in a public health or bioterror emergency.

But Frist aides said the bill's text was not finalized and would not rule out including a liability measure very late Sunday night or early Monday.

The bird flu funds were included in a defense spending bill, and the fate of that bill was uncertain in the Senate.

The House aimed to vote on it very early Monday and the Senate would then take it up later in the week. But it contains many controversial provisions, including opening up the Arctic National Wildlife Refuge in Alaska, and some Democrats and possibly some Republican moderates may try to block it.

Democrats in Congress had urged quick approval of the full $8 billion, which would also be used to step up worldwide surveillance of the disease and help localities cope with an outbreak. But with Congress already reeling under Hurricane Katrina cleanup and huge budget deficits, conservatives did not want to spend the full amount at this time without cutting other federal spending.

For the past several years, avian flu has been killing poultry flocks in Asia and the animal disease has been spreading globally.

At least 139 people have been infected with avian flu and about half have died. But scientists fear a pandemic-style human outbreak if the virus mutates in a way that allows person-to-person transmission.

Reuters AlertNet - U.S. Congress seeks $3.8 billion for avian flu

News - Customs Agents Seize Counterfeit Bird Flu Drug

Customs agents have intercepted more than 50 shipments of counterfeit Tamiflu, the antiviral drug being stockpiled in anticipation of a bird flu pandemic, marking the first such seizures in the United States, authorities said Sunday.

The first package was intercepted Nov. 26 at an airmail facility near San Francisco International Airport, said Roxanne Hercules, a spokeswoman for U.S. Customs and Border Protection. Agents have since seized 51 packages, each containing as many as 50 counterfeit capsules labeled generic Tamiflu.

The fake drugs had none of Tamiflu's active ingredients, and officials were testing the contents of the capsules. Initial tests indicated some vitamin C in the capsules, said David Elder, director of the Food and Drug Administration Office of Enforcement. Information on the packages was written in Chinese, but it is unclear where the drugs originated, he said.

They were sent by Asian suppliers to customers who placed orders over the Internet, Hercules said. She said none of the shipments intercepted was bound for doctors or hospitals.

Agents became suspicious because Tamiflu is produced by Swiss pharmaceutical manufacturer Roche, and no generic version is available.

Customs Agents Seize Counterfeit Bird Flu Drug

Saturday, December 17, 2005

News - Bird flu sickens man in China, kills 1 in Indonesia

China reported its sixth human bird flu case Friday as Indonesia awaited tests that could confirm its 10th human victim.

Chinese state media said a 35-year-old man in eastern China had become infected with the potentially deadly H5N1 strain of the virus after an outbreak was reported in ducks in his village.

In Indonesia, local tests showed that a 39-year-old man had died of bird flu earlier this week in the capital, Jakarta, a senior health ministry official said Friday.

The virus has ravaged poultry stocks across Asia since 2003 and killed at least 71 people.

Bird flu sickens man in China, kills 1 in Indonesia

Sunday, December 11, 2005

News - Central register in bird flu battle | the Daily Mail

Poultry keepers must now list their birds on a central register as an avian flu control measure.

Commercial poultry owners with 50 birds or more have just under 12 weeks to sign up to the mandatory scheme. Failure to do so could result in a maximum fine of �5,000 or three months in prison, a Defra spokesman said.

The database will collate information for poultry keepers in Wales, Scotland and England. A separate register has been set up in Northern Ireland. It will also be used to improve Government contingency planning for a potential bird flu outbreak.

Defra minister Ben Bradshaw urged relevant bird owners to register as soon as possible. "The first central database would build up a picture of the size, type and proximity of commercial bird flocks.", he said.

"The information on this register will help us improve our contingency planning to help manage any potential disease outbreak.", he added.

Owners with 50 birds or more on a commercial poultry premises are required to sign up under the Avian Influenza (Preventive Measures) Regulations 2005.

Premises with fewer than 50 birds may register voluntarily after February 28.

National Farmers' Union poultry board chairman Charles Bournes said: "Commercial poultry keepers must register their birds at the earliest possible time to ensure our valuable industry is best placed to deal with any potential disease outbreak."

Premises where all poultry and their eggs are kept for the owners' consumption or as pets do not have to sign up. Relevant bird owners have until February 28 next year to register.

The full list of species that must be registered is as follows: chickens, turkeys, ducks, geese, guinea fowl, partridges, pheasants, quail, pigeons reared for meat only, cassowaries, emus, ostriches, rheas, kiwis.

Central register in bird flu battle | the Daily Mail

News - Roche agrees with laboratories to produce extra flu treatment - US senator


Swiss drug giant Roche Pharmaceuticals has made agreements with 15 laboratories in the United States to produce extra quantities of its Tamiflu medicine to counter avian flu, a US senator said Thursday.

Senator Charles Schumer said in a statement that Roche was about to announce the accords, which have been made with Teva Pharmaceuticals, Mylan Laboratories and 13 other firms.

But he said the deal depends on the US government and other countries making firm orders for the extra Tamilflu.

"Roche has made the right decision," Schumer said. "Instead of closely holding their patent rights and production techniques, in the face of a global health risk, they've moved swiftly to partner with multiple companies to dramatically increase production of this potentially life-saving drug."

He urged the US administration and Congress to act quickly to vote money to build a Tamiflu stockpile. The treatment is considered the most effective available to counter the H5N1 avian flu which has killed almost 70 people in Asia since 2003.

Roche holds the exclusive rights to manufacturing Tamiflu, but demand for the drug has risen dramatically because of fears of an avian flu pandemic.

Schumer on Thursday praised Roche for its decision and called on officials in the administration of President George W. Bush to quickly take advantage of the company's offer.

"The administration and Congress must provide funding for those stockpiles immediately now that Roche has stepped up and made significant progress towards increasing Tamiflu production," he said.

Some scientists believe there may have been cases of human-to-human transmission of the virus, in addition to the cases of humans becoming infected after being in close contact with infected poultry.

Meanwhile, in a speech Thursday, the Republican leader of the US Senate, Bill Frist, said there is an urgent need to address the threat of an avian flu pandemic -- even moreso now that the US public appears less panicked about a future global outbreak of the disease.

Frist insisted that the threat of the disease remains undiminished.

"A viral pandemic is no longer a question of if, but it's a question of when," he said.

"In recent weeks, the growing death toll of the avian flu virus and that mounting drumbeat of discussion have placed the virus under the microscope of the public eye," said Frist, who is a medical doctor by training.

"While the story may recede from the cover of Newsweek and the centerfold of Time, I know that a threat that strikes at our very mortality, as this does, must not recede from the backdrop of our public concern," he said. - AFP /dt

Channelnewsasia.com

News - Avian flu outbreak would slam U.S. economy, report finds

A severe avian flu outbreak would cost the U.S. economy $625 billion - about 5 percent of the gross domestic product - as employers struggled with absenteeism, lost production and a sharp decline in consumer spending, a new government report has found.

The economic impact, driven in part by fear and confusion, would be equivalent to a recession, according to the Congressional Budget Office report. The estimates are based on a pandemic that would sicken 90 million people in the United States and kill about 2 million.

The findings are the government's first attempt at a detailed look at the cost of what could be the most devastating public-health threat in nearly a century. The analysis, while neither definitive nor exact, provides a clear understanding in dollar terms of why an influenza pandemic presents not only a health crisis but also a threat to national security and the economy.

The CBO report estimates that 30 percent of the American population would become ill in a three-month outbreak, and about one-third of the U.S. work force would miss three weeks of work.

Senate Majority Leader Bill Frist, R-Tenn., who requested the CBO report, told a National Press Club gathering Thursday that the findings were a "a grim prognosis" for a nation that's struggling to regain its economic footing.

"Voluntary quarantining would reduce turnout at restaurants, shopping malls, sporting events, churches and schools. Demand would fall by 80 percent in entertainment, arts, recreation, restaurants and lodging for a period of up to three months. Retail trade would fall by 25 percent. The demand for medical and hospital services would surge. And a fear of travel, coupled with likely government-imposed restrictions, would lead to a dramatic decline in domestic travel as well as international travel," Frist said.

Avian flu has been centered mainly in Southeast Asia but is moving westward through migratory birds. The disease is transmitted from animal to animal, mostly among birds. Humans are contracting the highly lethal disease after close contact with infected animals.

If the virus, known as H5N1, mutates into a form that passes easily from person to person, the world would be hit with a catastrophic pandemic because virtually no one would have immunity to the new virus.

To date, 133 people in five Asian countries have contracted the avian flu virus and 68 have died, according to the World Health Organization.

In testimony Thursday on Capitol Hill, Dr. Michael Osterholm told the House International Relations Committee that a U.S. flu pandemic would affect the world.

"The global economy will literally shut down," said Osterholm, the director of the Center for Infectious Disease Research and Policy at the University of Minnesota. "Pharmaceutical supplies, including drugs and very important childhood vaccines not intended for influenza but for our everyday lives, will be in extreme short supply, if available at all. Health-care systems will be overwhelmed and, frankly, panic will reign."

The CBO report estimates that a mild outbreak, similar to the 1968 flu pandemic, would infect 75 million people, kill 100,000 and cost the economy $160 billion, about 1.5 percent of the gross domestic product, the total value of goods and services.

The Bush administration has asked Congress for $7.1 billion to prepare for a flu pandemic. Part of it would go to increase the U.S. stockpile of antiviral drugs such as Tamiflu from 2.3 million full treatments to 81 million.

President Bush also wants $1.2 billion to purchase 20 million full treatments of an experimental H5N1 vaccine and $2.8 billion for research into a cell-based flu vaccine that would allow American manufacturers to produce enough for the entire U.S. population within six months of a flu outbreak.

Health and Human Services Secretary Michael Leavitt said the CBO report shows "it is time for Congress to act on the president's request so we can immediately begin to implement our plans to prevent and contain a pandemic."

Roche Pharmaceuticals, which manufactures Tamiflu, is in discussions with several drug companies, including Teva Pharmaceuticals and Mylan Laboratories, to increase production of Tamiflu as demand increases worldwide, Roche spokesman Terry Hurley said.

KRT Wire | 12/08/2005 | Avian flu outbreak would slam U.S. economy, report finds

Saturday, December 10, 2005

News - Child dies of avian flu - Thailand's 14th victim

A five-year-old boy in Nakhon Nayok province just north of Bangkok has become the 14th victim of H5N1 avian flu, the health ministry announced today.

Deputy Minister Anutin Charnvirakula said the boy was from Ong Karak district, and tests had confirmed the cause of death as avian influenza.

The boy lived in a rural family which kept a small number of chickens running free. He was six for nine days before his family took him to the hospital.

He is the 22nd Thai to contract the virulent virus. So far, 70 people, all in Asia, have died from the H5N1 flu strain.

Bangkok Post - Breaking News

News - EUROPA - Animal Health & Welfare - Animal Diseases - Avian Influenza - Introduction

Avian Influenza (AI) or "Bird Flu" is a highly contagious viral infection which can affect all species of birds and can manifest itself in different ways depending mainly on the pathogenicity of the virus involved and on the species affected.

Influenza infections in birds are divided in two groups on the basis of their ability to cause disease:

Highly Pathogenic Avian Influenza (HPAI): causing serious disease with high mortality (up to 100%) ? notifiable to the OIE;
Low Pathogenic Avian Influenza (LPAI): causing generally a mild disease ? not notifiable to the OIE.
Even if in certain cases LPAI virus may mutate in HPAI virus and cause a serious disease, the two infections are well distinct and should not be confused.

While domestic birds are generally highly susceptible to the clinical manifestation of the disease, wild birds, and especially waterfowls, are usually naturally resistant and often don?t show any clinical sign. Therefore, wild waterfowl represent a natural reservoir for these viruses and can be responsible for the primary introduction of infection into domestic poultry.

EUROPA - Animal Health & Welfare - Animal Diseases - Avian Influenza - Introduction

News/Editorial Poultry producers key to stopping avian flu?s spread

Like storm clouds gathering on the western horizon, reports of avian flu infecting humans in Asia and elsewhere have sent U.S. animal health experts to their computers trying to predict the next jump.

The highly pathogenic avian flu strain H5N1 has killed 60 people overseas after they caught the illness from domestic poultry. That in itself is of concern to all who work around poultry, but because the practices of Asian farmers are a far cry from those employed by western farmers the concern is diminished.

For example, in Asia live chickens and ducks are taken to outdoor markets to be sold. Those not sold are returned to the farm. Such practices present an unrivaled opportunity to spread disease among the poultry. In the case of H5N1, it also presents ample opportunity for those who work with poultry to become infected. Most of the people who have died worked with poultry.

But it?s the next potential step that has health officials worldwide most worried. A virus mutates and mutation can change how it is transmitted.

That means the potential exists for H5N1 to mutate so it can be transmitted from one human to another. If that happens, the general population will be at risk, not just those who come into contact with infected birds.

Another concern is the role migratory birds play in spreading the virus. That a migrating duck can contract avian flu in Asia and, potentially, spread it to domestic poultry in the United States or elsewhere is a concern all within the poultry industry should share.

In that context, health officials have been to plotting a strategy for heading off avian flu. When a flu appears, poultry are killed to prevent its spread. In Asia, millions of birds have been eradicated in recent months in an effort to stop the flu.

As recently as this fall, a less pathogenic flu was discovered in two domestic ducks in Canada. Authorities there immediately took steps to prevent the spread of that virus, killing 58,000 ducks and geese on two British Columbia farms.

That immediate response did much to assure consumers and others that authorities are on top of the situation, just as they were in 2004, when they ordered 17 million birds slaughtered to stop the spread of another, less-serious form of avian flu.

California poultry producers have successfully faced their share of difficult tests in recent years, too. Exotic Newcastle disease was first found in a backyard poultry flock in Los Angeles County in October 2002. That in turn led to a large outbreak of the fast-spreading disease. In all, more than 3 million birds were euthanized and about $160 million was spent to eradicate the disease.

Around the world, agencies are assembling their battle plans should H5N1 make its jump from person to person. From tiny Whatcom County, Wash., to worldwide health organizations, authorities are preparing for the worst and hoping for the best.

One conclusion they quickly reach is they need to work closely with the poultry industry.

?We need to reach out more,? Washington State Veterinarian Leonard Eldridge said. ?Industry participation and surveillance needs to be included.?

For poultry producers, that is a statement of the obvious. They have the most at stake, and they are the most knowledgeable about poultry.

They should not only be in the loop, they should be most of the loop.

Poultry producers key to stopping avian flu?s spread

News - Bird flu could be spreading across Crimea: official

Fears have been expressed that the outbreak of bird flu on the Ukraine's Crimea peninsula could have spread to other parts of the region.

"As of December 8, we had detected the deaths of poultry on new territories in Crimea," said a statement issued on Friday by the Health Ministry.

"As of December 9 the bird flu was confirmed by laboratory tests in nine villages. Dead poultry were detected in 17 villages," it added.

The disease appeared to be spreading north and south along the coastline, said the statement, adding that the main carriers of the disease are wild birds living in marshland on the Crimean east coast.

The new suspected cases were found in two villages near the Black Sea port of Theodossia in the south, in another village in the north of the peninsula and in Simferopol, the capital of the autonomous republic, according to the statement.

Further tests were required to confirm it was bird flu and establish the exact strain, said the statement.

In addition, information from Moscow confirmed on Friday that the bird flu virus detected last weekend in several villages in north-eastern Crimea is the H5N1 strain.

"This is so-called Asian strain H5N1 that poses a potential threat to man," Russian chief agriculture inspector Sergei Dankvert told Itar-Tass, referring to the virus found in the Ukraine and sent to the All-Russia Research Institute of Animal Protection for testing.

The disease has spread rapidly across the Crimea peninsula since last weekend, when around 2,500 birds died in a matter of hours in five villages in the region.

Earlier this week, President Viktor Yushchenko announced a state of emergency in the affected areas and the country's Emergency Situations Ministry seized about 28,000 birds in villages in a sealed-off exclusion zone.

No human case of bird flu was reported in the Ukraine so far, and the country is vaccinating the population in the affected are against regular flu to boost their immunity. Enditem

Xinhua - English: "Bird flu could be spreading across Crimea: official"

News - Bird-Flu Patients May Need Higher Dose of Tamiflu (Update1)

Bird-flu patients may need higher doses of the antiviral treatment Tamiflu than recommended by drugmaker Roche Holding AG, World Health Organization officials said.

Tamiflu can reduce the severity and duration of illness caused by seasonal influenza provided it is given within 48 hours of the onset of symptoms. The drug has been used in the treatment of more severe disease caused by the H5N1 strain of avian influenza, and is being stockpiled worldwide as the best protection against any pandemic flu.

Clinical trials may start as early as next month in countries including Vietnam to study whether doubling the recommended dose provides more effective treatment in H5N1 cases, Peter Horby, a Hanoi-based epidemiologist with WHO, said today.

``It's possible that increased doses of Tamiflu for treatment above the current recommended level may be more effective in H5N1 cases,'' Horby said by telephone from Bangkok. ``There are reports of some patients being treated with standard doses of Tamiflu in Vietnam and not being cured.''

Roche is working closely with the WHO and the National Institutes of Health in the U.S. to assist in the evaluation of a higher dose, company spokesman Daniel Piller said. Studies conducted during the drug's development showed higher dosages were safe. The lower dose was just as effective for seasonal flu.

``In terms of the clinical effect of the drug in people infected with H5N1, we have limited information,'' Piller said. ``We will look at longer duration of therapy and higher doses in critical case of H5N1 infected to derive the greatest benefit from Tamiflu for such patients.''

Vietnam

The ministry of Health in Vietnam has already instructed doctors to lengthen the treatment time for Tamiflu to seven days from five days for bird-flu patients, according to Tran Tinh Hien, deputy director of the Hospital for Tropical Diseases in Ho Chi Minh City, which has treated bird-flu patients in the past.

``The bird-flu virus is much more virulent, so it makes sense to double the dose for bird-flu patients,'' the doctor said in an interview. ``Given that Tamiflu has been unsuccessful in treating several cases in the north, I support that trial.''

Avian flu has infected at least 135 people the past two years in Vietnam, Thailand, Indonesia, Cambodia and China and killed 69 of them, Geneva-based WHO said on Dec. 7.

``In some cases in which people were given antiviral drugs, they died even after the treatment,'' Hitoshi Oshitani, Manila- based regional adviser in communicable disease surveillance and response with WHO, said this week. ``We don't know why the antiviral drugs didn't work in these cases. The current recommended dose of antiviral may not be enough to treat H5N1 cases.''

Too Late?

Another explanation may be that the patients began treatment more than 48 hours after their symptoms emerged, Oshitani told the Institute of Southeast Asian Studies on Dec. 6.

``This virus may be causing them more systemic infection so the usual recommended dose of antiviral is based on our experience on usual human influenza infections which only causes respiratory infection,'' he said.

Under the planned schedule for the Tamiflu trial, 150 milligrams of the medicine would be given twice a day for five days, Horby said. That compares with the recommended dose of 75 milligrams twice a day for five days, he said.

``We know that in trials using Tamiflu to treat normal influenza, you can increase the dosage safely,'' Horby said.

Details of the study are yet to be completed. The trials would be the first through a new research network established by the WHO to gather information on H5N1 cases, he said.

`Multiplying'

There are other reasons why H5N1 patients may require higher doses of Tamiflu, scientists said.

``The virus is multiplying to higher levels than normal human viruses, therefore it may take more drug to control this higher level of virus,'' said Jennifer McKimm-Breschkin, a virologist at Australia's Commonwealth Science and Industrial Research Organization (CSIRO) in Melbourne.

``Some H5N1-infected patients treated with Tamiflu have had resistant virus emerge during the treatment, hence the theory is that higher doses may prevent resistance emerging,'' McKimm- Breschkin said.



To contact the reporters on this story:
Jason Folkmanis in Hanoi folkmanis@bloomberg.net;
Jason Gale in Singapore at j.gale@bloomberg.net.

Bloomberg.com: U.S.

News - Expert says China hiding bird flu, WHO disagrees

OTTAWA (Reuters) - A Hong Kong virologist told a Canadian newspaper on Friday that Chinese officials had concealed bird flu outbreaks in several provinces but the World Health Organization said it had no evidence to suggest this was the case.

Guan Yi of the University of Hong Kong, one of the world's leading experts on bird flu, told the Globe and Mail that China had the virus all over the country.

"Quite honestly, some provinces have the virus and they still haven't announced any outbreak. I can show direct evidence, even though China is still trying very hard to block my research," the newspaper quoted him as saying.

The WHO said it had seen nothing to suggest China was hiding cases of bird flu.

"We don't have any evidence China is concealing anything ... We don't have any information to substantiate claims Guan Yi is making, but clearly he is a respected scientist," said WHO spokeswoman Maria Cheng in Geneva.

China has so far reported more than 30 outbreaks of bird flu and five cases in which the more deadly H5N1 strain of the virus spread to humans, two of whom have died.

Beijing has promised resources and openness in fighting bird flu after being widely criticized for an initial cover-up of the SARS outbreak in 2003.

The disease mostly affects birds, but scientists fear it could mutate into a form that can pass easily between people, leading to a human influenza pandemic.

The WHO said this week that bird flu might be going undetected or unreported in China, citing the case of a 10-year-old girl who fell ill in a village that had not reported any poultry outbreaks.

"We've seen a very high-level political commitment to combating avian influenza," said Cheng.

"We never expected that we would catch every single case of H5N1 in humans ... It is possible that we are missing mild cases, not just in China, but in any country reporting H5N1."

Guan said he had evidence that bird flu had been circulating in the southwestern province of Yunnan many months before officials there confirmed an outbreak on November 17.

"Why has this virus been burning for 10 years like a fire?" he asked the Globe and Mail.

"Ask the Chinese Ministry of Agriculture. They should not avoid the question. It's obvious that it's out of control in China. It started off in Guangdong province and now the whole of China has the virus."

Global Coverage Article | Reuters.co.uk

News - Can We Stop the Next Killer Flu?

JEFFERY TAUBENBERGER, VIRUS HUNTER, goes to work in a bland building overlooking I-270 in Rockville. It's the Armed Forces Institute of Pathology, and it is scheduled to be "disestablished" as part of the broader plan to close military bases around the country. Taubenberger doesn't know for sure what he'll be doing in a year or so. For now, he's still walking past the fluttering flags every day, down a flight of steps to a windowless office, where he's trying to save the world from a mysterious germ.

Doom and Gloom Talk Will Be Limited to 30 Minutes Daily, reads a sign on his bookshelf. I ask if that's a reference to the avian flu. No, he says, that's about the base closings.

The office is small and cluttered, with multiple stacks of documents, suggesting a man who is struggling to impose order on an overly busy life. His phone keeps ringing -- everyone wants a piece of him. You can't pick up a newspaper without seeing a story about the possible plague of avian flu, also known as bird flu or, to be scientifically correct, influenza A/H5N1. Millions could die, the stories say. Or tens of millions. Or hundreds of millions. Avian flu has reached a cultural and media tipping point, a kind of celebrity as the premier biological menace to civilization.

Avian flu is certainly a frightening virus. It kills birds, can infect human beings and has been lethal in about half of the documented cases so far in Asia and Indonesia. More than 60 people have died already. But so far it hasn't become easily transmissible from one human to another, unlike the common influenza virus that circulates every winter. Avian flu is still just that -- a bird flu, not a human flu. Every article about this flu has a boilerplate paragraph, as if mandated by law, stating that scientists fear the virus will mutate, become highly contagious in humans, and create a pandemic that will rival the catastrophe of the Spanish influenza of 1918.

Taubenberger is doing his part to keep that from happening. He wants to understand the various types of flu viruses at the most essential level -- tunneling deep into their genetic mysteries. What kind of mutation could turn avian flu into a pandemic pathogen? What genetic improvisations in these little nodules of RNA and protein -- these things so small and spare they hardly deserve the grandiose label of "microbe" -- can turn an ordinary flu into a cold-blooded killer?

He'll pause at some point to get a flu shot. "I'm susceptible to respiratory infections," he says. Taubenberger is something of an alpha nerd. Modest of stature, rather boyish at 44, quick of speech, he keeps on his desk a prop from his 10th-grade science fair project at Robert E. Lee High School in Springfield, the one that merited the grand prize for Fairfax County. It's a homemade model of the double helix, the structure of the DNA molecule. When discussing the genome of the flu virus, he will touch parts of the double helix and give a quick lecture on how life works: The adenine always binds to the thymine, the guanine to the cytosine . . .

The only flu in the room, as far as anyone can tell, is on a shelf. It's a stuffed, fuzzy influenza virus with plastic eyeballs,

a joke flu from a company called Giant Microbes. It's just a blob. That's scientifically accurate, because flu virus has an unremarkable appearance. In an electron microscope, you see a knobby little ball.

The effects of flu are more dramatic. Taubenberger keeps autopsy samples of lung tissue from a soldier who died of the 1918 virus. These are thin sections of lung, cut and stained, and preserved in paraffin on a glass slide. He puts a slide under his microscope. First we look at healthy tissue: Clearly visible are the air sacs, ready to breathe, with a scattering of red blood cells. Then we look at diseased tissue. They're filled, completely choked, with little red circles. Blood cells.

"You don't see any open air sacs anywhere. They're all filled with blood. This person drowned in his own blood," Taubenberger says. "This is not good, to use a highly technical medical term."

The 1918 flu killed more people in a short period of time than any other plague in human history. Taubenberger and his scientific collaborators hope that the virus will serve as a Rosetta stone for understanding avian flu. They have literally rebuilt the 1918 virus and brought it back to life. Taubenberger has come to the conclusion that there was something very weird about this germ. It was a bird flu that jumped to humans, but the fine print of its genetic code is noticeably different from that of other bird flus.

As he works on the mystery, one thing is clear: This is a scientific drama that involves not only disease but also evolution, the process by which organisms mutate and adapt to changing conditions. And it's evolution in real time, at a frantic pace, happening as we speak, here at the start of the flu season. There is much debate these days about whether evolution explains life on Earth, but in the real world, on the ground, among living things, evolution is not only real -- it's dangerous.

A Long War

MAN VS. MICROBE IS AN OLD NARRATIVE. The plot's been twisting. A few decades ago, medical science sensed that it had the germs in full retreat. Antibiotics saved lives once lost to the most routine infections. It's hard to remember, but people used to die of strep throat, a small cut, a hacking cough gone bad. Vaccines turned the tide; germs stopped killing babies in their cribs; smallpox disappeared outright.

And then the tide turned back. Drug-resistant bacteria began flourishing. HIV became pandemic. Scientists began talking of "emerging" diseases. They come from the rain forest, from the dark recesses of tropical caves, from foul duck ponds and fetid chicken coops. They take advantage of a world of abundant human and animal meat. It would appear from the unfolding concern over avian flu, and from recent outbreaks of panic over other pathogens -- SARS, for example -- that civilization is increasingly vulnerable to pandemics, and that the human face of the future will be covered with a mask.

By overcrowding the planet, by ravaging our environment, by jetting promiscuously around the world with all manner of microbes in tow, by overprescribing antibiotics and helping breed superbugs, we've set ourselves up for a plague. That's the basic argument.

But here's another possibility: That we're at a turning point in the war between people and germs. That we've learned, just in the past half-century or so, how to read the code of life. That we've

developed techniques, just in the past two decades, to discern the complete genetic code of an organism. That, just in the last few years, we've started to figure out the innermost secrets of microbes and what turns some of them into pathogens.

Jeffrey Gordon, who studies intestinal bacteria at Washington University in St. Louis, says: "We have the tools in the year 2005 to define the genetic evolution of a lot of these pathogens, particularly in the case of viruses like flu. It's a race between our society, our politics, our societal will and the viruses."

No one knows how the race will turn out, but the advantage at the moment is not necessarily on the side of the microbes. We're on to their game. Or, to use a more appropriate metaphor, we're not a bunch of sitting ducks.

The Secret of Life

TAUBENBERGER BECAME INSPIRED in 1995 by a story of human eyeballs floating in a jar. They belonged to John Dalton, the pioneering chemist. Dalton died in 1844, but his eyeballs stuck around. He was colorblind, and he saw his defective vision as an experiment waiting to happen.

He hypothesized that a fluid in the eye (the vitreous humor) would, upon close examination, prove to be blue, filtering out the normal hues. He instructed his assistant to pluck out his eyes upon his death. After the great man died, the assistant examined one of the eyes and saw no blue fluid. He nicked the other one in the rear and looked through it -- literally looked at the world through John Dalton's eye. The world appeared normal. The colorblindness was thus neurological, a problem rooted in Dalton's brain.

In 1995, researchers reported that they had taken the Dalton case a step further. Genetic testing -- a relatively new analytical tool unthinkable in the day of Dalton -- showed that he had an inherited colorblindness gene.

Taubenberger loved that. How very cool, he thought, to solve an old mystery through some aging tissue sitting in someone's lab. "Everything about life is interesting, when you start to get into the details of how things work," he says. Taubenberger, the head of the molecular pathology department at his institute, wondered: What could I do that would be really nifty, but also of significance to the world? A mentor once told him, "Work on an important problem."

He considered studying the yellow fever that killed so many people in the 1800s. But then he seized upon the Spanish influenza of 1918. It was wildly infectious, and virtually everyone on the planet was exposed. About 2.5 percent of those who became sick died, which seems like a modest level of lethality until you realize that it added up to more than 600,000 American deaths in just a matter of months and something like 40 million deaths worldwide. Taubenberger knew that the institute had millions of autopsy specimens from soldiers dating to the Civil War. If he could retrieve even a few genetic scraps of that virus, perhaps he could figure out why it was so contagious and virulent.

Ten years later, his project is still going, centered in the rather ordinary laboratory directly next to his office (he has collaborators in labs around the country). Taubenberger doesn't do a lot of bench work these days, what with giving interviews, taking meetings, trying to get things published, but he has assistants busily at work, filling tiny vials with fluids containing DNA, sequencing genes, tapping on computers, accessing databanks and doing all the highly detailed work of decoding the 1918 influenza virus. Taubenberger also has a new project in collaboration with the National Institutes of Health and a nearby genomics institute, to find the genetic codes of many thousands of different strains of viruses harvested from people and wild birds.

The overarching goal for both projects is to learn how these viruses evolve and which mutations might make them more or less likely to become adapted to humans and develop into potential killers. By removing from influenza some of its element of surprise, we might be able to forecast likely outbreaks, in the same way that we can forecast which tropical depression is going to turn into a hurricane. It's a sweeping plan, using all the hardware Taubenberger can round up.

If you take a left out of his lab, go through another lab (more vials, bottles, jars, tubes, refrigerators) and cross another hallway, you'll reach the room with the automated sequencers. There's a big one from Applied Biosystems, the 3132 Genetic Analyzer. Somehow, this thing can read the language of a genome, letter by letter.

Life on Earth operates on a genetic system that, at its core, is remarkably simple, considering that it gives rise to creatures as diverse as sea urchins, praying mantises and humans. The genome is written out on a very, very long molecule called deoxyribonucleic acid -- DNA.

Molecular biology is to some extent the study of architecture. It's all about structure. Proteins -- which do most of the heavy lifting in the body, such as building cells and tissues -- have many ways of folding themselves in three dimensions. Their structure determines their function. They roam the body in search of a correctly shaped receptor. They just want to fit in somewhere.

When Francis Crick and James Watson rocked the scientific world in 1953, it wasn't by discovering DNA. Rather, they found the structure of the molecule, and proved that it was the source of genetic information. "We've found the secret of life," Crick exulted that winter day to friends at the Eagle pub in Cambridge, England, and the secret, it turned out, wasn't some special juice, some exotic energy source, but just a well-framed, two-stranded, ladderlike molecule with rungs in all the right places and a nifty ability to make copies of itself.

A gene is historically defined as a segment of DNA with instructions for making a single protein, though the one-gene, one-protein rule is pretty loose. Humans have upwards of 30,000 genes. The flu virus has just 11.

The code of a gene is written in the form of tiny chemicals called nucleotides, more commonly referred to as the "bases" or "letters" of the genome. Life uses a very short alphabet. There are only four bases used by living things: adenine, cytosine, guanine and thymine, or A, C, G and T.

DNA sequencing, the process of finding the order of the letters, isn't terribly new. As far back as 1977, Fred Sanger and colleagues managed to piece together all 5,386 letters of a tiny organism called phi-X174. In the mid-1980s, Kary Mullis developed a technique still used in Taubenberger's lab, called polymerase chain reaction, which amplifies pieces of DNA and makes them easier to study.

Automated sequencing machines came online only in the past decade or so. They're like reverse vending machines. You open a door, place a tray of DNA samples in a slot, watch it recede into the interior of the machine, and wait. Inside the machine, needles descend into the DNA vials and pull the fluid through a tiny glass tube, known as a fiber-optic capillary. The machine examines the thin stream of fluid with laser light; the nucleotides, the bases, go slipping through the laser beam one by one, guanines glowing differently from cytosines, and so on. Soon, the results flash on an adjacent computer screen: the letters. The code. The process is hardly push-button simple -- the machines can examine only short segments of genes at one time, and scientists are often working with scraps to begin with. But it's definitely a scientific marvel.

"There's this kind of voodoo part," Taubenberger says. "Nothing you do can be seen. It's all invisible. It's all magic." But, he adds, in homage to the requirements of the scientific method, "it's reproducible magic."

Resurrecting a Killer

FINDING THE FIRST SCRAPS of the 1918 virus took a full year. Any flu virus is tricky to recover, because it tends to vanish under the onslaught of the body's immune system. In many cases the 1918 victims died of secondary bacterial pneumonia that flared in their ravaged lung tissues.

Taubenberger and his assistants searched scores of autopsy samples and finally came across one from a soldier who died at Fort Jackson, S.C., with pneumonia in just one lung. Taubenberger had a hunch: The soldier would have died with live, intact virus still in his "healthy" lung. Sure enough, in tissue from that healthy lung he found, and painstakingly recovered, remnants of the 1918 virus.

Then he got more of the virus from an unexpected source. After he published a paper in the journal Science in 1997 reporting his initial results, he received a call from an elderly pathologist named Johan Hultin. Hultin knew where to find bodies of native Alaskans who had died of the virus and were still preserved in the permafrost of Alaska. What happened next has been oft-told in recent years: Hultin returned to Alaska and, hacking into the frozen ground, found the corpse of a woman whose tissues preserved the killer virus. Eventually, Taubenberger teased out the entire genome.

Then came something unimaginable even a decade ago: Taubenberger, Terrence Tumpey of the federal Centers for Disease Control and Prevention, and their collaborators brought the 1918 virus back to life. Or more precisely, they re-manufactured it. They followed the genetic recipe and cooked it up.

The procedure involved a technique developed in 1999 called reverse genetics. Scientists can synthesize stretches of DNA, putting the chemical bases in a desired order. Genes can then be converted into a useful chunk called a plasmid and inserted into a cell culture. If all goes well, and if the scientists have stamped This End Up in all the right places, the virus will reassemble itself inside the cell.

Tumpey and his colleagues took antiviral medication and wore protective hoods as they rebuilt the virus in Atlanta. They actually made a number of variations of the 1918 virus. Some viruses had a few of the 1918 genes. One version had all the genes. The scientists infected mice with the different strains, and the strain with all the genes proved by far the most lethal, quickly killing all the infected mice.

This fall, the scientists published the genome and their test results in the journals Nature and Science. One syndicated columnist declared that we had just given our terrorist enemies a lethal weapon. It's certainly true that mad scientists could conceivably re-create the 1918 pathogen and combine it with some kind of warhead. Back in the day, the Soviets were enthusiastic about putting biological agents such as anthrax into their missiles.

But the 1918 virus wouldn't be the ideal bioweapon. Flu strains currently in circulation are descendants of that virus, so people carry some immunity to that subtype of flu. There are biological agents, such as anthrax, that would be easier to obtain, easier to weaponize.

The upside of publication is clear. Scientists can try to figure out where the 1918 germ came from and what made it so lethal. The paper in Science stated that all 11 genes, contained in eight gene segments, play a role in making an "exceptionally virulent virus" in the mice. To Taubenberger, that suggests that bird flu viruses need a small number of mutations on each gene, possibly in a certain order, to reach the elite level of a 1918-style killer. He thinks perhaps 25 mutations all told are necessary. He bases this on what appear to be some common mutations that differentiate human flus such as 1918 from ordinary bird flus. Alarmingly, strains of avian flu in Asia already show some of these mutations on four of the eight gene segments. On the three genes necessary for viral replication, for example, some avian flu strains already have two of what Taubenberger believes are 10 mutations common in human flus. "I am moderately worried," he says. "We don't know exactly what the rules are."

Sure, bad guys might somehow figure out how to use the published data about the 1918 virus to invent a new version of flu that can kill lots of people. But a simpler scenario is that Mother Nature will do it by herself.

She's got a bigger lab.

A Planet of Germs

GERMS COME IN MANY FORMS, from viruses to bacteria to protozoa to fungi, and we prejudicially lump them into a group called microorganisms, or "microbes," as though being a bulky, fleshy hunk of animated meat is the norm for life on Earth. But the microbes had dominion over the planet long before there were any humans, and they'll surely be here when we're gone.

"We're vastly outnumbered," says Ira Longini, a biostatistics professor at Emory University in Atlanta. "The microbial world is infinitely larger than we are. Much more varied, much more flexible. We virtually swim in it."

Although Anton van Leeuwenhoek developed the microscope in the 1600s and observed tiny "animalcules," no one could imagine that such humble organisms could bring a strong man to his knees, make skin burst into pustules and boils and lesions, cause wounds to putrefy and lungs to fill with blood. People assumed that illness came from the inhalation of noxious vapors, or as punishment for sins, or from the malign schemes of evil spirits.

The English doctor Edward Jenner noticed in 1796 that milkmaids sometimes caught a disease called cowpox. He showed that infected fluid from a milkmaid's hand, injected in another person, would provide partial immunity to the related disease of smallpox. But he had no idea that pox came from a tiny entity that would someday be called a "virus."

Medical science, so advanced today, was a primitive field compared with such noble endeavors as engineering and physics. But gradually, a germ theory of disease began to form. Englishman John Snow in the 1850s made careful observations of a cholera outbreak in London, plotting the location of the sick and dying, and eventually tracked the epidemic to a single contaminated well. Surgeons discovered that if they washed their hands their patients had a better chance of survival. Louis Pasteur argued that microorganisms caused not only fermentation but also any number of human diseases. In 1876, the German physician Robert Koch showed that anthrax came from a bacterium. One by one, science linked diseases to microorganisms. But viruses were hard to nail down. They were too small to see.

The 1918 pandemic was all the more terrifying for being so mysterious. Flu mortality by age group normally shows a bathtub-shaped curve, killing primarily young children and the very old, but the 1918 germ had a W-shaped curve, with a huge spike among healthy people in their twenties. Many were soldiers in military camps and troop transport ships. This seemed almost a medieval disease, wildly contagious, capable of killing its victims within two days. The lungs filled with a thick bloody fluid. A doctor at Camp Devens, near Boston, wrote of the dying soldiers, "Two hours after admission they have the Mahogany spots over the cheek bones, and a few hours later you can begin to see the Cyanosis extending from their ears and spreading all over the face, until it is hard to distinguish the coloured men from the white."

There were rumors that this pestilence was nothing less than the Black Death, the bubonic plague of the 14th century. When the disease spread to Philadelphia, there were not enough caskets, and bodies lay rotting in the slums, in hallways and on porches. The corpses were stacked by the hundreds at the city morgue. The pathogen swept the country, targeting crowded military installations, where the sick and dying overflowed hospitals and jammed every corridor, surrounded by bloody sheets, vomit, urine, feces and buzzing flies. At Camp Grant, in Illinois, more than 500 soldiers died, and the commander finally put a bullet through his brain. The explosive nature of the disease mimicked the behavior of the virus itself, replicating by the thousands in an individual cell, and bursting forth to run riot all over the lungs. Not until 1930 did scientists manage to isolate an influenza virus.

The horrors of World War II, and the search for cures for infections, helped usher in a glorious era in microbiology. A scientist named Alexander Fleming had made the fortuitous discovery that bacteria in his lab died in the presence of bread mold, leading to the invention of penicillin and other antibiotics. And, although agents that killed viruses weren't just sitting around in nature waiting to be discovered, scientists were able to develop vaccines for polio, measles and other childhood diseases.

Still, viruses were enigmatic. It took many decades, well into the 1970s, for science to grasp what these things were and to understand their diabolical genius.

A virus is arguably not truly alive. A virus cannot replicate or evolve unless it is inside a host. It's a parasite, hijacking the host's cellular machinery. For example, the flu virus when inhaled infects the upper respiratory tract (though the 1918 virus went deep into the lungs). The virus penetrates a cell, inserts its own genetic game plan and forces the cell to make copies of more virus. Cells can die in the process, and others can be killed by the host's immune system as it desperately tries to wipe out the invaders. Bacteria set up shop among the slaughtered cells. Death can often follow from this secondary bacterial pneumonia.

Modern medicine struggles to attack viruses, because they're so deeply insinuated into cells. It took the advent of recombinant DNA, the techniques of splicing and dicing genes, for medical science to produce the first antivirals, which don't kill viruses outright but suppress their ability to replicate.

When isolated, outside a cell, a virus is a biological zero. It has no metabolism, processes no energy and might hang together for just a day before falling apart.

Viruses are made of either DNA or RNA, the two genetic molecules of Earth life. There's not much else to them. You might describe them as data in search of an argument. The virologist Peter Jahrling has a sign in his office saying, "A virus is just a piece of bad news wrapped in a protein." Taubenberger likes an automotive analogy: "You can think of them as very streamlined life forms, like race cars. They don't have any extraneous stuff."

The success of viruses implies that the fundament of life is not liquid water, or carbon molecules, or some mysterious essence, but rather information.

Deeper Into the Code

TAUBENBERGER THINKS ABOUT LETTERS. TGG. CAG. TAC. AAA. These are the DNA bases, tripled up, forming what's called a codon, the instructions for an amino acid. Put enough amino acids together, and you've got a working protein. A single copying error during viral replication, an A becoming a G, can change an amino acid, alter the structure of the protein and perhaps change the way the virus behaves.

So Taubenberger has letters on his mind. He calls them up on his computer screen and prints them out, eight separate pages, a page for each influenza gene segment.

What's the message -- no, the music -- in those letters?

Music and genetics are both important to him. Like many scientists and mathematicians, he composes music in his spare time. Chamber music. Symphonies. He wrote a comic opera in college, at George Mason University. He used to play the oboe. Music and the genetic code, he says, "both rely on a stable kind of alphabet in a sense. There are only so many notes available, and there are 12 different tones. All music" -- he later stipulates that he's talking about Western music -- "whether it's Bach or rock-and-roll, it's all using selected combinations of those 12 tones."

Right there is the genius of life on Earth.

"There's an infinite way to arrange the genetic code. Here it is, it's only four different letters, and it makes things as different as flu viruses and oak trees and fruit flies and fruit bats."

Influenza is tiny. It's made out of RNA, the smaller, one-stranded cousin of DNA. A human being has a genome with about 3 billion letters, but a flu virus has just 13,500. Here, converted by scientific custom into the alphabet of DNA, are the first of the 1,681 letters that code for the protein hemagglutinin in the 1918 flu virus:

atggaggcaagactactggtcttgttatgt . . .

Wait, it gets better. Check this out, from the middle of the gene:

. . . ggggtctatttggagccattgccggttttattgaggggggatgg . . .

Perhaps it looks like gibberish at first glance. Also second glance. Even Taubenberger says, in a burst of honesty, "It's very hard to know where the meaning is."

But he sees patterns. All genes start with the codon ATG, which corresponds to the amino acid methionine; all genes stop with one of three codons that effectively shout, "Halt!" There's some slop in the system: There are 64 possible codons of the four letters, but only 20 amino acids are used by Earth life. This means several different three-letter combinations will sometimes lead to the same amino acid. Biologists, perhaps ungenerously, call the code "degenerate" because of this imprecision.

By studying these letters, Taubenberger has already decided that, among flu viruses, 1918 is strange. Down at the level of the GGC and ATA and CCT and TTT and so on, it just isn't like any of the bird flus currently in circulation. Could the differences be caused by bird flus evolving dramatically between 1918 and today? Taubenberger went to the Smithsonian and said, in essence, I need an old bird. A curator produced a carefully preserved brant goose, collected in Alaska in 1917. Taubenberger found a remnant of bird flu in the goose, studied it in his lab, and saw that it wasn't that different from contemporary bird flus. Samples of other birds circa World War I led to a firm conclusion: The Spanish influenza wasn't like the wild bird flus then circulating.

"It came from a donor host that we don't know about," he speculates.

A strange bird, never studied by virologists, perhaps. An odd duck. Or perhaps some of the 1918 virus's evolutionary history took place not only inside a bird but also within an entirely different sort of animal -- a mystery mammal.

The hemagglutinin protein is of particular interest, because it's on the surface of the virus, and it determines whether the virus will bind to a cell or keep swimming past. Because it sticks up on the outside of the virus, it's the target of the immune system's antibodies. A simple mutation can cause the hemagglutinin to change structure and suddenly be less recognizable to the antibodies that patrol for flu viruses.

Flu evolves at a breakneck pace, because it makes so many copying errors as it replicates. A CGT could become, for example, a CCT, changing one amino acid in the resulting protein. Chances are, that won't do the virus any good. Most mutations are deleterious. But every so often a copying mistake will lead to a virus that replicates faster, or can penetrate more deeply into the lungs, or can colonize the cells of a different animal.

Which mutations should we fear most? Taubenberger doesn't know.

"We don't know anything!" he says.

A Coming Plague?

HE'S EXAGGERATING. HE KNOWS A LOT. But probably the least appreciated and most important phrase in science is "We don't know." Uncertainty is built into the fabric of science. It keeps scientists humble. Sometimes it can make them sound a little dodgy. You can talk to scientists until the cows come home and never hear a completely definitive statement. Everything is hedged, preliminary, subject to revision. Scientists are uncomfortable with absolutes in a universe built on perplexing relativistic principles and spooky quantum mechanics. Even the constants of nature, like gravity, are now viewed as a little squishy around the edges.

If you ask Taubenberger a big, thorny question, he'll likely say, "The answer is 42." It's a reference to the signature irony in The Hitchhiker's Guide to the Galaxy, and the narrator's quest to find the meaning of life. Taubenberger responded to one overly broad biology question by saying, "I'll give you a highly technical answer: We don't know."

Everyone has the same question about avian flu: How worried should we be? The short answer (other than "nobody knows") is that, although it's a nasty virus, it would be premature to cancel plans for the rest of one's life. It's not time to go into survivalist mode, living off canned food and wearing a hepa-filter mask 24 hours a day.

When digesting stories about avian flu, one should remember that the media love a good End Is Near tale. Doom is good for ratings. The most alarmist voices invariably will be the most quoted. One network stated in prime time that a billion people could die of this flu -- yes, billion with a "b." Some of the experts sounding the most dire alarms may be on a quest for funding. One expert told a group of congressional staffers this fall that when the pandemic strikes, "time will be described, for those left living, as before and after the pandemic." Except that wasn't true after the pandemics of 1957 and 1968, and it wasn't true even after 1918. The Spanish influenza was so overshadowed by World War I that historian Alfred Crosby wrote a book about it called America's Forgotten Pandemic.

No doubt, the H5N1 strain (the H stands for hemagglutinin, the N for neuraminidase) is the most worrisome type of wild bird flu, because it has already shown that it can infect people and kill them. And each person it infects is a kind of petri dish for further mutation. If a person who already has a human flu is simultaneously infected with a bird flu, the two strains can "reassort" into a new flu that has the worst qualities of the original two. Or the bird and human viruses could reassort inside a pig. Researchers have heard tales of farmers feeding bird-flu-infected chickens to pigs.

All these animals in all these places represent yet more petri dishes. For this reason, "avian flu" is already an oversimplified term. The avian flu of the newspaper headlines, H5N1, has led to countless mutant strains. Viruses don't break down easily into distinct species. Rather, they're like a cloud, a mist of slightly different genetic entities, that blows across the landscape. The H5N1 strain catalogued as A/Vietnam/HN30408/05 is not exactly the same as the one called A/Vietnam/JPHN30321/05 or A/Duck/GuangXi/13/2004.

We also don't know what would happen to the virulence -- the deadliness -- of the avian flu if it did become a human contagion. Contagiousness and virulence are often at cross-purposes. Ebola, a frightening filament-like virus that causes uncontrolled bleeding throughout the victim's body, burns so hot as a disease that it usually kills people before they have much of a chance to spread it. Emerging viruses that are initially highly lethal, such as avian flu in the human cases seen so far, often evolve toward lower virulence for their own survival. Even the merciless 1918 virus evolved into a milder strain. Jahrling, the virologist, says: "The equilibrium seems to be toward lower virulence, toward an accommodation with the host. It's not smart to kill your host."

What does Jahrling think will happen in the case of avian flu?

"We can't prognosticate evolution," he says.

We can keep our eyes open. If, based on genetic flu research like Taubenberger's, scientists knew exactly which mutations were critical to the emergence of a pandemic strain of flu, and if health officials carefully monitored the strains evolving in the influenza hot spots of Southeast Asia, China and Indonesia, it might be possible to snuff out a dangerous strain before it could spread.

The U.S. government has to prepare for the worst, even at the risk of later being accused of overreacting. The Department of Health and Human Services, on November 1, issued its long-awaited pandemic influenza plan. President Bush, trying to recover from the Katrina fiasco, went to the National Institutes of Health to unveil the plan and, in effect, declare war on flu. He asked Congress to spend $2.8 billion to make vaccine production faster. He asked for $1.2 billion to stockpile an avian flu vaccine that is still in trials. He asked for another billion to stockpile antiviral drugs such as Tamiflu and Relenza. Bush said Americans can't wait for the microbial terrorists to come here, but rather must attack them where they originate. "Our country has been given fair warning of this danger to our homeland, and time to prepare," Bush said.

He'd run up a $7 billion tab in just a few paragraphs, but no one in the crowd, all leaders of the Disease Industry, was going to protest. (The germs themselves have no lobbyists.) The plan has run into some budgetary and political troubles, but the broader problem may be scientific and technological. Vaccines aren't magic bullets. Influenza, like HIV, is a moving target. This year's avian flu vaccine may not do any good in a couple of years. There are limits to our ability to force the natural world to conform to our schedules and projected budgets for the next fiscal year. Pandemics, like earthquakes and hurricanes, don't obey our dictates.

The H5N1 virus surfaced in humans in 1997, when it killed a 3-year-old child in Hong Kong. The flu experts sounded the alarm. Pandemic possible. No one has immunity. This could be the Big One. Then H5N1 receded from view. Robert Webster, perhaps the leading researcher on avian flu, told an audience soon thereafter, "If this virus had learned to spread from human to human, at least half of you would not be in this room today."

Eight years later, all the alarms are going off again. The virus reemerged in 2003 in southern China. It has devastated poultry farmers. Carried by migrating birds, the virus has spread westward across the Eurasian landmass, to Europe. In the United States, poultry farms have become high-security zones. And now winter is here. Flu season.

If one wants to be optimistic, one can consider that avian flu has had abundant opportunity in recent years to mutate or reassort into a pandemic human virus. Does it need more time? Or is there some biological barrier that it can't surmount?

"If it's going to do this, why hasn't it happened already?" Taubenberger asks.

There are at least 16 subtypes of bird flu, based on differences in the hemagglutinin protein coat. The subtypes are called H1, H2, H3 and so on, but the numbers are just convenient labels; an H2 flu doesn't have twice as much hemagglutinin as H1. We don't know how many of the 16 subtypes of bird flu are capable of jumping species and causing human flu pandemics, but it appears that the five most recent pandemics -- 1850, 1890, 1918, 1957 and 1968 -- were caused by just three subtypes (H1, H2, and H3). Could it be that those are the only three subtypes capable of causing flu pandemics?

We don't know.

If there's one certainty, it's that germs are a growth industry. When Richard Krause took over the National Institute of Allergy and Infectious Diseases in 1975, it ranked only eighth in funding among the various institutes of NIH, he recalls.

"We didn't get much funding because people no longer thought infectious diseases were important. Follow the money. If you want to know what the public thinks is important, follow the money," says Krause, who stepped down as director in 1984.

Many of the people who study pathogens have a new headquarters, or a new laboratory, or a new vaccine plant, or some other shiny piece of infrastructure. The infectious organisms themselves are nothing to look at -- microbiology as a science involves lots of tiny vials holding clear, colorless liquids -- but the buildings (the structures!) are increasingly impressive.

At the Centers for Disease Control and Prevention in Atlanta, the new security entrance leads to the new garage, the new visitor center and two new high-rise buildings jammed with offices and laboratories. Go to Fort Detrick in Frederick, where the Army has, for years, studied scary microbes in a drab, aging facility, and you'll learn of a new building going up under the auspices of NIAID. Just south of town, NIAID also has a new $65 million vaccine pilot plant tucked into an industrial park.

Perhaps what's truly different today is not that we're more vulnerable to disease, but that we're less tolerant of it. The idea of a loved one being swept away by a pestilence is unthinkable. We're eager to pay for protection against microbes. And we know that, even if H5N1 doesn't turn pandemic, some other flu strain could, and there are other germs out there, lurking, biding their time, evolving. The list is long and scary: HIV. Monkey pox. Ebola. Marburg. Dengue hemorrhagic fever. Lyme. Chronic wasting disease. Drug-resistant staph and strep. And there are diseases that don't even have names -- bacteria and viruses that doctors have never seen before.

In addition to remembering to wash their hands, Americans should realize that they're in a relatively privileged position, with access to health care and medication that's rare in much of the world. Countless people on the planet suffer from rather mundane but totally treatable and curable diseases. The leading killer worldwide of children is diarrhea caused by parasites. Those children don't need a new vaccine; they need clean water.

Most people in America aren't worried about TB, or malaria, or measles, or diarrheal diseases, because they don't know anyone who's dying of them.

Steven Holland, a physician who treats infectious diseases at NIH, says, "It's like most things: All politics is local, and all infectious disease is local."

Fighting the Mutant Swarm

ON THE NIH CAMPUS, MICROBIOLOGIST Kanta Subbarao has three candidates for an avian flu vaccine already in the pipeline. But she wants vaccines that might be useful against any of the 16 subtypes of flu. For example, she worries that an H9 flu virus could become pandemic. It's not very virulent in humans at the moment, but it's all over the place, and it could reassort into something more lethal. So add that to the list, next to the H5 subtypes: the threat of H9.

Also H7.

"There was a large outbreak in 2003 in poultry in the Netherlands," she reports. Several people who handled infected birds caught the H7 flu themselves, and one died. Then H7 vanished.

That's the nature of viruses that lurk in animal reservoirs. One reason we don't worry about a natural outbreak of smallpox is that it's an entirely human virus. It hasn't merely retreated, it has gone extinct in the wild. This is not the case with influenza, or with, to take the example of something that Subbarao has in her lab, the SARS virus. It put a scare in the world three years ago and killed about 800 people, but since has vanished. SARS turned out to be a public health triumph -- officials were able to quarantine infected people before the pathogen could become pandemic. No one ever figured out where SARS came from. Civet cats, maybe? Bats? Is it still out there, somewhere?

There is so much we don't know.

"The more you know," says Dave Evers, one of Taubenberger's postdoctoral fellows, "the more you know that you don't know."

Taubenberger wants more data. More code. "Maybe we're not doing enough," he says. "We need lots more sequences to help understand the significance of what's happening with H5." He wants to look at human flu viruses, pig flu viruses, horse flu viruses, everything out there.

As he talks about this, he appears a bit fatigued. It's so much work, breaking these codes. Just look at his desk already: too many papers, too many articles to read, too many printouts, all of it pushing up against that prop from his 10th-grade science project, that double helix, which looks simpler and more elegant by the minute.

"My life at work has basically spun a little bit out of control," the scientist says. "I live in barely contained chaos all the time."

But that's just life on Earth.

Joel Achenbach is a Magazine staff writer. He will be fielding questions and comments about this article Monday at 1 p.m. at washingtonpost.com/liveonline.

Can We Stop the Next Killer Flu?

News - Press Gaggle After Avian Flu Tabletop Exercise with Homeland Security Advisor

MS. TOWNSEND: Good afternoon, everyone. As you know, the Cabinet, this morning -- members of the Cabinet conducted an exercise related to the nation's preparedness to deal with a pandemic flu event. The President has made perfectly clear that our number-one priority, in the event of a pandemic, is to save lives. The President has a plan to do just that. He's released his national strategy for safeguarding against a pandemic flu. That plan includes a $7.1 billion request for emergency funding from Congress.

What we've learned today, as we -- as the President has said, is the most important part of that strategy will be vaccines and antivirals, and that is the bulk of what that funding is for. We urge Congress to fully fund the President's strategy to be implemented.

I should be clear that we currently have no evidence that a pandemic flu in this country is imminent. That said, we are fairly warned, and the time to prepare for that pandemic is now. That involves all levels of government: federal, state and local, non-governmental organizations, the private sector, the media. We all must be prepared and we all have a role to play in the nation's preparation.

Secretary Leavitt, this week, hosted a conference of state public health officials, and he'll be traveling to each of the 50 states to meet with public health officials and discuss preparedness. Secretary Rice, at the State Department, is spearheading the international partnership to ensure that we are fully knitted up at all levels of government and internationally, as well as private and individual citizens.

The key for individuals is education. And I'd like to talk about that for a moment. This is the time to go -- if you haven't gotten your annual flu shot, you might think about doing that this year. That's part of your individual preparedness plan. You want to educate yourself by going to the website, pandemicflu.gov.

We each have a role to play. I'm a mother -- I've got two small boys -- and you can be sure I take this seriously, as I'm sure all Americans do. You have a responsibility to make sure that you are informed so you can best prepare your family.

Now, we can take a couple of questions, and I have the secretaries here to help.

Q Fran, can you talk about exactly what happened today and how -- what you guys went through -- the drill you went through showed some of the problems that still remain?

MS. TOWNSEND: Let me say this, we're not going to go into the specifics of it. You know, the exercises are just that. It's a drill, it's meant to test -- it's meant to push federal resources to the breaking point and to ensure that we're prepared, that we identify gaps and then we plan to fill them. We accomplished that this morning.

Q How many gaps did you find?

Q -- what worked and what didn't?

MS. TOWNSEND: What you do is you walk through a fact set and you identify options, and then what you want to do is go back and make sure that -- do each of the federal agencies have plans to fill those gaps? And quite frankly, I think we did quite well. But the thing that we take away from it, more than anything, is the role that state and local governments would play. This is not going to be a federal answer to the problem. Federal government has got a support role to play, but frankly, I think, really, very important, is the state and local efforts that Secretary Leavitt is spearheading.

Q But were they involved in this at all, state and local officials?

MS. TOWNSEND: This is an opportunity to test the federal preparedness and understand what the connection is for our support with state and local government.

Q -- federal preparedness -- there was a congressional report that came out Friday that said the government was not prepared -- did not, on the medical side of things, set up field hospitals, and basically, the whole medical front. There were a lot of issues. And it was bungled, is what some people referred to it as. What's your response to that whole -- that whole accusation by this report that came out Friday?

MS. TOWNSEND: There's been a great deal of planning for preparedness in just that area. I've not seen the report, so I wouldn't comment on it specifically.

Q Could we hear from the two secretaries on how you thought things went today?

SECRETARY LEAVITT: This was a valuable exercise. I will tell you that maybe even of greater value was what happened in the last week-and-a-half as we prepared for it. It has moved us thinking deeper in preparing.

What became evident was the need for a comprehensive plan. We need to have a surveillance plan that allows us to identify when an incident has occurred in the world. The sooner we know, the more quickly and more adequately we can respond. We need to have a domestic surveillance system; when it happens in the United States, having the capacity to know what's occurring within the health care system is of vital importance. Antivirals -- we talked at length about how we would deal with the fact that we don't have an unlimited supply. Vaccines -- a very important part, something that we'll have a limited constraint of for a few years, but more importantly, we have -- we lack the capacity in this country to manufacture the number of courses needed to give everyone a vaccine. That's why the President has proposed this $7.1 billion plan to revitalize that industry.

But as was previously stated, state and local governments, state and local communities, schools need to have a plan, businesses need to have a plan, faith organizations need to have a plan, local officials need to understand. The public health community understands a pandemic; they understand the dangers of a pandemic. It's now time to engage a broader community so that we have a true nationwide response effort that's not only planned, but exercised and ready.

Q Why was the President not involved in this today?

MS. TOWNSEND: I think it's -- the President knows pretty clearly what his role is, and what this exercise was about was testing federal roles and the interagency coordination.

Thank you.

Q Secretary Chertoff, did you want to say something?

SECRETARY CHERTOFF: I was just going to add the fact that this is really about planning and putting capabilities in place. This is not something that we're saying is around the corner tomorrow, but it is something we have an opportunity to get ahead of. And if everybody at all levels of government takes the opportunity, we will put ourselves in a position to be ready if and when we have some kind of an outbreak.

Thanks a lot.

Q Is communication the biggest gap between the federal and state officials?

SECRETARY CHERTOFF: One more.

Q Given that you're going on the road next week.

SECRETARY LEAVITT: This is a time for us to be informing but not inflaming. It's a time for us to inspire preparation but not panic. We have time to become the first generation, literally, in the history of man to do something to be prepared for a pandemic. Pandemics happen. They've happened in the past, they'll happen in the future. This is about being ready for what inevitably will come. We're quite concerned now about this H5N1 virus as scientists suggest that it could, in fact, mutate into a virus of major concern. So we need to be ready.

Thank you.

Q Surveillance -- you mentioned the need for surveillance. Is that in the works or --

SECRETARY LEAVITT: It's actually expanding rapidly.

MS. TOWNSEND: Thank you.

END 12:53 P.M. EST

Press Gaggle After Avian Flu Tabletop Exercise with Homeland Security Advisor Fran Townsend, Secretary of Health and Human Services Michael Leavitt, and Secretary of Homeland Security Michael Chertoff

News - Bangkok Post Sunday 11 December 2005 - 16 nations vow to combat avian flu

The leaders of 16 countries in Asia and the Pacific are expected to issue a statement to express their concerns and pledge cooperation in the fight to combat avian flu, a senior official from the Asean secretariat said. The leaders of the 10-nation Association of Southeast Asian Nations (Asean) grouping will join those from China, Japan, South Korea, India, Australia and New Zealand at an inaugural East Asia Summit (EAS) in Kuala Lumpur on Wednesday to discuss issues of mutual concern. Their concerns over the spread of avian flu and pledge to cooperate in the battle to combat it are expected to be expressed in a statement, which will be issued separately from a joint end of summit declaration, the source said.

Australian Foreign Minister Alexander Downer said the 16 leaders would set the tone to the direction of the EAS. Australia believes the meeting will make a solid contribution to regional security and economic prosperity, he said.

A major focus for Canberra would be capacity building in education and technological development in Asia and the Pacific. Australia would fund a A$5 million (155 million baht) joint research project to help Asean countries develop closer economic links with other nations in East Asia.

Bangkok Post Sunday 11 December 2005 - 16 nations vow to combat avian flu

News - 5th bird flu patient receives 1st checkup after recovery

China's fifth patient contracted with human bird flu, a woman surnamed Liu from the northeastern Liaoning Province, was back at hospital Saturday for a thorough health checkup.

This is her first checkup after Liu was discharged from hospital on Nov. 29.

The No. 1 Hospital affiliated to the China Medical University in the provincial capital Shenyang conducted a CT (computerized tomography) test and collected Liu's blood samples for a comprehensive test of her immune system, including a chlamydial antibody test.

The results of the tests will be available on Monday, so Liu said she will spend the weekends in Shenyang.

Liu, wearing a red down-padded coat, was accompanied by her husband Guo Jiujun, three-year-old daughter and Wang Dong, a localgovernment official from her hometown in Heishan County.

"She couldn't have recovered without the timely and effective treatment," said Guo, who repeatedly thanked the doctors and nurses.

Liu, 31, was a chicken farmer in Fangshan town in Heishan County, which was hit by the H5N1 strain of highly pathogenic birdflu on Nov. 3. The town was declared free from the epidemic on December 1.

Liu got feverish on Oct. 30 with 38 degrees Celsius of body temperature. Then her condition worsened on Nov. 3, with more flu-like symptoms including coughs and shortness of breath. She suffered from respiratory exhaustion on Nov. 7, about one week after falling sick.

With prompt, successful treatment, Liu was discharged as healthy from hospital on Nov. 29, after no flu symptoms had been detected for 14 consecutive days.

Back home, the village doctor took her temperature twice a day, each time normal.

"We feel her immunity has enhanced and a relapse of the disease is unlikely," said Prof. Wang Qiuyue of the hospital's respiratory diseases department.

Liu, who had been much sought after by the media over the past month, told Xinhua in an exclusive interview Friday she felt well, and just wanted to "live simply and undisturbed". Enditem

Xinhua - English

News - Reuters AlertNet - Top Bush aides test bird flu preparedness

Warning an outbreak may be inevitable, the White House on Saturday conducted a test of its readiness for a feared bird flu pandemic and said federal agencies fared "quite well" without offering any details.

Cabinet secretaries, military leaders and other top officials took part in the four-hour tabletop drill, which officials said was designed to assess the level of federal preparedness for a possible outbreak of bird flu or another deadly virus.

"This is about being ready for what inevitably will come," Health and Human Services Secretary Michael Leavitt said.

But the White House refused to divulge details about the exercise and the test results, and officials said afterward that it was clear that state and local governments would have to assume a leading role.

"Quite frankly, I think we did quite well," White House homeland security adviser Fran Townsend said of the federal agencies that took part in the exercise.

The White House test came one day after a Thai boy became the 70th person to die of bird flu, which usually strikes those in close contact with infected fowl or their droppings.

Experts fear the deadly virus, known as H5N1, will mutate into a form that can easily infect and pass between people, causing a pandemic.

"We're quite concerned now about this H5N1 virus as scientists suggest that it could, in fact, mutate into a virus of major concern. So we need to be ready," Leavitt said.

HHS has projected that in a pandemic 92 million Americans will become sick and that as many as 2 million will die. Schools will close, businesses will be disrupted and essential services may break down.

"We currently have no evidence that a pandemic flu in this country is imminent. That said, we are fairly warned, and the time to prepare for that pandemic is now," Townsend said.

The preparedness drill was conducted in offices next to the White House.

Approximately 20 officials took part, including Townsend, Leavitt, Homeland Security Secretary Michael Chertoff and Marine Corps Gen. Peter Pace, chairman of the Joint Chiefs of Staff, White House spokesman Trent Duffy said.

U.S. President George W. Bush did not participate.

"The exercises are just that. It's a drill, it's meant to test, it's meant to push federal resources to the breaking point and to ensure that we're prepared, that we identify gaps and then we plan to fill them. We accomplished that this morning," Townsend said.

She said the biggest lesson from the test was the leading role that state and local governments would have to play in responding to a pandemic.

"This is not going to be a federal answer to the problem," she said. "The federal government has got a support role to play. But frankly, I think, really very important is the state and local efforts."

Leavitt said officials discussed at length how they would deal with limited U.S. supplies of antiviral and vaccines.

"We lack the capacity in this country to manufacture the number of courses needed to give everyone a vaccine," Leavitt said, adding that the United States also needed a surveillance system to detect the virus before it spreads.

Bush, who went for a bike ride in Maryland during the preparedness drill, has proposed a $7.1 billion bird flu plan, but Congress has yet to fund it.

The plan calls for building stockpiles of influenza drugs, which would not provide a cure but which might help make the most vulnerable patients less ill.

"We urge Congress to fully fund the president's strategy," Townsend said.

Reuters AlertNet - Top Bush aides test bird flu preparedness

News - CBC News: B.C. farms declared free of bird flu


The federal food watchdog has lifted a quarantine on dozens of poultry farms in British Columbia's Fraser Valley, saying they are free of avian influenza.

The Canadian Food Inspection Agency officials said Saturday that 21 days of testing turned up no sign of the disease on about 80 chicken and duck farms that had been quarantined.

The measure was originally imposed as a precaution after a low-pathogenic strain of the H5N2 virus was detected in November at a duck farm near Chilliwack and another near Abbotsford.

FROM NOV. 22, 2005: Bird flu found on second B.C. farm

Canadian Food Inspection Agency officials quickly determined the virus wasn't from the same deadly strain that has been blamed for killing at least 65 people in Asia since 2003 and led to the cull of millions of birds.

However, they imposed a quarantine on any operation that lay within a five-kilometre radius of either of the two infected B.C. farms.

On Saturday, CFIA veterinarian Cornelius Kiley said officials were confident the virus hadn't spread.

He said health officials would next focus their energies on trying to get other countries to lift bans on imports of poultry from British Columbia.

FROM NOV. 21, 2005: United States bans B.C. poultry

The United States, Japan, Taiwan and Hong Kong had all imposed temporary bans.

The two farms where the virus was detected will remain under quarantine until the area has been completely disinfected, Kiley said.

British Columbia's poultry industry was devastated in 2004 when the highly infectious H7N3 strain of bird flu spread rapidly from barn to barn, leading to a cull of more than 16 million birds in the Fraser Valley.

FROM APRIL 10, 2004: Avian flu detected on more B.C. farms

Copyright �2005 Canadian Broadcasting Corporation - All Rights Reserved

CBC News: B.C. farms declared free of bird flu

News - ABC News: Calif. Hunters Aid U.S. Bird Flu Defense

The first line of defense against the bird flu is early detection, so in California, scientists are enlisting an unusual ally -- hunters.

Side-by-side, the hunters and scientists are looking for birds migrating from infected Asia.

"Basically, hunters are sampling the birds for us," said Dr. Walter Boyce, executive director of the University of California-Davis Wildlife Health Center. "So when they bring the birds in, we can take our samples to see if those birds are infected with avian influenza virus.

"These swabs basically just give us a window of what is inside the birds, inside their intestinal tracks," he added.


Birds from Asia
California is under a microscope because it is part of what's called the Pacific Flyway, a migration path that includes birds from already infected parts of northeast Asia. They arrive in Alaska, then fly south through California on their way to South America.

That's unwelcome news for a lifelong hunter like Frank Melendez.

"To hear that those birds may mingle and work into this fly zone is something to be aware of," Melendez said.

California Fish and Game officers are cautioning hunters to wear latex gloves when handling dead birds.

Soon, hunters in other states will be doing that, too. The U.S. Dept. of Interior has requested $11.5 million for a national wildlife surveillance program in 2006.

If the virus ever reaches the U.S., researchers say the best defense will be to detect it early.

"The stakes are certainly very high with this virus," said Dr. Carol Cardona, a University of California-Davis researcher. "It has done things we have never seen before with influenza viruses."

The concern with migrating birds is that they travel over such a large area. Zoos nationwide are trying to figure out how to protect outdoor exhibits where wild birds can mix with zoo birds. Poultry farmers are working to avoid cross contamination with wild birds that may fly in -- by keeping chickens indoors and their feed covered.

"The Asian virus is a highly pathogenic virus," said Jim Haley, a farmer. "It if came to my flock, it would devastate them."

While so much attention is already focused on bird flu vaccine, the University of California-Davis scientists face the challenge of determining whether the virus is already in the seemingly endless sea of birds.

ABC News' Neal Karlinsky originally reported this story for "World News Tonight" on Dec. 10, 2005.

Copyright � 2005 ABC News Internet Ventures

ABC News: Calif. Hunters Aid U.S. Bird Flu Defense

News - Thailand's Thaksin Urges Caution After Bird-Flu Death (Update1)

Thailand's Prime Minister Thaksin Shinawatra ordered health officials and citizens suffering flu- like symptoms to be more alert to the possibility of avian influenza, after the country's 14th human fatality.

Thailand's Health Ministry yesterday confirmed a five-year- old boy had died of the H5N1 strain of bird flu, the country's fifth confirmed human infection and second death this year, following a resurgence of the virus since October.

``The boy's relatives didn't inform the doctors that some of the chickens in their house were dead, so the doctor didn't know the risk of bird flu until the lab results came out, when it was too late to cure with medicine,'' Thaksin said in his weekly radio address today. ``We have asked all medical staff at hospitals nationwide to be more cautious of patients with flu- like symptom. We have to be more cautious to prevent any further bird flu deaths.''

More infections are likely this month, a World Health Organization official said this week, citing outbreak patterns over the past two years. The disease has spread among poultry in Vietnam, increasing the risk that avian flu will infect more people and could potentially mutate into pandemic influenza.

Thailand's Health Ministry is closely monitoring 14 of the dead boy's relatives and treating them with anti-viral drugs, though none have shown symptoms of the virus, Thaksin said. Officials have culled chickens in the village.

Cheap Drugs

Thaksin also confirmed that Thailand is capable of producing a cheaper version of oseltamivir, an antiviral drug commercially known as Tamiflu, using local ingredients and some imported from India.

``With this achievement, the cost of Tamiflu generics is only 70 baht ($1.69) a capsule, compared with 120 baht a capsule for the original drug,'' Thaksin said in today's radio broadcast.

Thailand's Government Pharmaceutical Organization is equipped to manufacture 5 million capsules of the drug, the Bangkok Post reported Dec. 8, citing director Mongkol Jivasantikarn.

Bio-equivalent testing and medical safety tests still need to be conducted on the Thai version of the drug, the newspaper reported. Roche Holding AG, which produces Tamiflu, doesn't hold a patent for the drug in Thailand.

Oseltamivir can reduce the severity and duration of illness caused by influenza. Its use as a prophylactic treatment may help control the spread of any pandemic virus, according to the World Health Organization.

Two Years

Avian flu has infected at least 135 people the past two years in Vietnam, Thailand, Indonesia, Cambodia and China and killed 69 of them, Geneva-based WHO said on Dec. 7. At least 42 people have died from the disease in Vietnam and 13 in Thailand, it said.

Bird flu infected 17 people and killed 12 of those in Thailand between January and October 2004. It resurged 12 months later when a man died on Oct. 19 after slaughtering and eating a sick chicken. His son survived an infection.

Thailand, Southeast Asia's second-biggest economy, has culled more than 40 million chickens since the initial outbreak to thwart the spread of the virus.

Bloomberg.com: Asia

Friday, December 09, 2005

News - Reuters AlertNet - Reports detail bird flu effects on U.S.

A pandemic of bird flu could cause a serious recession of the U.S. economy, with immediate costs of between $500 billion and $675 billion, according to two estimates released on Thursday.

Both assume the H5N1 avian influenza now destroying flocks of poultry across Asia and parts of Europe makes the jump into humans and causes serious disease.

So far, H5N1 has killed 69 people and infected 135, but world health experts say it is very close to mutating into a form that easily passes among people.

If it does, it would likely closely resemble the 1918 pandemic strain of flu that killed anywhere between 20 million and 100 million people during World War I, both reports say. This means 30 percent of the population would be infected and more than 2 percent would die, the report from the Congressional Budget Office presumes.

"Further, CBO assumed that those who survived would miss three weeks of work, either because they were sick, because they feared the risk of infection at work, or because they needed to care of family or friends," the report reads.

"In addition to workers' absences, many businesses (such as restaurants and movie theaters) would probably suffer a falloff in demand because people would be afraid to patronize them or because the authorities would close them."

Doctor's offices and hospitals would be overcrowded, the CBO predicts.

"Currently, the United States has approximately 970,000 staffed hospital beds and 100,000 ventilators, with three-quarters of them in use on any given day. As a result, shortages could occur in critical areas such as ventilators, critical care beds, and drugs to treat secondary infections," the report reads.

HOSPITALS SPREADING INFECTION

Hospitals would have difficulty controlling infection and might become sources for spreading the illness, the CBO said -- a fear echoed by another group, the National Center for Policy Analysis .

A second report from New Jersey based WBB Securities LLC estimated 35 percent of the population would become ill and 5 percent would die.

It predicts a one-year economic loss of $488 billion and a permanent economic loss of $1.4 trillion to the U.S. economy.

"If the influenza affected humans at the same level of virulence as the current H5N1 strain, practically all patients would require hospitalization, which would result in a shortage of some 6.5 million hospital beds per day during the pandemic," the WBB report reads.

"Police, fire, sanitation and other critical service providers will be strained with short staff and overtime work, which will impact municipal and state budgets," it adds.

"There may even be civil disturbances caused by people who either believe they can take advantage of the situation or who feel they have little chance of survival so they may as well enjoy themselves while they can."

The reports support other predictions that have been made about the potential effect on the U.S. economy. The World Bank has predicted a pandemic could cost the global economy $800 billion a year.

U.S. President George W. Bush released a $7.1 billion bird flu plan in November but Congress has yet to fund it. Senate Majority Leader Bill Frist said he hopes for legislation before the recess this month, but many conservatives are afraid the deficit is already too big and want to make cuts to pay for the spending.

One part of the plan involves building stockpiles of influenza drugs, which would not provide a cure but which might help make the most vulnerable patients less ill.

Reuters AlertNet - Reports detail bird flu effects on U.S.

News - China confirm fifth human case of bird flu


A suspected human case of bird flu in October has been confirmed, the Ministry of Health said last night.

Nurses cordon a corridor inside a hospital as part of a drill on the outbreak of bird flu in Hong Kong November 8, 2005. [Reuters]
It is the fifth human infection China has reported in the past two months. Of the other four, two were reported in East China's Anhui Province, and one each in Central China's Hunan Province and South China's Guangxi Zhuang Autonomous Region.

The latest victim is a 31-year-old woman surnamed Liu from Heishan County in Northeast China's Liaoning Province.

She had symptoms of acute pneumonia, such as high fever and breathing difficulty, on October 30. She later recovered and was discharged from hospital on November 29.

Experts had known that she owned chickens which died of bird flu and kept a check on her.

She tested negative for laboratory tests before December 5 but on that day, experts from the Chinese Centre for Disease Control and Prevention tested her blood samples again and she tested positive for the deadly H5N1 strain of the virus.

All the people who had close contact with her are free from the disease.

Of the four earlier cases, the two in Anhui are dead. The Hunan boy has recovered and the girl in Guangxi, who was confirmed with the infection on Tuesday, is still in hospital.

Meanwhile, the State Forestry Bureau yesterday set up a State-level surveillance station for wild-life epidemics in Shenyang, capital of Liaoning Province.

The station will monitor various infectious diseases and their sources among wild animals, especially migratory birds, Zhao Liangping, director of the station, said yesterday.

Migratory birds have been confirmed by scientists as one of the carriers of the avian influenza virus.

China confirm fifth human case of bird flu

News - CBS News | Thai Boy Dies Of Bird Flu | December 9, 2005?01:33:34


Public health officials have confirmed that a 5-year-old boy in central Thailand died of bird flu, the government said Friday.

The boy died Wednesday in Nakhon Nayok province, and lab tests on Thursday confirmed he had been infected with the deadly H5N1 virus, said Thawat Suntrajarn, director-general of the Department of Communicable Disease Control.

"We can confirm that he died from the H5N1 strain of bird flu," Thawat said by telephone, adding that the boy died Wednesday afternoon.

The boy came from the Ongkarak district of Nakhon Nayok, 45 miles northeast of Bangkok.

Public health officials said the boy had been sick for nine days before being hospitalized, and that his parents failed to tell doctors that the family raised chickens at home. Officials said a relative, who lived in the same house, was raising about 10 chickens that had recently died.

The boy was taken to the hospital too late and was not given the proper medicine, said the official, who spoke on condition of anonymity because she is not authorized to speak to the media.

He is the 22nd person in Thailand to contract the H5N1 bird flu virus, and the 14th bird flu fatality. At least 70 people have died of bird flu in Asia.

CBS News Thai Boy Dies Of Bird Flu December 9, 2005?01:33:34

News - Surfbirds News: Autumn waterbird migration ends without spread of H5N1 bird flu

As the year draws to a close, millions of wild birds have flown to their wintering sites across, Asia,
Africa, Europe and the Americas without the widely predicted outbreaks of H5N1 bird flu associated with their migration routes.

"The most obvious explanation is that migrating wild birds are not spreading the disease," said Dr Michael Rands, Director & Chief Executive of BirdLife International.

"Migratory wild birds were blamed for spreading bird flu west from Asia, yet there's been no spread back eastwards, nor to South Asia and Africa this Autumn. The limited outbreaks in eastern Europe are on southerly migration routes but are more likely to be caused by other vectors such as the import of poultry or poultry products. The hypothesis that wild birds are to blame is simply far from proven," said Dr Rands. "Wild birds occasionally come into contact with infected poultry and die: they are the victims not vectors of H5N1 bird flu."

BirdLife maintains that better biosecurity is the key to halting the spread of bird flu.

In particular, BirdLife is urging governments and relevant agencies to concentrate their efforts on the poultry and cage bird trades and to impose the following prevention measures:

* Banning the movement of poultry and poultry products from infected
areas
* Banning the use of untreated poultry faeces as fertiliser and feed in
fish-farms and in agriculture
* Restricting the international movement of captive birds in trade

"Implementing measures like these are proven to work," says Dr Rands. "For example, Malaysia and South Korea both experienced bird flu outbreaks through importing infected poultry products, but stamped the disease out and have remained disease free through improved biosecurity. In the mean time, hundreds of thousands of waterbirds have arrived to winter in, or migrated through South Korea, and many migrant waders have passed through Malaysia."

"Better biosecurity is the key to controlling the disease's spread," said Dr Rands. "But the virus can rapidly mutate, so it's important to monitor wild bird populations to look for evidence of new strains
arising."

Surfbirds News: Autumn waterbird migration ends without spread of H5N1 bird flu

News - More Human Flu in China

China has announced a fifth human case of bird flu, as early results showed the deadly H5N1 strain of the virus was present in Ukraine.

Xinhua news agency said a 31-year-old female farmer fell ill with pneumonia-like symptoms after contact with dead birds in the northern Liaoning province, where there has been an outbreak of the disease among birds.

"The Ministry of Health reported on December 8 that a pneumonia case of unknown reason in Heishan county, Liaoning province, has been confirmed as deadly H5N1 bird flu," Xinhua said.

Following treatment at a hospital, the woman recovered and was discharged on November 29.

There have been two deaths among China's other four bird flu cases. A 10-year-old girl is currently undergoing emergency treatment for the disease in the southern region of Guangxi after falling ill on November 23.

It was unclear how she contracted the virus and investigations were ongoing.

The lethal H5N1 strain of bird flu has claimed almost 70 human lives in Asia since late 2003.

Thirty H5N1 outbreaks among birds have been confirmed across China this year.

The World Health Organisation (WHO) warned on Wednesday that more outbreaks were likely in China over the next few weeks.

China is seen as a potential flashpoint for a feared global pandemic because it has the world's biggest poultry population and is on three major global routes taken by migratory birds.

Ukraine tests

The lethal H5N1 strain is suspected in poultry that died en mass in the northeast corner of Ukraine's Crimea peninsula last week, according to preliminary test results.

Ukraine's former chief veterinary inspector, Pyotr Verbitsky, said preliminary results from a Russian lab showed the presence of H5N1.

"But the tests continue and tomorrow it will be known for certain," Interfax quoted Dr Verbitsky as saying.

President Viktor Yushchenko fired the chief vet this week for what he said was un-preparedness for a bird flu outbreak.

Mr Yushchenko declared a state of emergency in the affected areas of Ukraine's southern peninsula in the Black Sea and the villages where the H5 virus has
been confirmed have been placed under quarantine.

The poultry is thought to have contracted the virus from wild birds, millions of which use the nearby Sivash saltwater lake as either a wintering site or a stopover point on their winter migration route.

In Asia meanwhile, North Korea was to begin quarantining people with high fevers because of concerns over a possible bird flu outbreak, a South Korean news report said.

Pyongyang would step up quarantines to check airline attendants and sailors coming from overseas for symptoms of bird flu.

North Korea has reported no outbreaks of bird flu this year, but its reclusive leader Kim Jong-Il himself issued a rare public call in November for concrete precautions to prevent the disease.

Vaccines hampered

As countries in Europe and Asia stepped up bird flu monintoring, a British virologist says efforts to control the spread of bird flu in Southeast Asia were being hampered by the use of ineffective and often fake agricultural vaccines.

Such animal vaccines could be increasing the threat of the virus evolving and being able to pass to humans, US-based WHO animal flu specialist Robert Webster said.

He has called for more rigorous minimum standards for agricultural vaccines.

"There are good vaccines and bad vaccines. Good vaccines reduce virus load; bad vaccines stop the signs of disease but the virus keeps replicating, spreading and evolving," he told reporters in London.

In Asia, the potentially deadly H5N1 strain has already split into as many as five different lineages, he said.

Drug production boosted

Swiss drug giant Roche Pharmaceuticals has made agreements with 15 laboratories in the US to produce extra quantities of its Tamiflu medicine to counter avian flu.

US Senator Charles Schumer said Roche ? which holds the exclusive rights to manufacturing Tamiflu ? was about to announce the accords, but he said the deal depends on the US government and other countries making firm orders for the drug.

Mr Schumer urged the US administration and Congress to act quickly to vote money to build a stocks of Tamiflu, considered the most effective drug to counter H5N1.

SBS - The World News

News - RIA Novosti - World - Dangerous H5N1 bird flu strain found in Crimea


KIEV, December 8 (RIA Novosti) - The dangerous H5N1 bird flu strain, which has led to fatalities in Asia, has been discovered in the Crimea, the Black Sea autonomy, Vyacheslav German, an official with the Ukrainian Ministry of Agricultural Policy, said Thursday.

Petro Verbitskiy, a member of the government commission investigating the outbreak, said tests done in a Russian laboratory had proved the findings and that the final results of the investigation could be expected soon.

Ukraine also sent dead birds to a British laboratory for analysis.

The Ukrainian leadership recently imposed a state of emergency in the Crimea. Poultry imports from the area were banned and mass vaccinations of the population are under way.

RIA Novosti - World - Dangerous H5N1 bird flu strain found in Crimea

Thursday, December 08, 2005

News - Avian flu scare has Tamiflu maker navigating minefield

BASEL, Switzerland ? With its sales stoked by fears of an avian flu pandemic, a drug once considered a dud has turned into one of the world's hottest medicines. The anti-viral Tamiflu has emerged as the best available medicine against the H5N1 avian flu virus, which has killed 69 people in Asia since late 2003.

More than 50 governments are beating a frantic scramble to the door of Tamiflu's maker, Roche Holdings, ordering hundreds of millions of the yellow-and-white capsules for national stockpiles.

Multinational companies are buying all the Tamiflu they can to protect globe-hopping employees. And so many U.S. consumers were stashing away Tamiflu that Roche in October temporarily halted shipments, fearing there might not be enough later in the season for people with the regular flu.

The avian flu scare has raised Roche's profile and profits. Tamiflu's revenue is up 263% for the year through September to 859 million Swiss francs (about $650 million). But Tamiflu's serendipitous success has also brought the Basel, Switzerland-based Roche a host of delicate management challenges.

The company says it is doing all it can to increase its Tamiflu production and has said it will let other companies make it, too. But critics accuse Roche of being overprotective of its interests and moving too slowly to sanction other manufacturers. They want Roche to allow large-scale production ? even if it hurts profits.

"At the end of the day, Roche is just a company protecting shareholders," says James Love, head of the non-profit Consumer Project on Technology in Washington, D.C. "It wants to restrict access and restrict manufacturing so that prices stay strong for the drug."

Roche also is navigating a tricky minefield in which expectations for Tamiflu as a pandemic stopper may be unrealistic. There's no certainty that Tamiflu will be effective against H5N1, Health and Human Services Secretary Michael Leavitt told Congress recently.

"They're in a difficult situation," says Joseph D'Cruz, professor of strategic management at the Rotman School of Management at the University of Toronto. "They could be painted into a corner of being cold-blooded profiteers or if ... they sweep aside all commercial concerns, they have the possibility of a win," in terms of reputation if not in profits, he says.

Tamiflu stops the spread of the regular flu virus when taken soon after symptoms appear, which helps people recover faster. It's also been approved to prevent the flu. Should a cluster of avian flu cases break out in humans, the World Health Organization's plan is to flood that region with Tamiflu in hopes of containing the outbreak.

Tamiflu has proved effective against H5N1 in mice in laboratory tests. So far, the virus has not shown that it can readily pass between humans. But the fear is that it will mutate so that it can, setting off a pandemic that could kill millions because humans have no H5NI immunity.

Drugmakers and controversy

Major drugmakers are no stranger to controversy when public health emergencies arise.

A few years ago, the industry was criticized for charging prices for anti-HIV drugs that African and Brazilian governments couldn't afford. Drugmakers eventually cut prices for those countries, some to cost.

In 2001, Bayer cut the price of antibiotic Cipro under pressure from the U.S. government after letters containing anthrax spores were sent to politicians and others.

Roche says it isn't on a collision course with any country regarding Tamiflu. The company recently announced plans to bump Tamiflu production to 300 million treatments by 2007 vs. 27 million last year. It's donated 3 million Tamiflu treatments ? typically 10 pills over five days ? to the WHO. It's also cut Tamiflu government stockpile prices more than 40%.

Roche first doubled Tamiflu production in 2004 after a major avian flu outbreak in poultry in Asia, even though Roche had seven years of unsold Tamiflu inventory.

Roche is taking a similar risk now, says William Burns, CEO of its pharmaceutical division. While Tamiflu's demand currently exceeds supplies, Burns says, Roche doesn't yet have enough orders to eat up all the capacity it's putting on line.

Roche says it doesn't want to let just any company make Tamiflu because it wants to assure that the drug is properly made. It has held talks with 15 entities, among them large makers of generic drugs and a few governments.

While Tamiflu grabs headlines, Burns says, governments need to pay more attention to other pandemic preparations, such as increasing hospital beds and doctors.

"Tamiflu will be a key part of the response to a pandemic, should it break out, but it cannot be the only response," Burns says. "I'm not afraid of us taking our responsibility. But I wouldn't then want society to dump on Roche and say we're the problem child."

Roche already has been accused of worse. "They're getting rich as the world gets sick," says Rep. Dennis Kucinich, D-Ohio. "The company is able to control the supply and the price (of Tamiflu), and it's very dangerous for the health of this country to let them make all the decisions."

Kucinich and nine other lawmakers have urged the Bush administration to invoke the World Trade Organization's TRIPS Agreement. In a public health emergency, TRIPS allows countries to ignore patent protections for needed drugs. Others can make them without patent holders' consent, but the patent holder must be paid. The process is called compulsory licensing.

The idea had been discussed in Taiwan, but Roche said last month that it can make the drug faster and more cheaply than a Taiwanese company. It has also agreed to provide Taiwan with 1.3 million more Tamiflu treatments this year for a total of 2.3 million.

Tamiflu is not patent protected in some countries, including Indonesia. That means the drug can be made there without compensation to Roche. Indonesia has said it would make its own Tamiflu for domestic consumption.

Even if Roche lets some companies make Tamiflu, Kucinich says there still won't be enough. Public health officials recommend countries have enough Tamiflu for 20% of the population. The U.S. has ordered 4.3 million doses, enough for about 1.5%. The Bush administration has proposed stockpiling enough Tamiflu and rival anti-viral, Relenza, for 81 million people.

In addition to trying to make sure Tamiflu is properly made, Roche has legitimate business motives for wanting to retain control over Tamiflu, says John Calfee, an economist at the American Enterprise Institute. If the company were to allow broad Tamiflu manufacturing, it could lose control of the product for years to come ? even if there is no pandemic. "Everyone would keep making it and take their market," Calfee says.

Only by limiting the number of manufacturers does Roche have a chance of retaining the value of Tamiflu, which is patent protected until 2016, Calfee says. Profits on patented drugs fund new drug development.

Roche's Pitfalls

By controlling production, though, Roche could be blamed if there isn't enough Tamiflu if a pandemic hits. "They are damned if they do and damned if they don't" open up manufacturing, D'Cruz says.

Other pitfalls for Roche include:

?Excess product. Tamiflu capsules have a shelf life of five years. If there isn't a pandemic, the world will be flooded with Tamiflu, leaving little opportunity for new sales, Calfee says. "Roche could make lots of doses, and no one will use them," he says.